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ABSTRACT 
This thesis describes the design, development and testing of 
a mixed suspension, mixed product removal (MSMPR) 
crystalliser and an on-line flow cell for use in conjunction 
with a Mal vern Particle Size Analyser. In addition, in 
vitro exper iments are described in which this system was 
used to determine the rate of calcium oxalate 
crystallisation in minimally diluted urine. 
The MSMPR was designed according to chemical engineering 
principles and tests showed that it conforms to the 
assumptions necessary for conventional MSMPR analysis. 
Various crystalliser offtakes and six system designs were 
developed and tested to allow measurements using the 
thermostatted flow cell. The flow cell allows for 
continuous measurement of the sample dispersion using a non-
invasive monitoring instrument - a Malvern Particle Size 
Analys~r. In this technique, measurement of the steady 
state cryst al size distribution is based on a diffraction 
pattern produced by the particles in a parallel beam of 
monochromatic light. Comparative measurements were obtained 
by sampling directly from the crystalliser and analysing the 
product in a Coulter Counter. In this technique, the steady 
state crystal size distribution is measured by the change in 
resistance as particles, in an electrically conductive 
liquid, pass through the Coulter aperture. 
Due to the large volumes required by the 
crystalliser, it was necessary to pool urines. Aliquots of 
volume 1. 5 dm3 from the 24 hour urines of each of 8 male 
controls were pooled. The first series of experiments were 
performed to investigate the effect on calcium oxalate 
crystallisation of varying the concentration of sodium 
oxalate solutions used to initiate crystallisation, and also 
to investigate the effect of varying the temperature. A 
further series of experiments was performed to determine the 
effect of adding inhibitors individually (citrate, 
magnesium, chondroitin sulphate A) and in combination 
(citrate and magnesium). 
The inhibitor experiments were performed using two different 
approaches. In the first, the pooled urine was pre-treated 
with the inhibitor prior to being introduced into the 
crystalliser. In the second set of experiments, the 
inhibitor was introduced into the crystalliser via a 
separate, i ndependent feed. It is suggested that these 
approaches represent crude models respectively of (a) the 
endogenous presence of inhibitors and 




Each indiv idual experiment was performed using three 
different urine pools. The steady state crystal size 
distributions obtained from both the Coulter and the Malvern 
instruments were used to determine nucleation and growth 
rates in e ach urine. Scanning electron microscopy was used 
to obtain qualitative and semi-quantitative data related to 
crystal mor phology, number, size and degree of aggregation. 
Both nucle ation and growth rates increased as the 
concentrati ons of the initiating sodium oxalate solutions 
increased. Nucleation and growth rates also increased with 
increasing temperatures. In the latter series of 
experiments , different calcium oxalate crystal phases 
precipitated at the various temperatures. 
Citrate inh ibited nucleation and growth of calcium oxalate, 
irrespective of how it was admitted to the crystalliser. 
Magnesium was found to inhibit growth only and, like 
citrate, t h is role was independent of how it was introduced 
into the c r ystalliser. Although both inhibited growth, the 
effect of the citrate was greater. When both components 
were added in combination, inhibition was observed to be 
additive. In all cases, inhibitory effects increased with 
increasing concentration. 
Chondroitin sulphate A was found to inhibit nucleation; 
inhibition of growth was minimal at the concentrations 
tested. Aggregation of calcium oxalate crystals was found 
to be inhibited by chondroitin sulphate A. 
The results of the calcium oxalate crystallisation kinetic 
studies, obtained by using Malvern particle sizing and 
Coulter Counter techniques independently of each other, 
showed general agreement. These results, in turn, were in 
agreement with the published results of others, thereby 
lending confidence to the findings and highlighting the 
potential application of the non-invasive continuous 
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I.l EPIDEMIOLOGY OF URINARY STONE 
DISEASE 
1 
stone disea se can occur in various organs and glands in the 
human body , including the kidney, bladder, prostrate, 
salivary gland and pancreas [Lonsdale 1968a; Rodgers and 
Spector 1981]. Of the different kinds that can occur, 
urinary cal culi are probably the most clinically important. 
As a result there has been continual development of 
research t e chniques in an attempt to gain insight into the 
aetiology a nd physiochemical mechanisms of urinary stone 
formation. 
Bladder stones can be traced back as far as Egypt 4800BC 
[Clarke 1968]. Differentiation between vesical (bladder) 
and renal (kidney) stones was noted by Hippocrates (460 -
370BC) [Pri en 1971; Joly 1931 cited by Blacklock 1982]. 
Also known at this time was the technique of lithotomy 
(method of cutting for stone) ; mention was made in the 
Hippocratic oath that such operations should be carried out 
by special i sed lithotomists only [Prien 1971]. Surgical 
improvements were made in the 3rd century with the 
technique of lithotrity used by the Greek physician 
Ammonios. The process involved mechanically breaking up 
the stone so that it could be passed harmlessly in the 
urine. The disease afflicted so many people that 
exploitation up to the 17th century by a wandering band of 
lithotomists was inevitable. Unfortunately, they often 
caused more harm than good. 
In an attempt to alleviate the necessity for the difficult, 
painful and dangerous operations, herbal remedies for stone 
disease were concocted. The most famous of these was that 
of the 18th century charlatan Joanna Stevens [Prien 1971; 
Rodgers and Spector 1981]. The popular remedy, certified 
by physicia ns and supported by the prime minister at the 
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time Sir Horace Walpole, was later found to contain no 
stone rel~eving substances at all [Joly 1931, cited by 
Prien 1971]. 
Early insight into the causation of stone disease was shown 
by Celsus (23BC . - 45AD) who attributed its formation to 
bile, mucus and. wind. Modern day variables such as 
nutrition, heredity and climate were later described by 
Galenus (131- 201AD) [Lonsdale 1968a]. 
In more contemporary times, the incidence of bladder .stones 
has been r eported to be on the decline in technical~y 




endemic · stone regions. These are regions in 
i ncidence of stone disease per capita is higher 
r est of the country. Examples of such areas 
include northwest India, southern China, Japan and 
Thailand. These were identified long ago by Joly 1939 
(cited by [Prien 1971]) who also noted a prevalence of the 
disease in c hildren from agricultural regions. 
In contrast to vesical calculus [Norlin et al. 1976], there 
has been a n increase in renal calculus in first world 
countries s ince the late 19th century. Afflicted areas 
include Europe, North America and Japan [Blacklock 1982]. 
The disease has shown a predominance in males, who have 
double the s tone incidence of females [Hesse et al. 1986a]. 
Recurrence r ates in both sexes have been quoted as high as 
75% [Williams 1963] and 67% [Blacklock 1969]. 
A definite correlation has been made between stone belts 
and climate. Exposure to UV radiation has been shown to 
increase c a lcium uptake in the intestine [Robertson and 
Peacock_ 1983; Schwille and Hermann 1992] while an increase 
in atmospheric temperature has also been directly related 
to stone incidence. The latter factor causes an increased 
frequency of dehydration leading to concentration in the 
urinary tract of stone forming salts which are unable to 
pass in the urine [Embon et al. 1990; Schwille and Hermann 
1992]. St one occurrence in workers exposed to high 
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temperature s [Blacklock 1969,1982; Rose 1982] (eg cooks, 
desert trqops) are t~stimony to the necessity of a high 
fluid intake in such enviroments [Better et al. 1978; Fuss 
et al. 1979 ; Milvy et al. 1981; Robertson and Peacock 1983; 
Ferrie and Scott 1984; Pak et al. 1980,1984; Vahlensieck 
1986; Rodgers 1991]. Mates (1969) also noted a link 
between sedentary work and increased stone risk [Blacklock 
1969]. 
Several studies have addressed the question of whether tap 
water · composition (with particular reference to hard and 
soft water) is related to the incidence of kidney stones or 
not. However, the results of such investigations have been 
inconclusive. Some studies have reported a higher 
incidence o f urolithiasis in soft water areas [Rose and · 
Westbury 1975; Churchill et al. 1978), and others have 
found that water hardness is correlated with a low 
incidence o f urinary calculi [Sierakowsky et al. 1976; 
Juuti and Heinonen 1980). However, several investigators 
have failed to find any correlation between water hardness 
and urinary stones [Donaldson et al. 1979; Shuster et al. 
1982; Power et al. 1987; Singh et al. 1989]. 
To maintain a high fluid intake, many people drink bottled 
water rathe r than tap water. Mayne and Edwards (1990) 
conducted t ests on bottled water in the United Kingdom and 
have warned of the possible increase in calcium intake from 
some brands of bottled water. On the other hand, Jaeger et 
al. ( 1984) and Trinchieri et al. ( 1995) conclude that the 
calcium content of water is not of primary importance in 
either causing or preventing urinary calculi. 
Another c ontributing factor in urolithiasis is diet 
[Robert:son 1985; Breslau et al. 1988; Trinchieri et al. 
1991; Hesse et al. 1993; Goldfarb 1994; Hesse 1995; Siener 
and Hesse 1995). In modern day western diets, there is an 
ever increasing consumption of foodstuffs containing 
lithogenic substances [Vahlensieck 1986). Dairy products 
contain calc ium, phosphorous and lactose, all of which have 
been regarded for some time as being lithogenic. The 
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importance of diet is discussed in more detail in Chapter 
I. 3 under ."Diet". 
Besides diet, genetic, racial and heredity factors [McGeown 
1960] also play a role in urolithiasis. For example, South 
African blacks, Eskimos and the Indians of Peru and Mexico 
appear to be immune to this disease. 
The multif ctorial aetiology of stone disease [King 1967; 
Robertson et al. 1981; Blacklock 1982] illustrates the 
challenge faced by investigators in this field. Stone 
incidence figures quoted in the literature highlight the 
incre~sing necessity for the continuation of urinary stone 
research i n attempts to identify possible therapeutic 
andfor prophylactic measures. 
I.2 PHYSIOCHEMICAL ASPECTS 
I.2.1 PROCESSES INVOLVED IN CRYSTALLISATION 
Crystallisation from solution refers to the formation of 
solid particles and therefore to the creation of a new 
phase. In urine several distinct crystallisation processes 
must occur in order for a stone to form. These are 
supersaturation, nucleation, , growth, and aggregation 
[Finlayson 1978]. It is the understanding of the 
mechanisms which govern these processes and their 
interrelati on, using physicochemical principles [Nancollas 
et al. 1991 ] and modelling [Ramanarayan et al. 1984], that 
is the goa l of stone research today. 
Supersaturation 
For crystal lisation to occur in any medium, the solution 
must be supersaturated with respect to the mineral phase 
[Ryall et al. 1985]. Early research by Andrews et al. 
(1955) using equilibration of urine with excess pure salt 
and by Miller et al. (1958) using a precipitation test, 
both demons trated . that urine is normally supersaturated 
with respec t to calcium oxalate (CaOx). This has been 
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confirmed by more recent studies which have shown that 
there is a high level of caox supersaturation in urines 
from healthy controls and an even higher level in recurrent 
stone formers [Robertson et al. 1971,1976a]. 
It has bee n recognised that spontaneous crystallisation 
does not occur in "just-saturated" urines [Nancollas et al. 
1991]. Indeed, at certain levels of supersaturation 
nucleation will not occur. Even at levels where nucleation 
would be expected, the introduction of seed crystals is 
sometimes necessary to induce precipitation [Robertson and 
Nordin 1976]. 
The significance of a urinary metastable region in urine 
with respect to urolithiasis risk factors was first 
highlighted by Robertson and Nordin {1976). This state 
occurs when the salt (eg CaOx) is in equilibrium with its 
surrounding medium (urine) . It is in this region that 
spontaneous "homogeneous" nucleation may not take place (ie 
endogenous crystals are not present). However, 
"heterogeneous" nucleation can be initiated by the addition 
of seed crystals (which are of different composition to 
that of the endogenous material). 
Thermodynami cally, supersaturation can be expressed as free 
energy change {~G): 
. . . . . . . . . . . . . . . . . . 1 
where R is t he gas constant, T is the temperature and Ai,Ao 
are the a ctivities of the unionized salt species in 
solution under any given conditions and at equilibrium 
respectively . 
Equation 1 s hows that varying degrees of saturation depend 
upon the r elationship between the activities of the 
unionised s a lt species in solution [Finlayson 1978]. 
Thus, supersaturation in urine can be calculated using 
activities of the ionic species present. The method, first 
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developed by Robertson [Robertson et al. 1968; Robertson 
1969b; Finlayson 1978], uses ab initio calculations of mass 
action and conservation of mass equations. Measurements of 
the pH and total concentrations of all the main ionisable 
species in urine enable the calculation of the activity of 
ionised cal cium to be made. From this, the concentrations 
of all ot her ions in the system can be calculated. 
Relative s upersaturation for each stone .forming salt is 
then determined by comparison of the activity products with 
known solubility and formation products. 
Approximations involving this method were introduced by Pak 
and Chu (1973) and later by Marshall and Robertson (1976) 
and arose as a consequence of the impractibility of the 
calculations for routine analysis. A further semi~ 
empirical approach was introduced by Gillet al. (1974). 
Calculation of the supersaturation ratio for the important 
mineral components in kidney stones was first achieved with 
the Fortran program EQUIL developed by Finlayson ( 1977) . 
The program was subsequently rewritten by Werness et al. 
(1985)· in t he Basic language as EQUIL2. Ackermann et al. 
(1989) exte nded the EQUIL program with respect to charge 
balance, temperature dependence and range of chemical 
species to permit a priori estimation of pH or computation 
of the composition at a particular pH. 
More recently, an updated version of EQUIL2, called EQUIL93 
has been developed [Brown et al. 1994]. Improvements in 
the program include the incorporation of the interfacial 
chemistry o f calcium oxalate monohydrate (COM) crystals and 
the extension of the number of solutes considered. 
The calcul ation of the driving force has allowed 
researchers to identify differences in supersaturation 
levels of healthy subjects and stone formers [Robertson et 
al. 1968,1976a] and to identify patients at risk of stone 
recurrence [Robert et al. 1994]. 
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Vermuelen (1962) [cited by Finlayson et al. 1984] first 
postulate~ the role of. kinetics as follows: 
precipitate + matrix + time = stone . . . . . • . . . 2 
where the t ime factor encompasses the kinetic effects. The 
concept of a matrix is discussed in Chapter I. 2. 4. under 
"Role of t he matrix". 
Finlayson e t al. ( 1984) also reported that stone forming 
potential i s a function of both supersaturation and time, 
with long periods of high supersaturation being of greater 
risk than short periods at the same level. These 
considerati ons led to the concept of retention ·in stone 
formation. 
The geometr y of the urinary tract is such that there may be 
some regions that have poor flow characteristics and which 
therefore f orm "dead volume sites". With a decreased urine 
flow through these areas, crystals present in the supply 
urine have a greater chance of being retained at these 
sites. An increase in retention time would allow for 
longer gr owth periods giving rise to a possible 
pathologica l condition. 
The transit time of urine through the duct of Bellini is 3 
minutes [Fi nlayson and Reid 1978b], while that through the 
whole kidney is less than 10 minutes [Finlayson 1978]. 
This transit time determines the mean crystal residence 
time; ther efore significant deviations in the average 
transit time could occur due to these "dead volume sites". 
Measurement s by Burns et al. ( 1983) of retention time in 
humans showed no clear trends. Experimental modelling in 
rats by Kha n (1991) has illustrated that the renal papilla 
is the primary site for crystal retention in the kidneys. 
Khan (1991 ) demonstrated that crystal formation, growth and 
retention c ould occur in the upper nephron or papillary 
collecting ducts, or in the bladder, depending upon the 
intensity o f hyperoxaluria, duration of the hyperoxaluric 
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state, and the crystallisation inhibitory activity of the 
urine. 
Nucleation 
Nucleation refers to the formation of new particles and is 
a consequence of . rapid local fluctuations on the molecular 
scale in a homogeneous phase that is in a state of 
metastable equilibrium [Finlayson 1978]. 
In genera l , nucleation is a non-linear function of the 
amount of solids present, 
smalle_r than 5J,£m is . 
while the number of particles 
relatively independent of 
supersatura tion [Rodgers and Garside 1981]. 
The initial event in the creation of new particles can 
occur as a result of three mechanisms [Botsaris 1980 cited 
by Garside 1985): homogeneous nucleation, heterogeneous 
nucleation , or secondary nucleation. 
Homogeneous nucleation is 
from the l i quid phase as a 
However, Robertson ( 19 6 9) 
the formation of new crystals 
result of supersaturation only. 
[cited by Finlayson 1978) has 
reported t hat the number concentration of particles in 
normal urine is well below the critical value of 106 jcm3 
required f or 
that prima ry 
homogeneous nucleation, thereby suggesting 
nucleation probably occurs via some other 
mechanism. Heterogeneous nucleation seems to be the likely 
alternative . 
Heterogeneous nucleation is induced by foreign insoluble 
material pr esent in the solution. Indeed, urine is rich in 
cellular de bris which points to heterogeneous nucleation of 
the stqne s alt species [Trumpet al. 1972]. In support of 
this hypothesis is the fact that the kidney is incapable of 
creating sufficiently high enough supersaturation levels 
for homogeneous nucleation [Finlayson 1978]. 
An example of heterogeneous nucleation is illustrated by 
the concep t of epitaxy which may play a role in the 
formation a nd growth of 
Mandel and Mandel 1981]. - -
and bladde r stones is 
9 
urinary calculi [Lonsdale 1968a,b; 
A common feature of many kidney 
the co-existence of alternating 
layers of d iffering composition around a nucleus [Achilles 
1991]. us i ng x-ray crystallographic data of the components 
of urinary stones, possible epitaxial relationships have 
been demons trated [Lonsdale 1968a]. 
After homogeneous or heterogeneous nucleation has occurred, 
solute part icles will be present in the solution. This may 
lead - -to secondary nucleation. This is defined as 
nucleation which takes place only because of the prior 
presence of crystals of the deposited material [Garside 
1985]. The process can be classified into apparent, true 
and contact secondary nucleation [Rodgers and Garside 1981] · 
and is discussed in further detail in Chapter I.2.2. under 
"In vitro c rystallisation". 
Growth 
Growth is t he deposition of material from solution onto the 
surface of existing crystals [Dirksen and Ring 1991]. 
Crystal growth depends upon physiochemical factors such as 
supersatura tion, temperature and concentration of the 
solution. Many crystal properties such as size, shape, 
purity and strength depend upon growth mechanisms [Garside 
1985]. 
Growth is a diffusional process which takes place in the 
microscopic molecular and macroscopic size ranges, but will 
not occur without supersaturation. 
At the molecular level, diffusion of particles (or "growth 
units")_ to the crystal surface with subsequent attachment 
will either result in their staying at that location or 
their being incorporated into the surface by further 
diffusion [Nielsen and Christoffersen 1982; Garside 1985]. 
Integration into the crystal structure then follows. It is 
therefore r easonable to expect the nature of the crystal 
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surface to play a large role in the diffusion process 
[Dirksen a pd Ring 1991]. 
More bonding sites are available on a rough surface than on 
a smooth s urface [Garside 1985]. A rough surface not only 
increases the chances of contact, but also leads to a 
stronger bond (higher energy of bonding) [Garside 1985; 
Dirksen and Ring 1991]. A surface will remain rough after 
particle attachment due to the presence of new corners 
(from the newly attached particles) which then become 
preferred sites for further particle additions. It 
therefore f ollows that a higher rate of growth would be 
expect~d on a rough surface. 
In addition , there exists a rate limiting step when growth 
occurs. on a smooth surface. This step involves the 
addition of the first particle to the smooth surface which 
then provides a site for further additions. The second 
smooth layer after the initial addition has a higher 
activation energy . If a chemical process is used to induce 
precipitati on, it's reaction rate will also be a rate 
determining factor in any growth process. These 
distinctions between growth on a smooth and rough surface 
have led t o the terms "layered" and "continuous growth" 
respectivel y [Garside 1985]. 
Microscopically, there are two different sites where 
addition onto a crystal surface can be made. These are 
termed "steps" (often occurring in bunches) and "kinks" 
[Elwell and Scheel 197 5; Nielsen and Christoffersen 1982; 
Garside 1985]. Steps are areas of layering on the crystal 
surface whi le kinks are indentations occurring on edges; 
therefore, kinks often occur on the edges of steps. Once 
diffus~on onto the surface has taken place at these sites, 
the solvent molecules that surround the new attached solute 
particle d i ffuse away from the surface. Thereafter, the 
heat of c r ystallisation is released and the particle is 
incorporated into the crystal lattice. 
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Other fact ors determining growth rates include solute 
concentrati on and the presence of impurities. The increase 
in growth rates due to high concentrations of small 
particles i n solution have been calculated by Jaganathan 
and Wey (1981). Experiments by Garside and Jancic (1976) 
on single c rystals have shown a new effect termed "growth 
rate disper sion" which could be due to dislocations in the 
crystal or the presence of impurities. 
Aggregation 
Aggregation is the attachment of crystals to each other to 
form a_ col l ection of crystals joined at edges, corners and 
parallel faces [Nielsen and Christoffersen 1982]. The 
process is dominant in the presence of small particles 
(<1~m) . due to the relatively greater strength of adhesional 
forces in comparison to gravitational force [Finlayson 
1978]. 
It has been suggested that if aggregation could be 
prevented, urolithiasis would cease because stones are 
aggregates of smaller particles [Murphy and Pyrah 1962; 
Boyce 1969 ; Catalina and Cifuentes 1970] . This implies 
that aggregation is a key factor in stone formation. 
The extent to which aggregation takes place is dependent 
upon partic le surface potential. Those particles with low 
surface pot entials will minimize their surface area by 
forming lar ger aggregates. Secondly, aggregation is also 
dependent pen the number density of "growth units" in the 
suspension. The number of these growth units could be 
limited by controlling nucleation. In such a way the 
formation of nuclei clusters and therefore aggregates are 
also c9ntro lled. Finlayson (1978) displayed scepticism 
about the importance of aggregation in urolithiasis or 
crystalluria, while Robertson et al. (1976a) have used 
aggregation inhibition in their evaluation . of the stone 
forming pot ential of urine. Kok · et al. (1990) recently 
measured t he effect of agglomeration in urines from 
controls a nd stone formers. Their observations suggested 
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that agglomeration played a maj·or role in the formation of 
large part~cles in the _urines of stone formers. 
I.2.2 IN VITRO CRYSTALLISATION 
In in vi t ro systems, heterogeneous nucleation can be 
induced by foreign surfaces including the crystalliser 
walls. Walton (1965) suggested that submicroscopic 
particles e ntangled in the walls of a crystalliser affect 
nucleation . Due to reduced energy requirements, these 
foreign bodies provide sites for crystals to form at a 
lower criti cal supersaturation. 
To minimize the possibility of heterogeneous nucleation 
from fore i gn insoluble material, rigorous cleaning and 
filter_ing procedures are necessary since even clean 
solutions have been reported to contain submicroscopic 
particles of concentration 106 - 108 jcm3 (Walton 1961]. 
The physical difference between homogeneous and 
heterogeneous nucleation is that once heteronuclei are 
consumed wi thin the crystalliser, heterogeneous nucleation 
ceases, thus limiting the maximum possible nucleation rate 
for this latter process (Robertson and Nordin 1976]. 
Homogeneous and heterogeneous nucleation are not likely to 
take place simultaneously [Dirksen and Ring 1991]. 
As with heterogeneous nucleation, secondary nucleation 
involves nucleation on solute particles already present in 
solution. However, it can also occur as a result of the 
contact of crystals with any avail~ble surfaces such as the 
crystallise r wall. However, the effects of this process 
have proved negligible in most small scale isothermal 
crysta~lisation experiments [Uhlmann and Chalmers 1965). 
"Apparent s econdary nucleation" refers to small fragments 
washed from the surface of seed crystals. True secondary 
nucleation occurs when the current level of supersaturation 
is higher t han the critical level for the solute particles 
present in solution. "Contact secondary nucleation" occurs 
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when a gr owing particle contacts the walls of the 
crystallis~r, stirrer or other particles thus leaving 
behind residual solute particles [Garside 1985; Dirksen and 
Ring 1991]. 
Contact nucleation rates depend upon factors such as 
stirrer rate, particle mass density, saturation ratios and 
the geometry of the crystalliser [Garside and Davey 1980). 
The energy of contact is therefore the limiting factor of 
nuclei creation, and as such, secondary nucleation has been 
reported to be of lesser interest in urine where the 
maximum crystal concentrations are 104 jcm3 [Robertson 1969, 
cited by Finlayson 1978]. 
Secondary nucleation studies have been carried out by 
Garside and Larson [Garside and Larson 1978; Garside et al. 
1979] who investigated micro attrition on crystal surfaces. 
They observed the formation of large numbers of particles 
in the size range 1-10~m. 
Attrition i s the chipping or breaking by mechanical means 
(eg stirrer ) of existing crystals (formed by homo- or 
heterogeneous nucleation) into smaller pieces which 
themselves begin to grow. The process is dependent upon 
the mechanics of the system with agitation of the fluid by 
an impeller playing a major role [Garside 1985]. 
Because the re are three main nucleation mechanisms which 
can occur, investigators have to account for them in their 
design of i n vitro crystallisation systems. Research has 
shown that defining the specific mechanisms in any one 
situation is difficult. In addition, data from nucleation 
experiments are difficult to interpret due to the growth 
period _of new nuclei prior to their detection. However, it 
is important to understand the mechanisms of nucleation if 
surface active inhibitors are to be developed. 
The most informative studies on growth rates in urinary 
precipitation systems have been experimentally calculated 
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using the relationship (equation 3) of Finlayson et al. 
(1984): 
dcjdt = sk(C-C0 ) 2 • • • • • • • • • • • • • • • • 3 
where c is the solution concentration, c 0 is the saturation 
concentrati on, s . is the surface area and k is a rate 
constant. 
Unfortunate ly, most growth studies have been unable to 
disti"riguish between the growth of a crystal and growth by 
aggregatio . 
The methods used to study growth have been conducted using 
spontaneous precipitation [Markovic and Komunjer 1979], 
seeded prec ipitation [Werness et al. 1979; Will et al. 
1983], gel growth [Achilles 1991] and continuous 
crystallisers [Miller et al. 1977; Rodgers and Garside 
1981]. The se will be discussed in more detail in Chapter 
I.4. under "In vitro crystallisation studies". 
I.2.3 ROLE OF INHIBITORS 
Urinary inh ibitors are naturally occurring components of 
the urine which have been shown in model crystallisation 
systems to prevent or retard the nucleation, growth or 
aggregation of various crystals [Ryall and Marshall 1990]. 
Interest i n the possible role of inhibitors in caox stone 
formation began with Howard and Thomas (1958) who were the 
first to pr opose that inhibitors of mineralisation existed 
in urine. They further postulated that caox stone 
sufferers had a deficiency of these inhibitors (supported 
by [Roberts on and Peacock· 1972; Nakagawa et al. 1985]) . 
Since then , the isolation and characterisation of these 
inhibitors has been the main aim of many experimentalists 
[Lewis et al. 1966; Goldberg and Cotlier 1972; Fleisch 
1978; Kitamura et al. 1982; Nakagawa et al. 1983,1987; 
Atmani et al. 1993]. Robertson et al. ( 1971), supported 
qualitatively by the studies of Dent and Sutor (1971) 
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ascribed t he larger sized crystals in the urine of 
recurrent s tone formers relative to controls in in vitro 
studies, t o the absence of inhibitors. 
Identificat ion of the principle urinary inhibitor is still 
a high priority. Most information on inhibitors has been 
derived from model aqueous crystallisation systems using 
dilute or f ractionated urine [Meyer and Smith 1975a; Bowyer 
et al. 1979 ; Resnick et al. 1982; Drach et al. 1982; Scurr 
and Roberts on 1986; Gohel et al. 1992; Shum and Gohel 1993; 
Rodgers et al. 1993,1994; Rodgers and Jappie 1996]. These 
systems o f fer reproducibility and permit quantification 
[Nanco_llas 1970; Nancollas and Mohan 1970; Meyer and Smith 
1975a]. There are however large numbers of inorganic and 
organic compounds in urine (some in trace amounts) which · 
have peen r eported to affect crystallisation, whose effects 
will not be detected in systems using dilute urine [Hallson 
and Rose 1979; Ryall et al. 1985] or ultrafiltered urine 




constituents which have been reported as being 
inhibitors of caox crystallisation include 
magnesium, pyrophosphate, ATP, ADP, and certain 
trace meta l s and some anionic macromolecules such as GAGs, 
RNA, acidic glycoproteins and non-polymerised Tamm Horsfall 
mucoprotein (THM, also known as uromucoid). 
Due to the i r low urinary concentrations [Felix et al. 1977; 
Meyer and Smith 1975a; Nakagawa et al. 1985] the inhibitory 
role of s mall ions such as citrate, magnesium and 
pyrophosphate is not as significant as that of 
macromolec lar polyanions. Growth and aggregation 
inhibition by the latter within urinary concentrations has 
been shown to be significant [Bowyer et al. 1979; Ryall et 
al. 1981b; Gjaldbaek 1982; Resnick et al. 1982; Scurr and 
Robertson 1986; Edyvane et al. 1987a; Shum and Gohel 1993; 
Ebisuno et al. 1993; Rodgers and Jappie 1996]. A review on 
the role of urinary GAGs has been published by Hesse et al. 
(1991). 
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Results of studies on the inhibitory or promotory role of 
urinary ma cromolecules (UMM) in urolithiasis have been 
inconclusive. Studies using aqueous solutions (Pak et al. 
1979; Gjaldbaek and Robertson 1980; Nakagawa et al. 1985; 
Atmani et al. 1993], synthetic urine (Randolph et al. 1981; 
Scurr and Robertson 1986; Yoshioka et al. 1989; Ebisuno et 
al. 1993] and real urine (Azoury et al. 1985; , Edyvane et 
al. 1987a; Gohel et al. 1992; Rodgers et al. 1994] have 
shown no agreement on the effects of addition or removal of 
UMM's. The collective and singular roles of UMM's have 
been ·shown to promote nucleation (Rose and Sulaiman 1984; 
Gohel et al. 1992; Schum and Gohel 1993], inhibit growth 
(Sallis and Lumley 1979; Resnick et al. 1982; Bek-Jensen 
and Tisel i us 1991; Schum and Gohel 1993] and inhibit 
aggregation [Edyvane et al. 1987a; Koide et al. 1981; Ryall 
et al. 1991]. These findings have however been 
inconsistent. A possible reason for the inconsistencies 
may be re l ated to the phase in which the macromolecules 
(Cambell et al. 1989] are present in the urine. The 
results of Cambell et al. (1989), indicated that 
polyelectro lytes and proteins behaved as inhibitors when 
free in solution, but also as promoters of crystal growth 
when immobi lized on the crystal surface. 
There has been considerable ,disagreement in establishing 
whether the urinary concentrations of GAGs is different in 
stone formers and controls. Various workers have reported 
higher concentrations in controls (Robertson et al. 
1978,1984; Baggio et al. 1982; Michelacci et al. 1989; 
Nesse et al. 1992], while others have reported no 
difference [Sallis et al. 1981; Ryall et al. 1983, 1986b; 
Caudarella et al. 1983; Hesse et al. 1986b; Hwang et al. 
1988; Gianotti et al. 1989]. 
Chondroitin sulphate is the principle constituent of 
urinary GAGs and has been reported to inhibit aggregation 
(Ryall et al. 1981b; Gjaldbaek 1982; Robertson and Scurr 
1986) and a lso growth (Bowyer et al. 1979; Fellstrom et al. 
1986; Kok e t al. 1988]. However, Ryall et al. (1981b) have 
suggested t hat growth inhibition is due to additive or 
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synergistic effects of a number of urinary constituents. 
Heparin h~s been found to be a more potent inhibitor of 
growth and aggregation than chondroitin sulphate [Crawford 
et al. 1968; Robertson et al. 1973], but it is virtually 
absent from urine [Goldberg and Cotlier 1972]. 
Another controversial urinary component is THM which has 
been report ed as being a promoter [Drach et al. 1980; Rose 
and Sulaiman 1982; Yoshioka et al. 1989; Grover et al. 
1990a], and an inhibitor [Kitamura and Pak 1982; Scurr and 
Robertson 1986; Yoshioka et al. 1989; Grover et al. 1990a] 
of caox c r ystallisation. The role of this macromolecule 
has been r eviewed by Hess (1992). 
Inhibitors exert their effects by two mechanisms. Firstly, 
they are able to "poison" the crystal surface by blocking 
growth sit es. The binding of glycoproteins and other 
inhibitors by this method appears to be irreversible and 
follows t he Langmuir theory of adsorption equilibrium 
[Meyer and Smith 1975a; Sheehan and Nancollas 1980; Wilson 
et al. 1985]. The second mechanism involves the 
complexation of inhibitor substances with ca2+ or c 2o 4 
2-
ions to decrease the level of supersaturation; examples 
include cit rate [.Hastings et al. 1934; Scott et al. 1943 
cited by Berg and Tiselius 1989; Ryall and Marshall 1990; 
Tiselius e t al. 1993b] and magnesium [Desmars and Tawashi 
1973; Robertson et al. 1973; Scurr and Robertson 1986; 
Ryall and Marshall 1990]. 
As has a l ready been stated, different interpretations 
concerning the identification of inhibitors and promoters 
and the me chanisms by which they operate, abound in the 
literature . This is mostly due to the different 
measur~ment techniques which have been employed. 
result, some studies have focussed on nucleation 
As a 
[Thomas 
et al. 1963; Fleisch 1965; Crawford et al. 1968; Sutor 
1969; Fraser et al. 1972], while others have addressed 
growth [Fra ncis 1969; Dent and Sutor 1971; Ryall et al. 
1985], or aggregation [Robertson and Peacock 1972; Ryall et 
al. 1981b] . It has been shown that inhibitors in controls 
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act on growth and aggregation rather than nucleation (Sutor 
1969; Rob~rtson and . Peacock 1972; Robertson et a1. 
1969,1973; Kok et a1. 1986,1987,1990]. Werness et a1. 
(1981) however found that their stone formers had a greater 
number of crystals in their urine than normal subjects. 
This suggests a lower nucleation rate in the healthy 
subjects wh ich could possibly be due to the presence of 
endogenous inhibitors in their urine. 
Methods ·of assessing crystal 
simultaneously occurring in 
include measurements of mass 
growth while nucleation is 
the presence of inhibitors 
increase (Dent and Sutor 
1971] , _ meas urements of decreases in solute concentration 
(Meyer and Smith 1975a], measurements of increase in 
crystal diameter . [Miller et a1. 1977] and increase in 
crystal volume (Ryall et a1. 1981a]. 
The necess i ty for standardising the investigative methods 
of inhibitor activity in real urine is obvious from the 
above discussion. The two most promising techniques which 
take into account most of the main controversial factors 
are the constant composition system (Sheehan and Nancollas 
1980] and t he continuous crystalliser method [Randolph and 
Drach 1981; Rodgers and Garside 1981]. These will both be 
discussed i n more detail in Chapter I. 4 under "Constant 
supersaturation". 
1.2.4 ROLE OF THE MATRIX 
All urinary stones consist of a crystalline component and 
an amorphous organic matrix [Khan· and Hackett 1987]. The 
role of the matrix in stone formation is unclear. Some 
workers bel ieve that it is a framework for deposition of 
the nucleating crystals that leads to growth of the 
calculus. Other workers however suggest that the matrix is 
organic debris that becomes entrapped during the 
crystallisation process (Rodgers and Spector 1981]. 
The concept of an organic matrix occurs 
theories of different kinds of calculi 
in aetiological 
(Harrill et a1. 
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1959; Fox 1963; Boyce 1968; Sarles 1974]. Its presence has 
been demonstrated by removal of the crystalline components 
from stones [Carr 1953; Iwata et al. 1992] . In urinary 
stones, the organic matrix accounts for 2. 5% of the dry 
weight, but in some calculi it could be as high as 60% 
[Mall et al. 1975; Bommer et al. 1979). Boyce (1968) and 
Spector et al. (1976) were the earliest investigators to 
suggest tha t the organic matrix might play a role as a 
nucleating agent. 
Chemically, the matrix is made up of approximately 65% 
protein [Boyce and King 1962 cited by Roberts and Resnick 
1990), 10% non-amino sugars, 5% hexosamines [Boyce 1968; 
Finlayson e t al. 1961], and 10% bound water with the 
remainder being inorganic 
1983; Morse and Resnick 
substances [Thorne and Resnick 
1988]. Nishio et al. (1985) 
analysed mat rix GAG from urinary stones using 2 dimensional 
electrophoresis. They found that the principal matrix GAG 
content of caox stones was heparan sulphate and hyaluronic 
acid. This was supported by Roberts and Resnick (1986) and 
Wakatsuki et al. ( 1985) , who demonstrated that hyaluronic 
acid was exc reted in the urine of stone forming rabbits and 
that it was the major GAG in their matrices. 
THM is the most abundant natural urinary macromolecule in 
whole human urine [Lynn et al. 1982; Grover et al. 1994]. 
It is produced only by the kidney and comes from the 
ascending limb of the Loop of Henle and the macula densa 
region of t he distal tubule [Samuell 1979; Dawnay et al. 
1982]. It is present in varying amounts in renal stones 
[Grant et al. 1973] which has prompted studies to 
investigate whether a difference in THM levels exists 
between stone formers and controls. These studies have 
however been unable to detect such a difference [Bichler et 
al. 1976; Samuell 1979; Thornley et al. 1985]. 
Results of i n vitro studies performed to determine the role 
of THM on c aox crystallisation have been contradictory. In 
inorganic s o lutions, THM has been shown to be an inhibitor 
of caox nucleation [Kitamura and Pak 1982], growth 
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[Kitamura a nd Pak 1982; Fellstrom et al. 1985a,1986; Scurr 
and Roberts on 1986) , and aggregation [Scurr and Robertson 
1986; Hess et al. 1989,1991; Hess 1991). Deganello {1993) 
on the other hand, concluded that THM neither nucleates 
calcium oxalate dihydrate {COD) crystals nor influences 
growth or habit in aqueous solutions, even when the THM was 
immobilized upon .a rigid substrate. 
In ultrafi l tered urine, THM has been shown to promote the 
formation o f caox [Hallson and Rose 1979; Hallson et al. 
1981; · Rose and Sulaiman 1982; Yoshioka et al. 1989 .) . On 
the other hand, Ryall et al. {1991) found increased 
inhibition of aggregation and concluded that this 
inhibition was likely to occur in whole urine in vivo. 
Doyle _et al. {1991) have studied the protein content in 
caox crysta ls precipitated from urines of healthy subjects; 
they did not detect any THM. They therefore concluded that 
proteins do not play a direct role in crystal formation. 
Meanwhile, Hess et al. {1991) showed that THM from stone 
formers wit h severe nephrolithiasis had lower inhibitory 
power than normal THM. They suggested that this was due to 
self aggregation of THM in the stone former. 
THM can e x ist in several different polymeric forms under 
different i onic conditions [McQueen and Engel 1966; Wiggins 
1987; Hess et al. 1989; Hess 1991) which could possibly 
explain t he different results obtained from in vitro 
studies on the role of THM in caox crystallisation [Hess et 
al. 1991]. High concentrations of THM itself and cations 
like calcium, magnesium, sodium and hydrogen ions induce 
the self aggregation of THM [Hess 1991). The reversible 
self aggregation of THM to form a gel leaves fewer monomers 
in sol~tion , which in turn decreases the effectiveness of 
THM as an i nhibitor. 
At low pH and high ionic strength the inhibitory power of 
THM is lowe red. At high pH and low ionic strength, it has 
been shown to inhibit COM aggregation [Hess 1991]. 
Fellstrom et al. {1986) found that THM inhibited caox 
21 
crystallisa tion at ionic strengths and concentrations 
usually fou nd in urine. Meanwhile, Scurr and Robertson 
(1986) have shown that low concentrations of THM produced 
weak inhibition of caox aggregation, while promotion 
occurred at high concentrations corresponding to 
polymerizat ion of THM. This dual role of THM was also 
demonstrated by Hess 
strong pr omoter of 
( 1992) who found that THM became a 
crystal aggregation when the 
concentration of calcium ions was increased. 
1.2.5 THEORIES OF STONE FORMATION 
Stone dise ase is a multifactorial process. No single 
mechanism has been elucidated which satisfactorily accounts 
for stone formation. Two main groups of theories have · 
evolved. The first of these describes the formation and 
retention of the stone nucleus as an intracellular process. 
Retention i s achieved via lesions of the renal papilla 
(known as Randall's plaque) to which a calculus could 
remain anchored during its growth period (Randall 
1936,1940; Carr 1954]. 
The second group of theories is based on extracellular 
processes of stone formation (taking place entirely within 
the lumen of the urinary tract (Robertson and Nordin 
1976]). There are three such theories within this group. 
The first of these regards the matrix as the cause of stone 
disease (Boyce et al. 1954,1955; Boyce and Garvey 1956]. 
The primary step is thought to be the condensation of 
specific organic colloids (mucopolysaccharides and 
mucoproteins) within the collecting system of the urinary 
tract (Boyc e and King 1963]. The deposition of inorganic 
salts is t hen regarded as a rapidly occurring secondary 
phenom~non. 
The second of the extracellular theories postulates that 
the drivi ng force for precipitation is urine 
supersaturation (Keyser 1923]. In this theory, CaOx stone 
formation occurs as a result of persistent oversaturation 
of ca2+ andfor ox2- ions. Spontaneous precipitation of the 
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stone salts occurs when the activity product of the crystal 
forming iqns is greater than the minimum thermodynamic 
solubility product [Finlayson 1978]. Precipitation 
therefore occurs independently of a pre-formed matrix. 
The inhibit or theory is the third extracellular process in 
this group . It originated from work by Howard and Thomas 
(1958), and assumes that there are natural inhibitors in 
the urine that retard the various processes of stone 
formation. The presence or absence of these inhibitors can 
great1y aff ect the crystallisation kinetics of caox [Dent 
and Sutor 1971) . Typical small molecule inhibitors are 
thought to be citrate, magnesium and pyrophosphate [Fleisch 
1978; Ryal l et al. 1981b; Hallson et al. 1983; Robertson 
and Scurr 1986; Scurr and Robertson 1986; Grases et al. 
1988, 1989; Ryall and Marshall 1990; Tiselius 1995] while 
macromolecu les such as THM, chondroitin sulphate and 
hepar an sul phate have been reported as having inhibitor 
properties [Bowyer et al. 1979; Fellstrom et al. 1986; 
Scurr and Robertson 1986; Kohri et al. 1989; Shum and Gohel 
1993; Rodge rs et al. 1994]. 
The initia tion of stone disease involving either the 
fixation of a free particle or as the origination of a 
fixed part icle at a certain site is still unclear 
[Finlayson 1977a; Finlayson and Reid 1978b]. The free 
particle t heory addresses the question of whether a free 
particle c ould grow large enough to impede urinary flow in 
a renal tubule. Excessive supersaturation of urine with 
respect to the stone forming salts may lead to the trapping 
of an aggr egate · or large crystal in the urinary tract. 
Alternatively, the fixed particle theory supposes that 
blockage of the narrow tubules could result from a high 
rate o~ crystallisation. This attachment of the crystal to 
the wall o f the renal system could be aided by a gluing 
substance. Subsequent growth and aggregation could produce 
a calculus . Finlayson concluded that the fixation of the 
particle on the luminal wall was necessary for upper tract 
urinary stone disease to occur. 
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Although the basis of the two main theory groups is 
different, _ they do have some common features. It is 
generally believed that stones form from a nidus, and that 
it is this process that is the most difficult to control. 
Once nucle ation has occurred, growth and aggregation 
follow. I t is the processes of growth and aggregation that 
have to be overcome so that stone disease can be prevented 
Grases and Costa-Bauza 1990; Kok et al. 1990]. 
I.3 UROLITHIASIS THERAPY 
Surgery, lithotripsy 
There are several different types of urinary stone, each 
one of whic h requires its own specific method of treatment. 
This implie s that analysis of the stone itself is necessary 
to help t h e clinician decide upon the most appropriate 
therapy. Conservative or non-surgical treatments are based 
upon the ne ed to decrease the supersaturation of the stone 
forming sal ts as this leads to the attainment of a state of 
undersatura tion in which any pre-formed stones should 
dissolve. 
However, i n some cases, removal of the stone by surgery or 
lithotripsy (in vivo destruction) is needed [Chaussy and 
Schmiedt 1983; Chaussy et al. 1980,1982; Sofras et al. 
1988]. The latter method can be achieved in numerous ways 
with the pu lverised stone being eliminated spontaneously in 
the urine [Wickham 1982; Politis and Griffith 1987; Brecht 
et al. 1988 ; Chaussy 1988; Tiselius et al. 1989; Schulze et 
al. 1989; Constantinides et al. 1989]. Litholysis (Sheldon 
and Smith 1982] refers to dissolution of the stone in vivo 
and has be en used successfully in the treatment of uric 
acid, qysti ne and struvite stones (Jacobs and Gittes 1976; 
Smith et al . 1979]. However, removal of a renal stone only 




Recommendat ions on dietary management have now become the 
norm [Baker and Mallinson 1979; Vahlensieck et al. 1984; 
Vahlensieck 1986; Hesse et al. 1992, 1993; Goldfarb 1994] . 
Calcium oxa late stone patients are frequently advised to 
restrict t heir intake of dietary calcium [Rao et al. 1982; 
Vahlensieck 1986; Rose 1987; Goldfarb 1994] as there exists 
the widely believed hypothesis that a high calcium intake 
increases the risk of stone formation. However, in a 
recent pros pective study of the relation between dietary 
calcium int ake and the risk of symptomatic kidney stones in 
over 45000 male subjects, Curhan et al. (1993) demonstrated 
precisely t he converse - namely, a high dietary intake of 
calcium decreases the risk. The authors suggest that this 
might be due to increased binding of oxalate by calcium in 
the gastro intestinal tract, leading to a decrease in 
urinary oxa late excretion. Since urinary oxalate is more 
important than urinary calcium in determining stone 
formation [ Finlayson 1974; Robertson et al. 1978; Hesse et 
al. 1993], the risk decreases. Stone formers are therefore 
advised to restrict their intake of oxalate rich foods such 
as chocolat e and tea. 
A high inta ke of animal protein has been shown to produce 
an increase in urinary calcium, oxalate and uric acid. It 
has therefore been suggested that a reduction in dietary 
animal prot ein rather than dairy products would be more 
beneficial for recurrent stone formers [Andersen 1973; 
Robertson e t al. 1979]. Indeed, increased stone incidence 
and recurre nce [Leusmann et al. 1990] could be a direct 
consequence of higher animal protein ingestion when 
compared to population groups from economically poorer 
regions in which stone incidence is lower. 
These find i ngs support the results of other workers who 
have shown that a low calcium diet increases the excretion 
of oxalate [Zarembski and Hodgkinson 1969; Marshall et al. 
1972]. I ndeed, the potential danger of dietary calcium 
restriction has been demonstrated by Bataille et al. (1984) 
who reporte d an increased probability of forming stones in 
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patients with certain types of hypercalciuria when 
following s uch a diet. Such studies suggest an apparent 
protective effect of dietary calcium. It therefore seems 
feasible t o advise stone formers to increase their dietary 
intake of c alcium. 
A high flu i d intake is necessary for decreasing the risk of 
stone formation (Fuss et al. 1979; Pak et al. 1980; 
Robertson a nd Peacock 1983; Vahlensieck 1986]. This advice 
is given with the knowledge that it will ensure larger 
volumes pas sing through the kidney which will ultimately 
lead to a decrease in residence time of the crystals due to 
larger_ flow rates. 
in supersaturation. 
Medical _treatment 
This in turn, will lead to a decrease 
Medical tre atment of stone formers include careful use of 
compounds s uch as cellulosephosphate and thiazides which 
bind with ca2+ thereby decreasing the supersaturation of 
the urine with respect to caox [Pietrek and Kokot 1973; 
Williams 1974; Yendt and Cohanim 1978; Ohkawa et al. 1992]. 
Direct inhibition of crystallisation in vivo has been 
accomplished using inhibitors such as disodium ethane-1-
hydroxy-1,1 diphosphonate (EDHP) (Bone et al. 1979], 
succinimide for oxalate stones (Thind et al. 1980], 
methylene b lue (Boyce et al. 1967; Wein et al. 1976] and 
inhibitor stimulating agents such as phosphate (which 
increase t he concentration of the inhibitor pyrophosphate) 
(Russel et al. 1976] for non-obstructive renal calculi. 
Role of urate 
Allopurinol which has been used for the treatment of uric 
acid stones (Coe 1977; Fellstrom et al. 1985b; Tiselius et 
al. 1986] has also been used in the treatment of recurrent 
caox stone formers. This arises as a result of its 
supression of urinary urate 
Kavalach 1974] which has 
(Coe and Raisen 1973; Coe and 
been shown to retard the 
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inhibitory capacity of naturally occurring UMM's [Finlayson 
and Dubois_ 1978; Pak et al. 1979; Fellstrom et al. 1982; 
Ryall .et al. 1986c; Hesse et al. 1987]. 
There are two theories on the role of urate in the 
formation of caox stones. The first is that sodium urate 
crystals i nduce heterogeneous nucleation of caox [ Coe et 
al. 1975; Pak and Arnold 1975; Finlayson and Dubois 1978; 
Pak et al. 1979; Grases et al. 1991]. This theory has 
arisen due to the good epitaxial fit of Caox and sodium 
urate · cie c aox adheres to the sodium urate crystal surface 
due to a good crystal lattice match) [Lonsdale 1968a, b]. 
The se~ond theory, as mentioned in the previous paragraph, 
is that the inhibitory potency of GAGs is reduced by the 
binding of colloidal urate [Robertson et al. 1976b; 
Fellstrom e t al. 1982; Hesse et al. 1987]. 
More recent ly however, Grover et al. ( 1990b) found that 
reducing t he urate concentration in several urines did not 
produce any reduction of the metastable limit (MSL), of the 
volume of crystalline caox deposited or of the size of 
crystals a nd aggregates. In a later study, they found that 
the addition of dissolved urate to ultrafiltered urine 
promoted Ca ox crystallisation in a manner similar to that 
in the pre sence of GAGs [Grover et al. 1992]. In yet 
another study, they found that the promotion of caox 
crystallisa tion by urate was not due to its binding of GAGs 
nor to epit axial nucleation of caox [Grover et al. 1993]. 
They have proposed that a "salting out" mechanism is 
responsible for the promotion of · caox crystallisation by 
urate [Grover et al. 1990c,1993]. 
Alkaline citrate therapy 
Prophylacti c treatment with alkaline citrate is used to 
increase t he concentration of citrate in urine; this 
retards the formation of caox by decreasing the calcium 
specific i on activity and the relative supersaturation of 
caox. 
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Treatment o f calcium stone patients using potassium citrate 
or potass~um sodium citrate has been shown to increase 
urinary pH and citrate excretion both in the short term 
[Preminger et al. 1985; Nicar et al. 1984,1986] and the 
long term [Pak et al. 1985; Butz 1986; Barcelo et al. 
1993]. Dec reased levels of calcium have also been reported 
[Butz and Dulce 1981; Butz 1986; Khazziani et al. 1993; 
Leusmann e t al. 1993]. The effects of different doses of 
citrate have been investigated by Berget al. {1990,1992), 
while Schwi lle et al. {1992) suggest the introduction of 
medication free intervals for patients on long term oral 
potassium c itrate medication. 
Hofbauer e t al. {1994) however, have been unable to show 
objectively any evidence to support claims of the · 
therapeutic benefit of oral alkali citrate therapy. They 
do however justify its use subjectively due to its low 
incidence o f side effects. Their work was carried out 
using stone formers with regular stone recurrences. They 
claim that a drawback in other investigations is the 
absence of randomisation as the time factor of recurrency 
was not t aken into account when selecting stone forming 
subjects. 
Abdulhadi e t al. ( 1993) compared patients 
citrate and hydration therapy with those 
on long term 
on hydration 
alone. They observed an increase in urinary citrate levels 
but could find no significant difference between the two 
groups. 
The use of alkaline citrate thermodynamically favours the 
crystallisation of calcium phosphate [Berg and Tiselius 
1989]. Thi s is because calcium phosphate precipitates at 
high p~ (>5 .5), whereas caox precipitation occurs at lower 
pH levels [Tiselius 1987]. The primary crystallisation of 
calcium phosphate is capable of inducing heterogeneous 
crystallisation of caox at lower supersaturation levels 
than those favouring precipitation of pure caox. The use 
of alkaline citrate could therefore increase the risk of 
heterogeneous crystallisation of caox. Despite this 
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hypothesis, Berg and Tiselius ( 1989) and Tiselius et al. 
(1993a) f ound that . increasing citrate concentrations 
inhibited the heterogeneous growth of CaOx on calcium 
phosphate. 
Pak et al. (1992) have shown the greater inhibitory action 
of potassium-magnesium citrate over potassium-citrate (at 
the same dose of potassium [Koenig et al. 1991]) on the 
crystallisation of calcium oxalate. Recently, therapy 
using oral sodium-potassium citrate has been investigated 
by Ogawa ( 1994) using different regimens and fractional 
urine collections. He found that an evening dose in 
addition t o a three times a day sodium-potassium citrate 
regimen significantly reduced the caox saturation level in 
the early morning. 
Magnesium therapy 
Interest in the beneficial effect of magnesium in the 
prevention of caox stone formation began with animal 
studies [Cr amer 1932; Andrus et al. 1960; Lyon et al. 1966; 
MacManus a nd Heaton 1969; Rushton and Spector 1982] as well 
as other s tudies [Takasaki 1972; Robertson et al. 1973; 
Fetner et al. 1978; Johansson et al. 1980b; Resnick et al. 
1982] . The se studies have since formed the rationale for 
the treatment of caox stone sufferers with magnesium in the 
form of magnesium oxide [Kohler and Uhle 1966; Melnick et 
al. 1971; Prien and Gershoff 1974; Ahlstrand and Tiselius 
1983; Ratt an et al. 1994] and magnesium hydroxide 
[Johansson et al. 1980a]. 
Magnesium therapy has been shown to be effective in 
increasing magnesium excretion 
incidences [Moore and Bunce 1964; 
Melnick et al. 1971; Johansson et 
1985]. However, Fetner et al. 
and reducing stone 
Kohler and Uhle 1966; 
al. 1980a; Danielson 
(1978) suggest that 
magnesium therapy may be successful in reducing the 
formation product ratio and the growth of caox only in the 
long term. On the. other hand, Tiselius et al. (1980) found 
that patients on magnesium oxide therapy increased both 
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their magne sium and calcium urinary excretion. Since this 
resulted i n the calcium:magnesium ratio being unaffected, 
they concl uded that magnesium therapy is not always 
effective. 
Therapy us ing magnesium attempts to correct the low 
magnesium: calcium ratios in stone formers which have been 
shown by several authors (Tiselius et al. 1978; Johansson 
et al. 1980b]. Low values of this ratio can be related to 
either low magnesium levels [Evans et al. 1957] or high 
calcium levels (Takasaki 1972]. However~ Fetner et al. 
(1978) suggest that the physiochemical meaning of this 
ratio is limited because the action of magnesium would be 
better desc ribed by the urinary concentration of magnesium. 
They propos e that the action of magnesium in decreasing the 
supersaturation with respect to caox by complexing with 
oxalate or by exerting inhibitor activity is dependent upon 
the concentration of magnesium rather than the amount of 
magnesium in relation to calcium. An increase in the 
magnesium: c alcium ratio may therefore not necessarily 
indicate a lowered supersaturation or an increased 
inhibitor activity (Fetner et al. 1978]. They therefore 
suggest t hat the effect of magnesium on caox 
crystallisation should be accounted for in terms of 
magnesium concentration rather than the magnesium: calcium 
ratio. 
As yet, s tudies have been unable to demonstrate any 
difference in the 24 hour magnesium excretion between stone 
formers and controls (Robertson et al. 1968,1978; Welshman 
and McGeown 1975; Johansson et al. 1980b; Bach et al. 1981; 
Resnick et al. 1982]. 
Comment 
Once a kidney stone has been formed, there exists the 
potential for recurrence. Many therapies are based upon 
prophylact i c oral medication, but lifelong management using 
drug treatments is undesirable. Such drugs should possibly 
be used when dietary management has been unsuccessful or, 
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as suggested by Pak et al. (1984) as a supplement to 
dietary ma~agement. 
I.4 IN VITRO CRYSTALLISATION STUDIES 
Methods 
Many methods have been used in the in vitro study of caox 
crystallisa tion [Hess and Kok 1996]. As a result, 
comparison and interpretation of data have been difficult 
to adhieve . Clearly, no single method can model all the 
processes i n stone formation since there are many in vivo 
variabJes s uch as urinary flow rates, pH and composition 
which cannot be mimicked. In addition, factors such as 
inhibitors of growth and aggregation, matrix, retention and 
site qf crystal formation cannot be reproduced in the 
crystallisa tion system. 
Although crystalluria cannot be equated with stone 
formation, much useful information can be deduced from the 
study of urinary crystallisation processes [Gaur and 
Nancollas 1984; Baumann 1985; Azoury et al. 1987]. 
The importa nce of supersaturation as a determining factor 
in crystal l isation theory has already been discussed. The 
presence of crystalluria in the urine of stone formers and 
controls [Hallson and Rose 1977] is proof that a . state of 
supersatura tion exists or existed somewhere in the urinary 
tract. On this basis, Kavanagh (1992) has summarised 
crystallisa tion experiments into three categories: 
(i) initial supersaturation with subsequent 
supersaturation decay; 
(ii) initial undersaturation with concentration to 
supersaturation; 
(iii) constant supersaturation. 
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Supersaturation decay 
crystallisa tion experiments using supersaturation decay and 
substrate depletion are based on a batch principle in which 
no additions are made to the system once nucleation has 
begun (Kha n et al. 1988,1990). Using this approach, 
Brecevic e t al. (1989) found that the order in which feed 
solutions of calcium chloride (CaC12 ) and sodium oxalate 
(NaOx} were mixed, as well as their initial concentrations 
affected t he abundance of the various caox hydrates which 
were ·formed . The type of stirring was also found to be a 
determining factor. 
Precipitati on can be initiated by use of a seed crystal 
which does not necessarily have to be a crystal of the 
nucleating phase (Ryall et al. 1981a; Bijvoet et al. 1983; 
Kok et al. 1988; Yamaguchi et al. 1993). Baumann et al. 
(1990} mea sured the inhibition of growth of COM seed 
crystals i n whole urine using an ion-selective calcium 
electrode. Heterogeneous nucleation of caox has been 
measured by Burns and Finlayson (1980} by examining the 
CaOx produc tion in the presence of sodium acid urate seed 
crystals, hydroxyapatite seed crystals and caox seed 
crystals. The inhibition of caox monohydrate crystal 
aggregation by THM and nephrocalcin has also been measured 
using COM s eed crystals (Hess et al. 1989]. 
Use of seed crystals obviates nucleation 
growth and aggregation need be considered 
1981a; Wil l et al. 1983; Kok et al. 1990]. 
so that · only 
(Ryall et al. 
This does not 
apply if t e seed is heterogeneous, in which case the role 
of heteroge neous nucleation is then important. The effect 
of aggregat ion alone has been measured using seeded systems 
at saturation (Hess et al. 1989]. Although the seeding 
method does not mimic physiological conditions (because it 
negates the process of nucleation) , it does offer many 
advantages such as high reproducibility, control over seed 
variables, and easy interpretation of results (Kavanagh 
1992]. However, a disadvantage is that inhibitory activity 
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is measured at concentrations much lower than those found 
in urine unlike those of unseeded methods. 
A second batch method is that of oxalate tolerance which 
involves t i tration of urine with NaOx to determine the MSL 
[Robertson and Nordin 1976]. This is the minimum amount of 
oxalate required .to induce detectable precipitation [Ryall 
et al. 1985]. After determination of this limit, 
crystallisa tion is induced by addition of further oxalate 
[Edyvane e t al. 1987a,b; Ryall et al. 1991]. Results from 
this · method are more difficult to interpret due to the 
simultaneous occurrence of several crystallisation 
mechan~sms , but the method can give estimates of a urine's 




results can be obtained for a given set of 
however comparisons with other systems are 
This is due to results being dependent upon the 
specific characteristics and conditions of the particular 
experiment [Hesse et al. 1991]. Different conditions 
existing i n different crystallisation systems could induce 
a "ripple e ffect" in which numerous inter-related processes 
involving inhibition and promotion of nucleation, growth 
and aggregation interact with each other to finally produce 
a nett, system dependent mechanism [Rodgers and Jappie 
1996]. Examples of system dependent factors that would 
influence c rystallisation are: the rate of supersaturation 
increase a bove the MSL, agitation [Brecevic et al. 1986], 
and the me thod of monitoring the crystallisation. This 
latter fact or arises as a result of the limited sensitivity 
of the individual items of equipment (Hallson and Rose 
1990]. Th is leads to difficulties in measuring the size 
distribution in the chemically and physiologically most 
interesting region of 0.1 1~m. A review on size 
measurement techniques has been published by Stresty and 
Venkateswar (1980). 
The progress of the reaction in both seeded and unseeded 
methods can be monitored continuously or at time intervals 
using methods such as nephelometry [ Grases et al. 
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1988,1989; Rodgers et al. 1993], Coulter Counter (Robertson 
1969a; Ry~l l et al. 1981a,b; Tiselius 1985; Grover et al. 
1992; Tisel ius et al. 1993b], calcium electrode [Wolf and 
Stoller 1994], calcium or oxalate depletion [Gjaldbaek 
1982] and flow cytometry (Blomen 1982; Rodgers et al. 
1995]. 
Methods f or following calcium depletion include atomic 
absorption spectrophotometry (AAS) [Pak and Holt 1976; 
Finlayson a nd Reid 1978a] and the more elaborate methods of 
colorimetri c analysis [Hodgkinson 1980], complexiometric 
titration [Fleisch and Bisaz 1964], and radioactive 45c 
tracers [Wi ll et al. 1983; Blomen et al. 1983; Hesse et al. 
1987]. 
Altho~gh r adioactive 14c-oxalate 'tracers have been used for 
the measurement of oxalate depletion [Gill et al. 1974; 
Ligabue et al. 1979; Tiselius and Fornander 1981; Rose and 
Sulaiman 1982; Fellstrom et al. 1982; Grover et al. 1990a], 
there are nevertheless difficulties associated with this 
method. These arise because of the relatively small change 
in oxala te concentration which occurs during 
crystallisa tion. 
In seeded systems, calcium or oxalate depletion methods 
usually ignore aggregation in interpretation of the results 
and assume that only growth is occurring. Particle sizing 
methods can measure the effects of nucleation and growth or 
nucleation and aggregation by measuring the increases in 
crystal vol ume or crystal number respectively (Ryall et al. 
1981a]. Due to the interdependence of aggregation and 
growth, i t is difficult to measure these processes 
independent ly without undertaking complicated mathematical 






of crystal type is 
such as the Coulter 
Counter. Scanning electron microscopy 
used for this purpose [Werness et al. 
(SEM) is usually 
1981; Khan et al. 
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1983; Khan and Hackett 1987b; Kohri et al. 1989; Ryall et 
al. 1991; _Rodgers et _al. 1994; Rodgers and Jappie 1996]. 
Use of par ticle counters also requires pre-treatment of 
urine, either by filtration or centrifugation, to remove 
all non-crystalline material [Robertson 1969a; Ryall 1978]. 
such pre-tr eatment is necessary because sizing instruments 
cannot d i stinguish crystals from other particles. 
Unfortunate ly filtration removes THM which has been shown 
to play a r ole in caox crystallisation as discussed earlier 
[Dawnay et al. 1982; Wiggins 1987; Doyle et al. 1989,1991; 
Grover et al. 1990b; Ryall et al. 1991; Suzuki et al. 1994; 
Rodgers et al. 1994]. Despite this, the Coulter Counter 
has b~en u s ed successfully in the study of various aspects 
of caox crystallisation [Markovic and Komunjer 1979; Bowyer 
et al. 1979; Ryall et al . 1981b,1985,1991; Brecevic and 
Garsid~ 1981; Scurr and Robertson 1986; Edyvane et al. 
1987a,b; Gr over et al. 1992; Doyle et al. 1995; Rodgers and 
Jappie 1996]. Apart from the Coulter Counter, other more 
sophisticated particle size analysers are now in use that 
apply Chemi cal Engineering principles to determine crystal 
growth proc esses [Randolph and Larson 1971]. 
Results obt ained by batch methods are usually qualitative 
due to the changing contributions of nucleation, growth and 
aggregation on the particl.e size distribution {PSD) 
throughout the reaction. A limitation of decreasing 
supersaturation systems is that different crystal phases 
may form, making it difficult to relate results to in vivo 
conditions where supersaturation may be maintained at a 
relatively constant value. 
Undersaturation conversion to supersaturation 
Supersa_turation of an initially undersaturated solution can 
be achieved by a number of techniques; for example, in 
semi-batch methods reactants are added to the crystallising 
medium either continuously or periodically. A second 
approach involves the process of diffusion . In this 
approach, no attempt 
crystallisation process. 
is made to quantify the 
The gel crystallisation method 
35 
(GCM) [Achilles 1989; Achilles et al. 1983,1991) is an 
example ot: a diffusion process that has been successfully 
applied to the crystallisation of caox hydrates [Achilles 
1985 cited by Baumann 1988b; Achilles 1991; Achilles et al. 
1994a,b). The method involves adding the second component 
of a precipitating binary phase into a gel containing the 
first component. Crystal growth can be followed by 
photometric methods. 
Concentrat i on by water removal is another method for 
achieving s upersaturation to initiate precipitation. It is 
postulated that this process is analogous to the 
concentrati on of urine in the renal tubules, whereby water 
is removed and a state of supersaturation is maintained 
[Hallson a nd Rose 1978]. The rate of evaporation is slow 
if it _takes place under normal atmospheric conditions, but 
can be incr eased using reverse osmosis or evaporation under 
reduced pre ssure at 37°C [Azoury et al. 1987; Hallson and 
Rose 1990). Crystals obtained by these methods can be 
studied by SEM to give a qualitative estimate of 
aggregation , or isotopically by the addition of 14c oxalate 
[Gill et al. 1974; Rose and Sulaiman 1982; Grover et al. 
1990a) before evaporation (which is very expensive), or by 
chemical a nalysis [Azoury et al. 1987]. 
Constant supersaturation 
Steady stat e supersaturation systems can be classified as 
either constant composition crystallisation or mixed 
suspension mixed product removal (MSMPR) crystallisation 
techniques. Both have an advantage over those already 
discussed in that they are more representative of the 
conditions within the kidney. 
The constant composition method [Tomson and Nancollas 1978] 
involves addition of calcium and oxalate to the reaction 
vessel to maintain a constant composition . . Calcium ion 
activity i s measured by a specific electrode [Sheehan and 
Nancollas 1980]. Use of a protected calcium electrode has 
made it possible to study the reaction kinetics in 
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undiluted urine [Gaur and Nancollas 1984]. Seed crystals 
have also been used in the constant composition technique 
[Sheehan and Nancollas 1981; Lanzalaco et al. 1988]. 
Reaction k i netics and inhibitor kinetics are based on the 
rate of cal cium and oxalate depletion. The method can be 
used at ver y low supersaturations and is accurate, but may 
be expensive. An advantage of the method is that it 
resembles the conditions found in the kidney as 
crystallisation occurs at a stable supersaturation. 
Any chamber continuously receiving a stream of 
supersaturated liquid and continually ejecting a stream of 
liquid and suspended particles is a continuous crystalliser 
[Finlayson 1972]. Finlayson (1972) first described the 
concept of the urinary tract as a biological analog of a 
sequence of continuous crystallisers. Further work by 
Miller et al. (1977) led to the development of a continuous 
MSMPR crystalliser using artificial urine as the 
crystallising medium. 
The MSMPR crystalliser is now widely used for measuring 
nucleation and growth rates of caox [Miller et al. 1977; 
Drach et al . 1978,1980,1982; Rodgers and Garside 1981; Li 
et al. 1985 ; Robertson and Scurr 1986; Kohri et al. 1988; 
Nishio and Kavanagh 1990; Kavanagh et al. 1993; Nishio et 
al. 1990, 1994] as well as for the determination of 
inhibitor activities [Drach et al. 1978; Li et al. 1985]. 
Drach et al. (1980) attempted to distinguish between 
controls a nd stone formers by adding 5% urine from each 
group to 95% synthetic urine. They proposed that uromucoid 
played a role in producing the differences found between 
the two groups. Robertson and Scurr (1986) determined the 
effect of urinary concentrations of various inhibitors 
using an MSMPR crystalliser with a Coulter Counter. The 
effects of chondroitin sulphate, hyaluronic acid and 
heparin on the nucleation and growth rates of caox in 
artificial urine have also been investigated by Kohri et 
a1. ( 1989) . 
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In the past, MSMPR crystallisers have required volumes in 
excess of _200ml. However, recently an MSMPR crystalliser 
of volume 20ml has been used successfully to obtain caox 
crystal s ize distributions (CSD's) using inorganic 
solutions [Nishio et al. 1991]. 
An advantage of the MSMPR crystalliser system is that 
simultaneous measurement of nucleation and growth rates 
can be ach ieved, at the same level of supersaturation, 
level of ag itation [Brecevic et al. 1986], temperature and 
suspension density. These kinetic measurements are derived 
easily from the data output of the particle sizers. 
Howeve~, aggregation is more difficult to measure. 
An attempt has been made by Springmann et al . (1986) to 
measur~ a ggregation in a flow system using an MSMPR 
crystallise r with an on-line Couette agglomerator. They 
compared s ynthetic urine controls with 5% volfvol additions 
of human u r ine from healthy subjects and stone formers and 
found that the latter had significantly greater numbers of 
large parti cles than those of the heal thy subjects. The 
number of large 
healthy sub jects 
concluded that 
particles in both the stone formers and 
was lower than that of the control. They 
urine contains an inhibitor of caox 
aggregation and that there is a deficiency of such 
inhibitors in the urines of stone formers. 
Comment 
Experiments using synthetic, dilute or fractionated urine 
have been carried out using many of the techniques 
mentioned earlier [Gardner and Doremus 1978; Bowyer et al. 
1979; Kohri et al. 1989]. Crystallisation in these 
artifiqial solutions requires simple equations for growth 
calculations [Robertson 1982] . The use however of these 
solutions i n determining inhibitor or promotor activity is 
questionable [Dhanalekshmy et al. 1994]. Extrapolation 
from such experiments to in vivo conditions may not be 
possible because of an obscuration of the inhibitory power 
due to di l ution [Baumann 1985,1988a]. Most data about 
I . 
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inhibitor activity have been acquired using batch systems 
[Ryall et _al. 1985]. Seeded experiments using whole urine 
have been s uccessful in providing insight into the effects 
of low mole cular weight inhibitors [Baumann 1985, cited by 
Baumann 1988b], and have allowed the determination of 
urinary sat uration. 
Measurement s of inhibitor activities should preferably be 
performed i n freshly voided urine, since substances used to 
preserve the urine (eg HCl) may influence the 
crystallisation processes. Lanzalaco et al. . ( 1982) 
investigated the effects of freezing and refrigeration on 
the growth of COM crystals in the absence of bacteriostatic 
agents. They concluded that the refrigerated samples 
remained more stable than those that were frozen. 
The need f or experiments using whole urine is becoming 
increasingl y important. It is therefore necessary to adapt 
the above s ystems in order to accommodate such experiments. 
The use o f whole urine in continuous crystallisation 
experiments [Springmann et al. 1986] has been suggested, 
but has not been pursued because of the large volumes 
required. Improvements in the MSMPR crystallisation 
technique have led to the use of 92% urine [Kavanagh et al. 
1993]. I n addition, two parallel MSMPR crystallisers 
[Kavanagh 1992] have been used to measure the effect of 
additives on crystallisation. Baumann et al. (1990) have 
recently a dapted the system of Meyer and Smith (1975a) to 
enable meas urements in whole _pre-treated urine. 
There are however, shortcomings associated with the 
measurement of crystallisation kinetics in whole urine. In 
whole urine there is already a high inhibitory presence; 
this need s to be overcome to enable significant 
crystallisation to be detected. As a result, the addition 
of large s e ed crystal concentrations or the achievement of 
very high supersaturations which are not found at 
physiologic al levels [Baumann 1995) are required. 
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The point has already been made (Chapter !.4 under 
"Supersatu:;-ation decay") that methods employed in test 
systems eac h yield results that could be system specific. 
In order t o compare data, standard methods of experimental 
procedure a nd result analysis must be achieved [Kavanagh 
1995b]. Gr over et al. (1990a) have demonstrated this need 
experimenta lly by using two methods for determining the 
effects of THM on crystallisation in ultrafiltered urine. 
The method of oxalate loading showed that THM had no effect 
on the amount of caox deposited. On the other hand, the 
evaporation technique using 14c-oxalate showed that THM 
promoted caox crystallisation. 
Since the ultimate aims of urinary crystallisation 
experiments are to understand and thereby attempt to · 
preven~ and treat stone disease, such experiments need to 
be conducted in the same crystallising medium (or as close 
as possible) as that found in vivo, namely whole urine. 
1.5 OBJECTIVES 
The objectives of the present study are as follows: 
(i) to design, construct, develop and test an MSMPR 
crystalliser that conforms to strict chemical engineering 
design princ iples; 
(ii) to design, construct, develop and test a thermostatted 
flow cell which can be accommodated in a Malvern Particle 
Size Analyse r; 
(iii) to se a Malvern Particle Size Analyser for the 
rapid, non-destructive and non-invasive measurement of 
calcium oxalate crystal size distributions in a series of 
crystallisat ion experiments in minimally diluted urine; 
( i v) to mea sure crystal size distributions simultaneously 
in a paral lel series of crystallisation experiments in 
minimally d i luted urine using a Coulter Counter; 
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(v) to use the data acquired in these experiments to 
compute calcium oxalate crystallisation kinetics in 
minimally d iluted urine; 
(vi) to test the efficacy of the system by investigating 
the effect of temperature on the kinetics of calcium 
oxalate c r ystallisation processes in minimally diluted 
urine; 
(vii) to t e st the efficacy of the system by investigating 
the effects of various oxalate feed solution concentrations 
on the k inetics of calcium oxalate crystallisation 
proces~es i n minimally diluted urine; 
(viii) to t est the efficacy of the system by investigating 
the indiv idual effects of citrate, magnesium and 
chondroitin sulphate on the kinetics of calcium oxalate 
crystallisation processes in minimally diluted urine; 
( ix) to test the efficacy of the system by investigating 
the synergistic effect of citrate and magnesium on the 
kinetics of calcium oxalate crystallisation processes in 
minimally d iluted urine. 
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Particle size analysis can be traced back to antiquity with 
evidence o f the use of sieving by the Egyptians in 4000BC 
[Groves 1974]. The behaviour of particulate solids has 
gained increasing importance since then and is now used in 
modern technolo~ies such as pharmaceuticals, pesticides, 
polymers, emulsions and biological materials. 
Development of particle s1z1ng techniques [Laws et al. 
1963] pas l ed to sophisticated instrumentation that require 
mathematical equations to manipulate the data. As a result 
of the wide range of methods that are available today, 
theoretical and practical factors must be considered when 
deciding which method is to be implemented. 
This chapte r describes the theory and principles of two 
well known particle sizing techniques, viz Malvern and 
Coulter, both of which were used in the present study. 
11.1 MALVERN THEORY 
11.1.1 THEORIES OF LIGHT SCATTERING 
The scattering of light is fundamental to the Malvern 
particle sizing technique and as such, a discussion thereof 
is therefore included in the following section. 
Historical background 
At the beg inning of the 19th century Young and Fresnel 
complet_ed decisive studies which contributed towards 
understanding the nature of light (van de Hulst et al. 
1964]. The ir work was followed in the latter part of the 
century by Maxwell's electromagnetic theory . of light [ Chu 
1974; Bohren and Huffman 1983; · Haken 1984] in which 
electric a nd optical phenomena were linked. A problem of 
the era was the scattering of light by a homogeneous sphere 
42 
and though many special cases were solved, its full 
solution was eventually formulated by Mie in 1908. 
Classically , light can be expressed as an oscillating 
electric f i eld. The electrons from particles upon which 
the light impinges, vibrate due to this electric field and 
radiate light in all directions causing scattering. The 
vibrations of the electrons depend on their natural 
frequency in a particular atomic configuration and on the 
frequency of the electric field oscillations [Haken 1984; 
Narducci and Abraham 1988]. 
When light falls on a small particle, a fraction of the 
light is a bsorbed into the particle while the rest of the 
incident light is scattered. The angle of the scattered 
light relat ive to the incident beam is known as the 
scattering a ngle. 
Light scatte ring can be divided into models dependent upon 
particle size relative to the wavelength of the light and 
also dependent upon the refractive index (RI) value of the 
particle rel ative to that of the surrounding medium. 
The RI of the medium characterises the potential of an 
electron in a particular atomic configuration to follow the 
oscillations of the electric field of light [Jonasz 1991]. 
The RI depends on the chemical composition of the particle 
and its density. A sphere with a high RI will scatter 
light at large scattering angles in comparison to the low 
scattering angle of a low RI particle. The relative 
refractive i ndex is the ratio of the RI of the particle to 
that of wate r. Therefore the higher the water content of a 
particle, t he closer to 1 is the RI of the particle. 
Measurement of the RI is explained by Lightfoot and Watson 
(1990). 
Raleigh theory 
Raleigh partially solved the problem of electromagnetic 
wave scatt ering from small homogeneous particles 
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[Rayleigh,Lord 1871,1881; van de Hulst et al. 1964; Bohren 
and Huffm~n 1983]. He assumed the homogeneity of the 
electric f i eld of the incident wave within the particle. 
His theory required firstly that the particle be very much 
smaller tha n the wavelength of the incident light, and 
secondly t hat the velocity of light does not decrease 
appreciably inside the particle [van de Hulst et al. 1964]. 
Raleigh-Debye-Gans theory 
Expanding on the first model led to descriptions for small 
particles with RI's close to that of the suspending medium 
[van d_e Hul st et al. 1964; Bohren and Huffman 1983] • . To 
account for the inhomogeneity of the electric field in a 
large particle, the latter was considered as being made up 
of mal')y s mall fragments of Raleigh's model. The light 
scattering from a particle fragment depen~s on the field of 
the incident wave and on the waves radiated by other 
fragments. The latter waves depend on the light scattered 
by the fragment in question. If the RI of the particle is 
only slight ly different to that of the medium, then the 
particle i nteracts- weakly with the incident light. The 
scattered waves from the fragment are too weak to affect 
neighbouring fragments which "feel" mostly the incident 
wave. The model also requires that relative to a common 
origin, the phase differences between waves scattered by 
the fragment s depend on the RI of the particle. 
Fraunhofer and Anomalous theories 
For spheric al particles with a diameter greater than the 
wavelength of the illuminating radiation, the diameter of 
the diffraction pattern is inversely proportional to the 
particl_e d i ameter. In other words, the scattering angle 
for particle s of sizes greater than the wavelength of light 
is independent of the optical properties of the particles 
or suspension. Therefore, for particles bigger than this 
size, no knowledge of the material or of the medium's 
optical properties is necessary. However, in the range 
0.5-11-£m (measurement over 50° from forward direction) the 
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light coupled into the particle is not completely absorbed 
as in the case above 1~m, but can emerge as a refracted ray 
[Lightfoot and Watson 1990; Kusters et al. 1990]. 
The Fraunhofer theory assumes that particles scatter light 
like discs of the same diameter. The assumptions are that: 
(i) the particle is much larger than the wavelength of 
the light employed (typically SA) [de Boer et al. 
1987]; 
(ii) all particles scatter with equal efficiencies; 
(iii) the particle is opaque and does not transmit any 
light . 
The anomalous theory proposed by van der Hulst et al. 
(1964) is us ed for a particle in a liquid and is similar to 
the Fraunhofer theory. Light passes through transparent 
particles and interferes with the diffracted light 
producing a modified scattering pattern. The anomalous 
theory invokes equations that take into account the 
contribution from light passing through particles. If the 
condition t hat the RI of the particle is close to that of 
the medium is fulfilled, the particle merely shifts the 
phase of the ray. The shift is the product of the ray's 
path length inside the particle and of the difference 
between the RI's of the particle and the medium. Thus the 
electric f i eld immediately behind the particle can be 
calculated. 
The Fraunhof er and anomalous assumptions are not completely 
valid especi ally when the relative refractive index of the 
particle and medium are close to 1 [Lightfoot and watson 
1990; Kuste rs et al. 1990]. When the particle size 
approaches t he wavelength of light, the scattering becomes 
a complex f unction with maxima and minima. Mie theory 
fully describes light scattered from spherical particles. 
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Mie theory 
Gustav Mie (1908) (cited by Jaggard et al. 1981) completely 
solved the equations for the interaction of light with 
matter [van de Hulst et al. 1964; Kerker 1969; Bohren and 
Huffman 1983]. The model is a solution of the Maxwell 
equations [Born and Wolf 1975] describing the propagation 
of the electromagnetic wave of light in space. Although 
the theory is valid for any particle diameter and particle 
RI, it is only fully applicable to spherical, optically 
homogenous particles. Mie theory often requires a 
knowledge o f the shape and orientation of the non-spherical 
partic_les. However, an equivalent sphere diameter can be 
obtained due to the thousands of randomly orientated non-
spherical particles involved in a single measurement. · 
Greenb.erg (1980) gives a brief review of the uses of Mie 
theory and the difficulties associated with non-spheres. 
The Mie the ory assumes a volume for the particle as opposed 
to the Fraunhofer theory which assumes a projected area for 
the particle. It also requires a knowledge of the ratio of 
the RI of the particle to that of the suspending medium. 
The relativ e refractive index has both a real and imaginary 
contribution. The real contribution controls how the light 
is deflected by the particle and the imaginary contribution 
determines how much light is absorbed by the particle. In 
practice it is found that non-spherical particles or 
particles with a high degree of surface roughness behave as 
if they had a higher than expected imaginary RI compared 
with the properties of the bulk material [Bohren and 
Huffman 1983]. 
The theory assumes that the dispersant is transparent and 
theref~re has a zero imaginary contribution. For crystals 
in a satura ted solution, the relative refractive index is 
close to 1 . For systems with relative RI's close to 1, 
refraction of light through the particle contributes to the 
forward sca ttering. Quantification of the errors in this 
respect using a Malvern 2600 particle sizer (as used in the 
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present study) has been carried out by Kusters et al. 
(1990). 
Thus, Mie theory describes exactly how particles of 
different sizes and optical properties interact with light 
[Jonasz 1991]. However, for some materials in which the 
particles have sizes smaller than the wavelength of light, 
a simplification of Mie theory (Raleigh-Debye-Gans theory) 
can be used . For particles less than 1/10th the wavelength 
as Raleigh of the illuminating beam, all materials act 
scatterers. In other words, the scattering 
(equal energy is scattered at all angles), 
is isotropic 
allowing for 
further simp lification. 
Limitations of the Mie theory for various particles (eg 
latex sphere s, air molecules) have been examined by Jaggard 
et al. (1981). They validated the use of this theory for 
latex spheres, but noted an underestimation of the phase 
function at large scattering angles. This has also been 
reported by other workers [Zerull et al. 1977; Perry et al. 
1978], and suggests that the difference between 
experimental data and theoretical Mie values will increase 
for larger or more irregular shaped particles. 
The Equivalent Sphere theory 
A problem in particle size analysis is the calculation of 
volume distr ibutions for non-spherical particles, since the 
shape of such particles is unknown. However, if the mass 
of the part icle is known, it can be converted into the 
weight of an equivalent sphere (w = 4~r3 p) from which the 
diameter can be calculated. 
For example , to calculate the spherical equivalent diameter 
D2 of a cyl i nder of diameter D1 = 20~m and height 100~m the 
following c a lculations are necessary (where X is the radius 
of the equivalent sphere): 
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Volume of cylinder = ~r2h = 10000~(~m3 ) •••.. 1 
Volume of sphere . . . • . . . • . • • . • • • 2 
X= (JV/4~) 1 / 3 = 19.5~m 
o2 = 39.1~m 
The equiva lent spherical diameter for the cylinder is 
therefore approximately 40~m. 
ll.1.2 MALVERN PARTICLE SIZER: THEORY 
Research i nto particle size measurements using non-imaging 
light scattering techniques [Cornillault 1972; Weiss and 
Frock 1976 ] led to the development of the first commercial 
laser diffr action size analyser. One such device which is 
now marketed by Mal vern Instruments was invented in the 
Department of Chemical Engineering and Fuel Technology at 
Sheffield University, England [Swithenbank et al. 1977; 
Felton 1978 ]. Early research into crystal growth rates of 
potassium iodide, formed using seed crystals, 
conducted using this machine [Felton and Brown 1980]. 
were 
The first particle size analysers used Fraunhofer theory to 
account f or the extra scattering of light by small 
particles. Newer machines (eg Malvern Mastersizer) use a 
combination of the Fraunhofer and full Mie scattering 
theories [Agrawal et al. 1991]. The Malvern 2600 used in 
the present study uses the Fraunhofer theory for 
measurement s of liquid droplet sprays and metal in liquids. 
The anomal ous theory is used for particles in air and 
particles i n liquid (the latter was used in this study). 
The Malver n particle sizer uses Low Angle Laser Light 
Scattering (LALLS) . The method is rapidly becoming the 
preferred s tandard for measurements in industry due to its 
accuracy and wide range of applications [Mohamed et al. 
1981; Burkholz and Polke 1984]. 
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A diagram of the 2600 Malvern optical unit is shown in 







Piqure 1: 2600 Malvern particle sizer optical unit used 
in the pres ent study. 
The optical measurement unit consists of an optical 
transmitter , a receiver and an optical bench. The 
transmitter unit consists of a He/Ne laser, its power 
supplies and the beam expanding optics that create the 
laser beam. · The receiver unit consists of the range lens, 
the detector and the associated electronics and computer 
interfaces. The optical bench maintains the alignment of 
the transmit ter and receiver units relative to each other. 
Mounted on this bench is a moveable holder for the flow 
cell. The optical configuration· is shown in Figure 2 

















Figure 2: The Malvern optical configuration. 
Diffraction 
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Light from the low power HejNe laser is used to form the 
analyser beam. This beam is collimated and is 
monochromati c; it is typically about 18mm in diameter. The 
light scatte red by the particles in the sample cell and the 
unscattered light are incident on the receiver lens (range 
lens). The unscattered light is focussed to a point on the 
axis. The Fourier transform lens forms the far field 
Fraunhofer diffraction pattern of rings of the scattered 
light around the central spot [Thyagaragjan and Ghatak 
1981]. 
The scattere d light over a range of solid angles of scatter 
is then gat hered by a detector which is usually a thin 
wafer of photosensitive silicon. This detector, which is 
placed at t he focal plane of the lens, is in the form of 31 
concentric a nnular sectors. The dimensions of the detector 
are listed by Dodge (1984) and Hirleman et al. (1984). The 
diffracted light is concentrated concentrically at a 
distance f r om the point of focus. This distance is a 
function of the particle diameter. The remaining light 
which is not diffracted is focussed on the detector and 
passes stra ight through a small aperture and out of the 
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optical sys tem. A sample volume concentration can thus be 
determined _by monitoring the - total laser power passing out 
of the system in this way. 
The position of individual particles and their state of 
motion have little effect on the diffraction pattern which 
is created . The range lens configuration has the property 
that whenever the particle is in the laser beam, it's 
diffraction pattern is stationary and centered on the range 
lens optical axis. This means that no matter where the 
particle i s in the beam or even if it is moving through the 
beam, the l ight diffracted at an angle 9 will result in the 
same radial displacement in the focal plane. The lens 
transformat ion is optical and fast. This property is shown 
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Fiqure 3: Properties of the range lens. 
In practic e many particles of different diameters are 
illuminated by the beam at the same time. A series of 
concentric light rings are generated at various radii, each 
being a f nction of a particular size. The rings of light 
intensity are superimposed to form a combined pattern. The 
amount of light intensity at any point on the matrix of 
detectors allows the number of particles present to be 
calculated and the particle size is given by the distance 
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from the c enter of the diffraction pattern. The smaller 
the partic J_.e is, the further ·is the ·-diffraction response 
from the center as shown in Figure 4 [Lines 1990]. 
large part icles 
scatter at low angles 
small part icles 
scatter at high angles 
detector measures 






Figure 4: Properties of the scattered light. 
To avoid unrepresentative sampling of the bulk, a time 
averaged observation of the scattering as the material 
continuously flows through the analyser beam, is used. 
This time averaging occurs over any period in the range 
between 5 s econds and 2 minutes. 
During this time, the measured light scattering is 
continuously changing, forming the instantaneous integral 
of the material illuminated by the beam. By averaging the 
measurements of the detector readings (sweeps) it is 
possible t o build up an integral light scattering matrix 
based on mi l lions of individual particles. 
Range lens 
For particl es of size greater than l~m, the scattering 
angle is i ndependent of the optical properties of the 
medium or the suspended particles. The scattering is 
therefore due to the diffraction of light around the 
particle. No knowledge of the optical properties of the 
medium or t he suspended particles is necessary. This is 
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due to t h e fact that any absorption of light into the 
particle j s ignored by the Fraunhofer and Anomalous 
theories. 
For particl es of size less than 1~m, the coupled light is 
not complet ely attenuated and can therefore emerge as a 
refracted r ay. Knowledge of the refractive indices then 
becomes necessary and light scattering theory is used. 
Photon correlation spectroscopy (PCS) [Berne and Pecora 
1976; McCave and Syvitski 1991) can be used in the 
analysis o f the particle range where the diffraction theory 
breaks down . The method is able to size particles in a 
state of Brownian motion suspended in a liquid. The 
technique c an measure particles in the size range 1nm-1~m 
at scattered light intensities so low that a 
photomultip lier tube with a signal correlator is needed. 
Measurement of movement enables calculation of particle 
size due t o the inverse proportionality relationship. 
Alignment of the optical system 
Alignment of the laser beam is achieved using the align 
display mode with . subsequent movement of the detector using 
X and Y ad j usters on the transmitter unit. The detector is 
moved until the focussed laser spot coincides with the 
central det ector which is located behind a small hole in 
the main de tector. Maximising the power of the beam on the 
central det ector achieves alignment of the optical system. 
This procedure is followed in the absence of any sample . 
Diagramatically the change from misalignment to alignment 
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Figure 5: Misalignment (a) and alignment (b) of the 
laser. 
Vignetting 
Lens cut off (vignetting) occurs when the sample to be 
measured i s too distant from the range lens. As a result, 
the range lens, with its limited aperture, is unable to 
capture the maximum scattering angle of the material. 
Vignetting is noticeable in the alignment procedure of the 
Malvern ins trument. A display of the beam alignment shows 
the light energy falling on each detector. Rapidly 
decreasing energy at large angles is characteristic of 
vignetting and this is illustrated in Figure 6 [Mal vern 
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Figure 6: Align display showing vignetting error. 
Background measurement 
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The range l enses have a wide angle of light acceptance 
which makes the subtraction of extra contributions from the 
sample measurement necessary. This background measurement 
takes into account both the "blank" sample and the stray 
light contr i butions. Background light should be measured 
under the s ame conditions as sample measurement. It is 
also necess ary to measure the background as close as 
possible to the time of sample measurement to ensure that 
there are no time variations in the stray light. After the 
blank measur ement, the sample cell should not be moved as 
the cell wi ndows are part of the measurement zone [Chu 
1974]. An internal electronic background is automatically 
subtracted f rom the blank and sample measurements. 
Refractive index 
Laser light scattering is a flexible technique with one 
qualification that each phase must be optically distinct 
from the other and the medium must be transparent to the 
laser wavele ngth. In other words, the RI of the material 
and the supporting medium must be different. 
Measurement of the RI of the particle is achieved by 
suspending the sample particles in a mixture of two 
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liquids, t h e RI of each being known. The mixture of these 
two liquiqs is constituted - in such ·---a way that minimum 
scattering is obtained. At this point, the RI's of the 
sample and the medium are the same. The RI of the sample 
is then obtained from measurement of the RI of the 
suspension. Choice of the suspension liquids is limited as 
the RI of the sample must be between those of the two 
suspending liquids [Phahla 1991]. 
Since calci um oxalate is the material of interest in the 
present study, calculation of its RI is accomplished . using 
the Lorentz-Lorentz formula which was obtained from the 
Clausius-Mossotti relation (Equation 3) 
Guenther 1990]: 
[Atkins 1982; 
a (n) = (3/4~N) [(nr- 1)/(nr + 2)] • • • • • • • • • • • • 3 
where a(N) = the molar polarisation of the suspending 
medium 
N = Avogadros number 
nr = refractive index of the medium. 
Molar refractivity, Rm, is given by Equation 4: 
Rm = [(nr- 1)/(nr + 2)]Mm/p . . . . • . • . . . . . 4 
Where Mm = molar mass and p = density. 
Equation 5 is used for a mixture of liquids: 
where j = 1 to N (where N is the number of liquids) 
w = weight of mixture 
Wj = weight of jth component of the mixture. 
Thus: 
Rm = I[ (n · 2 J J - 1)/(nj 2 + 2)] {Wj/Pj) 
= I[ (n · 2 
J J 
- 1)/(nj 2 + 2) ]Vj because Vj = Wj/Pj 
where j = 1 to N. 
•••••• 5 
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The refractive index of the suspension is thus given by 
Equation 6: 
where Vm = total volume of the medium. 
Substituting for solid caox: 
Rm = (Ca2+) + (C-C) + 2(C=O) + 2(C-O) 
= 1.19 + 1.2 + 2(3.34) + 2(1.41) 
= 11.89 
Mm = 146.111gjmol 
Vm = 146.11/2.25 = 64.94 
• . . . . . . . 6 
therefore 
and nr = [(64.94 + 23.78)/(64.94- 11.89)] 1 / 2 
= 1. 29 
This value is very close to that of water ie 1.33. 
Assuming a value of 1.33 for urine, a large log difference 
value can be expected because of the closeness of the 
refractive indices. The log difference value gives an 
indication of the fit of the data to the chosen model. The 
larger the difference, the worse the fit. Smaller log 
difference values might be possible if an approximate 
scattering matrix is used (ie one that is determined from 
the calculated refractive index). 
Obscuration and sample measurement 
Under measur ement conditions, the suspending medium must 
have a stable refractive index. Variations in the index 
arising from inconsistencies in the suspension may lead to 
extra scattering signals during sample measurement. 
Air bubbles in the suspension, turbulence and beam steering 
all cause s cattering and result in unstable alignment. 
Beam steering is caused when the magnitude of the variation 
in the RI is large relative to the magnitude of the beam 
diameter. Such variations arise from slight changes in the 
temperature (temperature gradients) between different 
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regions in t he sample. on the other hand, turbulence gives 
rise to sm~il scale inqex variations that diffract light in 
the same way as particles do. These variations appear as 
apparent scattering contributions at low angles and appear 
to come f rom very large size particles. This is 
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Fiqure 7: Alignment display showing extra scattering in 
the first t wo inner rings. 
Figure 7 r epresents the alignment screen display of the 
Malvern in t he presence of the suspending fluid only. The 
fluid flows through the beam under identical conditions as 
those when the sample particles are also present. The 
extra scattering appears in the first 2 rings of the bar 
graph at the right of the figure. These lower rings 
represent s cattering by small particles. In the case shown 
in Figure 7, the extra scattering would be erroneously 
measured as small particles. On the other hand, second 
order scatte ring would show fluctuations in the outer, high 
angle detect ors [Chigier 1984]. This scattering does not 
occur in the sample shown in Figure 7; however, if it were 
present it would appear in rings 30 and 31 in a similar 
fashion to t hat shown in rings 1 and 2. 
These index variations also manifest themselves in the 
changing obs curation values in the Malvern data. A stable 
obscuration shows a stable size distribution. If the 
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obscuration decreases constantly from one reading to the 
next, then _· the crystal size- could be- increasing or the 
material c ould be precipitating because of inadequate 
pumping speeds. Another possibility is that the sample 
could be d i ssolving into the suspending fluid. On the 
other hand, if the obscuration values increase rapidly it 
could be indicative of the particles preferentially 
attaching themselves to the glass cell windows due to 
surface char ges. The particles would thus be in the beam 
continuously , causing increased concentration values. 
Over-concent ration of the particles in the sample can also 
lead to mult iple scattering [Felton and Brown 1980]. This 
widens the a ngle of light scatter. This in turn, results 
in a broade r size distribution with a smaller mean size 
becaus~ the scattering angle is inversely proportional to 
the particle diameter. Corrections for multiple scattering 
using the i ndependent model have been developed by Hamidi 
and swithenbank (1986). 
The Mal vern instrument has an option to view the sample 
concentration before measurements to allow dilution to be 
effected if necessary to obtain acceptable obscuration 
values (dimensionless) within 0.1 - 0.5. 
11.1.3 MALVERN PARTICLE SIZER: DATA ANALYSIS 
The scattering matrix 
Both the Mi e and diffraction theories may be used to 
calculate s cattered light intensity as a function of 
scattering angle and particle size~ The total light energy 
distribution is the sum of the products of the energy 
distribution for each size range and the weight fraction in 
that range. Because only relative distributions are 
produced, the weight and volume are synonymous. 
The scatteri ng pattern for a single sphere is shown in 
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Fiqure 8: A single sphere scattering pattern showing an 
intensity d istribution of scattered light energy (symbols 
are explained below in equation 7). 
The centre o f the diffraction pattern gives maximum light 
intensity wh ich oscillates with decreasing amplitude as the 
distance from the axis increases. The diameter of the 
diffraction pattern is inversely proportional to the 
particle diameter [Riley and Agrawal 1990]. The particle 
size distribution cannot be determined from the intensity 
distribution , but it can be determined from the light 
energy distr ibution. The light energy within a circle of 
radius s in the focal plane is given by Equation 7 [Brown 
and Felton 1985; Felton 1990]: 
where L = light energy 
f = focal length of the lens 
a = radius of the particle 
x = diffracted light energy (Figure 8) 
. • • • . . • • • • 7 
s = radius of circle in which the light energy is 
contained 
>.. = wavelength 
Jo,J1 = Bessel functions [Felton 1990] 
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Felton (1990) and also Gouesbet and Grehan (1988) have 
shown that ·the light energy within a ring between radii s1 
and s 2 from a particle of radius a is given by Equation 8: 
Ls1,s2 = E{Jo2 (kas1 /f) + J 12 (kasl/f) - Jo2 (kas2 /f) -
J 1
2 (kas2 /f)} ............................... 8 
where k = 2 1£ I). 
' E = e nergy falling on particle. 
This is p r oportional to the cross-sectional area of the 
particle f or a uniform beam: 
. . . . . . . . . . . . . . . . . . . . . . . . . 9 
With more t han one particle, the sum of contributions from 
the size classes leads to Equation 10: 
..................... 10 
Vi is the volume fraction in the ith size class. 
Substitution for a particle of radius a, gives the first 
maximum at: 
21rasj).f = 1. 357 ••••••••••••••••••••••• 11 
The total l ight energy distribution is equal to the sum of 
products of the energy distribution for each size range and 
the volume fraction in that size range. 
The derivation of the volume size distribution V(j) can be 
related to the measured data L(i) by the following matrix 
equation [Malvern Instruments User Manual]: 
L(i) = V(j)T(i,j) ..........•..... 12 
where i = t h e index of size bands 
j = t h e index of detector elements 
T(i,j) describes how particles in size band i 
sca tter light to detector element j . 
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Figure 9 s hows the matrix calculated from the Fraunhofer 
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Figure 9: The calculated scattering matrix. 
The main pe ak arises from the interaction of the forward 
scattering lobe and the detector. As the particles get 
smaller, t h e forward scattering lobe gets broader and 
therefore t he matrix peak moves to larger angles. The 
forward sca ttering lobe is the major component of the 
Bessel function which describes the diffracted light 
distribution. The smaller peaks to the right of the main 
peaks are the 2nd and 3rd Bessel function peaks. The 
detector d i mensions and size bands are optimised so that 
the peaks i n the matrix fall close to the diagonal. The 
scattering functions have been normalised so that the peaks 
all have the same height [Hirleman et al. 1984]. 
Light passi ng through the particle would be indicated by 
higher secondary peaks which, if not analysed properly, 
could be mis-interpreted as the main peaks generated by 
smaller particles. Only one matrix is calculated for each 
lens corresponding to a particular refractive index ratio. 
Kusters et al. ( 1990) computed that the Malvern matrix 
corresponds to a refractive index ratio of approximately 
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1. 2. They proved that serious errors can occur when the 
systems to be sized have a -refracti ve---i.ndex ratio close to 
1. 
The distribution functions available for use with the 
Malvern instrument are the Normal, Log normal, Rosin-
Rammler and the Model Independent (Histogram) [Cadle 1955]. 
Analysis model 
In the pres ent study, no mathematical description relating 
the volume in one sizeband to that in any other was 
assumed, v i z the Model Independent Analysis [Randolph and 
Larson 1971] model was used. This model performs a 
deconvolution analysis of the measured intensity to extract · 
a siz~ dis tribution without relying on a specified size 
distribution function. Inversion methods are not possible 
because of the constraint that V(j)~O (Equation 12). 
Therefore a volume distribution is estimated based on the 
measured l ight energy data and a new light energy 
distribution is calculated using Equation 12. The 
parameters are then iteratively adjusted until the sum of 
the squared errors in L(i) are minimised [Malvern 
Instruments User Manual]. 
The residual (log difference) is calculated as 
Residual= log10 (~(L(i) - V(j)T(i,j)) 2 •••• 13 
where L(i) is the data calculated from the estimated volume 
distribution. The parameters of the volume distribution 
above are then iteratively adjusted until the residual is a 
minimum. A log difference of less than 5 shows a good fit 
of the data to the model. 
Various i ntrinsic sample factors and the experiment 
protocol c a n contribute to poor fitting of the data. Most 
of these have been described in detail in this Chapter 
II.1.2. Br iefly, sample errors include contamination from 
particles too large to measure, and use of an inappropriate 
model for the sample distribution. Errors arising from the 
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experiment include incorrect optical alignment, incorrect 
background_ measurement_, incorrect choice of lens and dirt 
on the opt ics. Sufficient signal accumulation is also 
necessary f or representative measurements. 
Sample concentration 
As previous ly mentioned, the undiffracted light which is 
focussed onto the center spot allows for the calculation of 
the sample concentration. This was calculated directly 
without "in-situ" calibration for the first time by Brown 
and Felton (1985). 
The ratio of the light intensity at the center spot before 
and after sample measurement gives the fraction of light 
obscured by the particles [Felton 1990]. Using the Beer 
-
Lambert Law (Equation 14): 
ln (I/Io) = -Tl ................... 14 
where 
I = light i ntensity with sample 
Io= light i ntensity without sample 
1 = optical path length 
(i = 1 to m) 
Ni= number of particles of size class i per unit volume 
Ai= mean pa rticle projected area of ith size class. 
The measur ed obscuration can be related to the total 
projected cross-sectional area of the particles. The 
concentrati on is also dependent on the beam length. 
The concentration is expressed as a % of the volume of 
dispersant in Equation 15 [Mal vern Instruments User 
Manual]: 
c = 100loge(1-0b) ............. 15 
-(3/2)b~(V·Q·jd·) 1 1 1 1 
where b = beam length 
Ob = obscuration 
Qi = extinction coefficient of sizeband i 
V · 1 = volume in sizeband i 
d· 1 = mean diameter in sizeband i. 
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Measured and derived diameters 
The relative volume corresponding to the 32 size bands is 
obtained from the output of the Malvern and is presented in 
table form. The entire volume of the particles present is 
assumed to lie within this range. Since the weight of a 
sphere = 4 /3wr3p, the mean diameter is calculated by 
Equation 16 : 
Mean diameter= (~d3/n)1/3 •••.••..•••• 16 
This is a number mean (number volume or number weight) 
because the number of particles (n) is taken into account 
in Equation 16. Mathematically this is represented by 
D [ 3, 0] • D [ 4, 3] and is known as the volume mean diameter 
(VMD) or De Broukere diameter. In terms of an arbitrary 
shaped particle, 0[4,3] is the sphere of equivalent volume 
to the particle and is calculated in Equation 17: 
••••••••••••••••• 17 
The sphere of equivalent surface area is 0[3,2] also known 
as the Saut er Mean diameter (SMD) and is given by Equation 
18: 
••••••••••••••••• 18 
The number of particles does not appear in Equations 17 and 
18. Laser diffraction does not require the number of 
particles to obtain a size distribution. 
In a simila r way, the number mean (number length mean) and 
number-surface mean are defined in Equations 19 and 20 
respectively: 
0[1,0] = ~d/n ..... 19 0[2,0] = (~d2 /n) 1 / 2 ..••• 20 
A D [ 1, 0] would be generated using an electron microscope 
for example and a method using image analysis would 
generate 0[2,0]. 
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The natural result of the Malvern measurement is a volume 
distribution . This may be converted to a number, surface 
area or length distribution, but care must be taken when 
doing so t o ensure that the reproducibility error in one 
distribution is not too large in another. The different 
means can be converted to each other using the Hatch-Choate 
transformat i on [Hatch and Choate 1929]. 
The transformation of the distribution is achieved by 
Equation 21 : 
X, - V·d·T-3 l. - l. l. •••.•••••••••.•.•.•.• 21 
where Xi = t ransformed distribution 
Vi = v olume in sizeband i 
di = mean diameter of sizeband i 
{geometric mean, square root of the product of 
s ize boundaries) 
T = 3 :volume, 2:surface area, 1:length, O:number 
The distributions can be described using statistical 
parameters. The first 3 moments, mean, standard deviation 
and sk.ewnes s are best described in terms of the derived 
diameters D[m,n] as shown in Equation 22: 
......... . .. 22 
where Vi = volume in sizeband i 
di = mean diameter of sizeband i. 
Equation 23 sums the relative volume in each sizeband 
multiplied by a power of the mean diameter of that 
sizeband: 
D[m,n]{m-n) = ~m 
ofn,ofn •••••••••••••••• 23 
The span is calculated from the percentiles in Equation 24 
[Malvern Ins truments User Manual]: 
Span= orv.0.91 - orv.0.11 
D[v,O.S] .•...•.....•. 24 
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D[v,0.9] and D[v,0.1] show the diameters at 90% and 10% of 
the distribution respectively ; -
The span g ives a measure of the width of the volume 
distribution relative to the median diameter D[v,0.5]. 
The uniformi ty (volume median diameter) D[v,0.5] is defined 
in Equation 25: 
u = ~ildrv.o.5J - dil 
d[v,0.5J~i ...........•...... 25 
and is a measure of absolute deviations from the median 
diameter. 
The specific surface area is the surface area of a unit 
volume of p a rticles expressed in Equations 26 and 27: 
SSA = Total area 
Total volume 
= 6~iMi 
~ i ........................... 2 6 
Vi = volume in size band i 
di = mean d i ameter of size band i. 
SSA = 6/0[3,2] . . ................. 27 
All of these measured and derived diameters are produced in 
the output from the Malvern, the software of which allows 
for the easy transformation into the other distributions. 
11.2 COULTER MULTISIZER: THEORY 
Single part i cle stream scanning methods involve a stream of 
particles p a ssing through an optical or electrical sensing 
zone. 
The Coulter Counter is an example of the electrical sensing 
zone method . It was developed by Coulter in 1956 [Coulter 
Multisizer Manual Issue C] and was originally applied to 
blood cell counting and later to bacterial cell counting 
[Coulter 1957]. Use of the method for cell-volume 
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distribution measurements was demonstrated later by 
Kubitschek _· (cited by [Alleh -1981]). ·--Further improvements 
by Coulter Electronics have led to the use of the Coulter 
Counter in particle sizing. 
The counting and sizing of caox crystals in urine using the 
coulter Counter . was reported first by Robertson (1969). 
Since then , the technique has been applied extensively in 
the analysis of caox crystallisation processes in urine 
(Markovic a nd Komunjer 1979; Ryall et al. 1981a; Tiselius 
1985; · Azour y et al. 1987; Grover et al. 1990b] with much 
emphasis be ing placed upon inhibitor activities [Robertson 
and Peacock 1972; Robertson et al. 1973; Bowyer et al. 
1979; Ryal l et al. 1985,1991; Edyvane et al. 1987; Berg and 
Tiselius 1989; Grover et al. 1990a). Computer modelling 
programs to aid in the calculation of growth in 
supersatura ted solutions using the changes in size 
distributions have been developed by Ryall et al. 
( 1981b, 1984 , 1986) . Calculation of growth in the presence 
of simulta neous aggregation is made possible by these 
computer c r ystallisation models. 
Operating principles 
A diagram of the Coulter Multisizer equipment [Allen 1981] 
used in the present study is shown in Figure 10. 
A B c 
Figure 10 : The Coulter Multisizer. 
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The instrument comprises a sampling stand (B), a vacuum 
control un :j..t (C) and the ma1rt electronics unit with printer 
(A) • 
The Coulter method involves determining the number and 
volume of s ingular particles suspended in an electrically 
conductive liquid. The stirred suspension is forced 
through a small aperture by means of a vacuum. Two 
electrodes are placed in the conductive liquid on either 
side of the aperture and a constant current is maintained 
between them. 
As each par ticle, moving along a randomly distributed path, 
passes through the aperture, it changes the impedence 
between the two electrodes. The first electrode is inside · 
the aperture tube and holds that part of the electrolyte at 
ground potential. The second electrode is connected to a 
constant c urrent supply and is immersed in the solution in 
the sample cup. The change in resistance between the two 
electrodes generates a voltage pulse, the amplitude of 
which is a pproximately proportional to the displaced volume 
of the part icle. The principle limiting resistance to the 
current is the electrolyte within the aperture itself. The 
Coulter is able to maintain a positive voltage pulse due to 
internal c orrections of positive and negative current 
polarity. 
The number of particles in a unit volume of suspension can 
also be de termined using the built-in manometer syphon 
system. This allows for the determination of particle 
concentration. Particle shape cannot be measured by the 
method, so results are expressed in spherical equivalents. 
This proves to be valid, as sufficiently high numbers of 
particles are counted to ensure an averaging of 
orientations of particles traversing the aperture [Fine 
Particle App lication Coulter IssueD]. 
Measurement of crystal growth is achieved by monitoring the 
increase i n the crystal volumes [Markovic and Komunjer 
1979; Ryall et al. 1981a] whereas the percentage change in 
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total crys tal numbers gives an indication of crystal 
aggregatio!'i [Ryall et al. 1"98la]. 
After coincidence corrections, the measured pulses are 
electronica lly amplified, 
This accumu lation occurs 
sized, counted and accumulated. 
in equivalent spherical diameter 
size channels which are pre-calibrated. The size 
distribution of the suspended phase can then be determined 
from derived data . 
The analys i s of liquid and electrical current flow through 
the apertur e is not simple. Assumptions are therefore 
necessary i n the derivation of the electrical response from 
particle pa ssage. These assumptions are as follows [Fine 
Particle Application Coulter IssueD]: 
1. The ape rture contents form a cylindrical resistor in 
which curre nt density is uniform. 
2. Multiply ing the aperture length by an appropriate factor 
incorporate s the electrically effective zones outside the 
aperture. 
3. The pass ages of individual particles occur at random and 
are evenly distributed through the aperture cross-section. 
4. The elec trically effective volume of a particle in the 
aperture ma y be expressed as a cylinder having the same 
resistivity as the particle. 
Notwithstanding that the electrical pulse is correlated 
with the particle volume, the two variables cannot be 
related simply unless the particle is a smooth sphere. 
This is due to the dependency of the signal on the shape of 
the particle. Calibration is effected by smooth latex 
spheres and is based upon -the assumption that the pulse 
height is proportional to the particle volume. The data 
from the Coulter are therefore equated for spheres and as 
such are not absolute for irregularly shaped particles. 
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Figure 11 illustrates the Coulter principle (adapted from 
(Allen 198~ ]). 




























counter stop/start counter 
tacts register 
Figure 11 : The Coulter principle. 
A controlle d external vacuum unbalances the mercury siphon 
and initiates sample flow from the standard sample cup, 
through the aperture and up into the aperture tube. The 
system is t hen isolated from the external vacuum and sample 
flow continues due to the siphoning action of the 
rebalancing mercury. The 
mercury c o lumn contacts 
suspension continues to 
count procedure beg ins when the 
the start probe. The sample 
flow through the aperture, up 
through t he aperture tube and into the waste flask. 
Counting stops when the mercury column reaches the stop 
probe. The distance between the start and stop probes is 
fixed and i s directly related to sample volume. 
The immersed electrodes measure ·the change in resistence 
resulting f rom particle passage through the orifice. The 
size distri bution of the suspended phase is calculated from 
the derived data generated from the voltage pulses. All 
amplified voltage pulses that are above the adjustable 
threshold level are counted. These counts represent the 
number of particles larger than a determinable volume 
proportiona l to the appropriate threshold setting (Allen 
1981]. The determination of number frequency as a function 
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of volume can be achieved by analysing counts at various 
amplificati ons and threshold settings. 
A modificat ion for urinary crystal size measurement with 
the Coulter Counter was described by Ryall and Marshall 
( 1978) . The method ensured that there was no skewing of 
the results by large particles. This was accomplished by 
ensuring t hat the counting was taken at equal size 
increments instead of the constant threshold settings 
previously used. 
There is a wide range of operating modes available to 
obtain opti mum results from the sample analysis (Operating 
Manual Coul ter Multisizer Issue C]. Methods of sampling 
include manual startjstop, and pre-selection of time, 
volume and total count. Various levels of resolutions of 
the size distribution are also available ranging from 
division i nto 16 to 256 channels (Operating Manual Coulter 
Multisizer Issue C]. 
Interfacing of the Coulter with a computer has allowed the 
manipulation of raw data (Muerdter et al. 1981]. 
Distributions of number, volume and surface area are 
available in both differential and cumulative modes. 
Calibration 
Calibration of the Coulter Counter is effected by the count 
integration procedure using narrow distribution (monosized) 
smooth particles of known density. 
The scaling of current to voltage conversion is set during 
the calibra tion so that specific particle sizes can be 
recognised. Effectively the calibration establishes the 
particle s i ze (volume) that is represented at one channel 
edge. (Exp lanation of the calculation of channel sizes is 
described l ater in this Chapter II. 2 under "Channel size 
calculation") . There is a regular geometric size 
progression between all the channels in use so that as soon 
as a part i cle size is represented by one channel, the 
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remaining channel sizes are automatically computed. The 
Coulter is_ equipped with automated ca-libration procedures 
for standar d orifice tube sizes to make calibration easier 
[Coulter Mu ltisizer manual Issue C]. 
Electrolyte 
In general, water insoluble particles can be dispersed 
using appropriate surfactants in aqueous electrolytes such 
as sodium chloride (NaCl). When choosing an electrolyte, 
it is . neces sary to ensure that it is compatible with the· 
material being analysed. 
Orifice tube 
The percentage current 
through the aperture 
change as each particle passes 
is proportional to the ratio of 
particle vo lume to volumetric aperture size (cross section 
multiplied by length through wafer). Although there is a 
wide range of aperture diameters available, the upper 
particle vo lume diameter which can be measured by each 
aperture is limited. This is due to the previously 
mentioned proportionality being linear to only 40% of the 
aperture d i ameter because of aperture blockage when larger 
particles a re present in the suspension. For particle 
diameters below about 2% of the aperture diameter, the 
current change is too small to detect reliably. 
Coincidence correction 
The Coulter Counter automatically corrects the particle 
counts for coincident particle passages [Wales and Wilson 
1961, 1962]. There are two types of coincident particle 
passage, namely primary and secondary [Allen 1981]. 
Primary coi ncidence, also known as horizontal interaction, 
occurs when two particles give rise to pulses at the same 
instant. The result is an overlapping of the two pulses. 
Secondary coincidence, or vertical interaction, occurs when 
the individual pulses from two particles are addi ti vely 
large enough to be sensed. The result is the measurement 
of a single large pulse. This occurs when the two 
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particles a re of similar size and are close to each other. 
Coincident, · particle p~ssage - can affect the measured size 
distribution due to the errors of primary count loss, 
secondary c ount gain, and shadow loss [Kaye 1981]. The 
latter occurs when a particle is not sensed due to its 
proximity t o another particle that is being measured. The 
measured particle can desensitize the measurement zone 
around itself for a short period thus enabling closely 
following particles to go undetected. 
Overall coi ncidence can be avoided by observing alLowable 
limits in counts per second for the aperture in use. 
Calculation of these limits from first principles is given 
by the formula described by McCave and Jarvis (1973). 
Dilution 
limit is 
of the sample is necessary if the coincidence 
e xceeded. This is because loss of data in the 
small size classes will occur, leading to a narrowing of 
the distribution. As long as the acceptable coincidence 
levels are maintained, the number of particles in the large 
size classe s will be low. This is due to the logarithmic 
decrease i n the population distribution as size increases. 
To avoid poor analytical resolution in these size ranges, 
sufficient crystals must be counted leading to long 
counting t i mes. 
It is neces sary to filter the electrolyte and blank sample 
solution s o that the lowest possible background count is 
obtained. Attempts have been made to analyse unfiltered 
and undilut ed urine with the Coulter Counter [Hennequin et 
al. 1991]. However, their coincidence levels were found to 
exceed the limit of 20%. This was due to the large number 
of particle s in the unfiltered sample. Blocking of the 
aperture wa s found to be due to gross particulate matter 
which is pr esent in all unfiltered urines as opposed to it 
being caused by large crystals per se. 
In practic e it is necessary to keep the coincidence 
correction at a level of about 10% while ensuring the 
standard deviations are kept below 0.5% by reading particle 
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numbers in the tens of thousands. This will lead to an 
overall acquracy of co~nting better than 1%. 
Channel size calculation 
A simplified diagrammatic representation of the full range 
analysis is shown in Figure 12 [Coulter Multisizer manual 
Issue C] where LC and RC are the left and right edges 
respectively of any channel other than channel X. 
With reference to Figure 12, the size of the right edge 
(RE) of any channel (X) is given by Equation 28: 
d~m = (Kc*X)/(J(I*G) 1 / 3 .••.•.•.•.•..•. 28 
where Kc i s the overall calibration constant, J is the 
number of c hannels in use, and I and G are the current and 
gain respect ively. 
J CHANNELS 
X 
· d MIN LC RC LE RE dMAX 
Cursor positions 
at LC,RC 
Any channel X, 
with left edge (LE) 
and right edge (RE) 
Figure 12: Full range analysis of the Coulter counter. 
The calculat ion of the diameter of any channel X is given 
by Equation 29: 
•••••••••••••••••••• 29 
where U = 256(X/J- 1). 
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Equations 30 and 31 allow for the conversion into area and 
volume respectively: 
area (J.Lm2 ) 1rd2 •.......•........ 30 
volume (J.Lm3 ) = 7rd3 /6 ........•.... 31 
The true midpoint (dm) of each channel (Equation 32) is 
used in the weighting procedure: 
dm = (d(x-1) + dx)/2 •.•••••••..•• 32 
Diameter weighting is then given by Equation 33: 
X= };[f(dm)Jj};f •••••••••••••••••• 33 
where m = (X-0.5) and f represents the channel contents. 
A similar p r ocedure to that for the full range shown above, 
is followed for the narrow and window ranges. These ranges 
are used when greater detail of a specific size range is 
required aft er an accumulation in full range has given some 
knowledge o f the sample distribution. 
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CHAPTER III 
DESIGN AND DEVELOPMENT OF THE 
MSMPR CRYSTALLISATION SYSTEM 
III.l INTRODUCTION 
The mixed suspension mixed product removal (MSMPR) 
crystalliser s ystem is an example of a steady state continuous 
crystalliser. It can be used to generate particles by 
evaporation, cooling, or chemical reaction (Randolph and 
Larson 1971; Youngquist and Randolph 1972; Jancic and Garside 
1975; Garside and Jancic 1976; Brecevic and Garside 1981; 
Grootscholten et al. 1982; Bennett 1984; Nishio et al. 
1990,1991; Kavanagh et al. 1993]. Evaporation is normally 
achieved unde r vacuum to remove the solvent which causes 
deposition of the solute (Grootscholten et al. 1982]. 
Crystallisation by cooling involves lowering the temperature 
of the crysta lliser which contains a concentrated pre-heated 
solution. The cooling results in deposition of the solute due 
to a decrease in solubility at lower temperatures (Garside and 
Jancic 1978]. 
Precipitation systems are the most common for laboratory use. 
In this type of crystalliser, a third component (in which the 
solute is ins oluble) is added to · the system, or a chemical 
reaction is i n itiated in which the product is insoluble in the 
crystallising medium [Brecevic and Garside 1981]. An 
advantage of the precipitation crystalliser is that it can be 
used in isothermal conditions and at atmospheric pressure 
(Randolph and Larson 1971]. 
The MSMPR c r ystalliser which generates supersaturation by 
chemical reac tion is the type used in the present study. 
Supersaturation is generated by the continual feeding of 
reactants into the crystalliser; constant supersaturation is 
achieved afte r 10 volumes have passed through the chamber 
(Randolph and Larson 1971; Brecevic and Garside 1981; Rodgers 
and Garside 1981; Li et al. 1985]. Constraints of the steady 
state operat i on are that the feed rate, composition and 
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temperature are constant as well as crystalliser volume and 
temperature LRandolph and Larson 1.971]. 
111.2 CRYSTALLISER 
Several design requirements were necessary in order to satisfy 
fundamental MSMPR crystalliser constraints. 
Firstly, the design must allow perfect mixing to be achieved 
in the cryst alliser such that the liquor composition and 
crystal .size d istribution are uniform throughout. 
Secondly, there must be no size classification ( ie the mean 
retention probability of the particles must not vary over the 
particle size range to be measured) at the offtake, ensuring 
that the_ discharge suspension density, size distribution and 
liquor compos i tion are the same as in the crystalliser. 
Thirdly, the size of the crystalliser should be such that a 
minimum volume of feed is needed and minimum disturbance is 
caused by samp ling [Randolph and Larson 1971]. 
Crystal . breakage is assumed to be negligible and shape is 
assumed to be uniform. 
The design f e atures of the crystalliser used in the present 
study were modelled on guidelines by Brodkey and Hershey 
(1988) and are shown in Figure 3.1. 
The following definitions are used to describe the physical 
dimensions of the agitation vessel: 
B Width of e ach baffle 
C Distance f rom tank bottom to impeller center line 
D Impeller d iameter 
T Inside diameter of tank 





11 impeller l ~ 









dimensions of the 
crystalliser. 
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An impeller i s a device that provides agitation and mixing of 
a liquid. Impellers are classified into both axial and radial 
flow with the three main types being propellers, paddles and 
turbines. 
In designing the crystallisation unit, the following ratios 
had to be satisfied [Brodkey and Hershey 1988]: 
D/T = 1/3 (For turbulent flow regimes) 
B/T = 1/18 (For propellers) 
(The ratio B/T applies for center-mounted impellers and is 
usually equal to 1/12 for turbine or paddle agitation. 
Propellers are high speed, axial-flow impellers for low 
viscosity l i quids, and as such, do not require baffles as 
large as those for radial-flow impellers). 
C/T = 1/3 (Bottom clearance of any impeller) 
Z/T = 1 (Fluid level in the tank) 
These ratios have been derived from many laboratory scale 
experiments a nd are the principle dimensions used during the 
scale-up to plant size systems. The first three ratios ensure 
a maximum leve l of mixing while at the same time keeping the 
power input and operating costs to a minimum. The fourth 
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ratio ensures that the most distant regions of the 
crystalliser a re mixed. 
The physical dimensions that satisfied these conditions and 
which were use d in the present study for a vessel of volume 
200cm3 (as quoted by other workers in the literature) are: 
T = 63.5mm 
z = 63.5mm 
D = 21.17mm 
c = 21.17mm 
B = 3.52mm 
The crystallis er consisted of a rounded flat bottomed 200cm3 
glass vessel. It was surrounded by a water jacket to allow 
for thermostatting and was closed at the top by a tight 
fitting lid. The lid incorporated holes to allow for an 
overhead stirr er and for input and output feed lines [Bennett 
1988]. The overhead stirrer was centrally mounted and the 
input and output feed lines were on opposite sides to each 
other. This was done to ensure that the solutions were not 
withdrawn from the crystalliser prior to their being mixed. 
The feed lines and offtake were also positioned midway between 
adjacent baff les. Introduction and withdrawal of the 
solutions in t his position ensured better mixing than if they 
were introduce d along the baffle positions. 
III.3 IMPELLER DESIGN 
Mixing 
The overall process of mixing consists of macro-, meso- and 
micromixing. Macromixing is concerned with mixing on the 
scale of the whole vessel (ie. bulk blending) [Baldyga and 
Pohrecki 1995 ) and is considered in more detail later in the 
following four pages. Mesomixing is the turbulent dispersion 
of the inlet feed just after it has entered the reaction 
vessel [Baldyg a et al . 1993]. Micromixing then occurs in the 
turbulent concentration field created by the mesomixing 
process. Baldyga and Pohorecki (1995) have reviewed turbulent 
micromixing wh ile Bourne and Dell' ava ( 1987) have considered 
the different types of mixing on scale-up. 
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Garside and Tavare ( 1984, 1985) and Tavare ( 1986, 1989) have 
shown that micromixing can significantly -~nfluence the overall 
performance of the crystalliser. Tavare (1994) has also shown 
that micromix ing effects are more important when reactants 
enter the MSMPR crystalliser separately rather than when they 
are pre-mixed. Baldyga and Bourne (1992), showed 
experimentally that competition between micromixing and the 
reaction dete rmines the product distribution at low feed 
rates. Using a semi-batch reactor, they considered the 
importance · of micro- and mesomixing as process controlling 
rates. 
Bourne and Yu ( 1994) integrated their theoretical model of 
micromixing with an experimental flow model. Using two and 
three paralle l reactions they investigated the effect on· 
micromixing of feed positions, dished and flat bottomed 
vessels, vess el size, stirrer speeds and impeller diameter. 
Using a Rus hton turbine to develop and maintain fully 
turbulent fl ow, Bourne et al. ( 1995) have shown that fluid 
viscosity is a relevant variable for micromixing. Also, using 
a computational fluid mixing model, Bakker and Fasano [ 1994] 
theoretically calculated blend time and chemical product 
distributions in turbulent, agitated vessels and considered 
the effect of inlet feed positions. 
In precipitat ion processes, the crystal size distribution 
(CSD) is dependent upon all the three processes of mixing 
[Pohorecki a nd Baldyga 1988]; however, since chemical 
reactions, n cleat ion and growth occur on a molecular level, 
only molecular level mixing should affect their course. 
Laminar and turbulent flow 
As already mentioned, the flow patterns of a liquid in a 
vessel depend upon various factors such as the size of the 
vessel, presence of baffles, the characteristics of the fluid, 
and the mode of stirring [Skrtic et al. 1987]. The design of 
the impeller has a strong impact on the type of flow and the 
energy requir ements [Bates et al. 1963]. The degree of 
suspension r equired also determines the amount of power used 
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with each specific impeller. Although there is a large range 
of impellers _available for mixing, the choice is restricted to 
whether laminar or turbulent flow is required (Brodkey and 
Hershey 1988] . Laminar flow occurs when the flow patterns 
produced by the impeller are radial and tangential only. 
Turbulent flow causes axial flow patterns which incorporate 
the radial, tangential and longitudinal components of flow as 
discussed later in the next section "Velocity components of 
flow". 
If laminar flow is required an anchor or a helix impeller can 
be used. Typically laminar flow impellers are large and 
operate at low speeds, providing poor mixing. For turbulent 
flow there is a range of turbines with pitched blades and also 
a range of pit ched blade mixing propellers. 
The performanc e of various impellers and the effect of the D/T 
ratio has bee n examined by Shaw (1992). More specifically, 
three and s ix bladed axial flow propellers have been 
considered by Musil et al. (1984). To ensure thorough mixing 
for a uniform size distribution, turbulent flow was necessary 
in the system used in the present study. 
Velocity components of flow 
The overall f l ow pattern in the vessel depends upon variations 
of the three velocity components of fluid flow from point to 
point. The r adial component acts perpendicular to the shaft 
of the impelle r. The longitudinal component acts parallel to 
the shaft, and the tangential or rotational component acts in 
a direction tangent to a circular path around the shaft 
(McCabe and Smith 1976]. 
For mixing, t a ngential flow is undesirable. Using an impeller 
located vertically and at the center of an unbaffled vessel, 
the tangential component poses two problems. The first is 
laminar flow of the liquid around the impeller. This flow 
causes rotation of the fluid in distinct levels which do not 
intermix, leading to the absence of longitudinal flow 
necessary for thorough mixing. Centrifugal forces from these 
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circulatory c urrents then force the particles to the vessel 
walls. Thi~ eventually leads - to a ·concentration of the 
particles at the center of the vessel bottom. This entire 
process is due to the same angular velocities of the impeller 
and fluid. 
Vortices 
The second problem of tangential flow is the formation of a 
surface vortex , which, if deep enough, can entrain air into 
the fluid. The presence of a vortex can also raise the level 
of the outer fluid which could lead to spillage. 
Vortex systems also occur in the region around the impeller 
blades [Calabr ese and Stoots 1989]. These are different for 
each imp~ller design, and an understanding of this region is 
necessary for various agitation applications [Kumar et al. 
1991a,b]. 
To counteract the tangential velocity component, four equi-
spaced baffles were incorporated into the crystalliser design 
for the present study. Mounting the impeller off-center 
[Garside and Jancic 1976], or in the side of the vessel 
[McCabe and Smith 1976] can also prevent the circulatory flow. 
The effect of mixing intensity on the particle size obtained 
from both baff led and unbaffled vessels in a semi-continuous 
and batch process has been investigated by Pohorecki and 
Baldyga ( 1983 ) both theoretically and experimentally. They 
developed a new model of micromixing to determine the CSD from 
precipitation reactions. Their predicted results agreed with 
experimental r esults for the precipitation of Baso4 in a 
stirred crystalliser and showed that the rate of 
crystallis_ation and the CSD are directly influenced by the 
mixing intensit y. 
Propeller 
The flow currents leaving a propeller continue through the 
fluid until t hey are deflected by the wall or the bottom of 
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the vessel. If there is no slip between propeller and the 
fluid, then one full revolution of the propeller would move 
the liquid longitudinally through a fixed distance [McCabe and 
Smith 1976]. This distance is dependent upon the angle of 
inclination of the propeller blades. The ratio of this 
distance to the propeller diameter is known as the pitch of 
the propeller . 
To provide t he necessary turbulent flow, a vertical, center 
mounted two b l ade propeller with a pitch of 45° was chosen for 
the present s tudy. The steel propeller and baffles were 
coated with teflon [Bourne and Zabelka 1980] as soft-coated 
impellers were found to produce fewer nuclei than steel 
impellers in s tudies of secondary nucleation of K2S04 [Shah et 
al. 1973; Randolph and Sidkar 1974,1976; Evans et al. 1974]. 
In the present system, the propeller was driven by a Heidolph 
RZR50 motor. A commercially available heavy base stand was 
required to s upport the motor as a consequence of its weight 
and strong vibrational motion [Fasano et al. 1995]. 
A schematic d i agram of the liquid flow in a baffled vessel is 
shown in -Figure 3.2. The propeller drives the liquid straight 
down to the bottom of the vessel. The flow currents then 
spread radial l y outwards toward the wall, upwards along the 
wall, and then finally return to the suction of the propeller 






Flow currents in the 
crystalliser. 
J~ \.."'-. 
If control ove r the direction and velocity of flow to the 
suction of the impeller is required then a draft tube can be 
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used [Garside and Jancic 1978]. Oldshue (1969b) has discussed 
the general _ principles of suspending ·-solids and gases in 
liquids and has considered variables such as D/T, the height 
of suspension and settling velocities. He has also reviewed 
general and s pecific mixing [Oldshue 1969a,1989]. 
111.4 THE OFFTAKE TUBE 
The validity o f the kinetic measurements depend upon achieving 
the conditions which were assumed when the size distribution 
equations were derived. However, even if the crystalliser 
conditions a re achieved, the sampling procedures and 
subsequent sample treatment can destroy the validity of the 
results. Therefore, much time was spent on achieving 
representative sampling in the present study. 
A pipette was used by Rodgers and Garside ( 1981) for the 
intermittent r emoval of the product from the crystalliser. In 
the present s t udy, it was decided to withdraw the crystalliser 
product using a vertical tube immersed into the sample rather 
than a built-i n offtake at the side of the crystalliser [Zacek 
et al. 1982]. This ensured that the offtake direction was the 
same as the d irection of flow in the crystalliser. In this 
way it was hoped to mimic sampling by a pipette. The offtake 
was positioned midway between two adjacent baffles and also on 
the opposite s ide to the input feeds [Zacek et al. 1982]. 
The first des ign was a simple glass offtake tube. The tube 
was made as s hort as possible to minimize any changes which 
might occur in CSD as the mixed product flowed from the 
crystalliser t o the cell in which the CSD was to be measured 
(Figure 3.16 page 99). The glass was not connected directly 
to the cell be cause of the difficulty of glueing it to teflon. 
Therefore a s hort connecting section of tygon tubing was used. 
Due to restr i cted laboratory space for the crystalliser and 
cell, the offt ake tube incorporated a u-bend. The bend angle 
was made as s mall as possible to minimize any laminar flow 
effects. 
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With this des ign, it was not possible for the entire offtake 
tube to be j_acketed for . thermostatting ·-due to constraints on 
the physical space available. 
During this e arly stage of system development, an attempt was 
made to use t he offtake tube not 
levelling device as well. 
only for sampling, but as a 
The offtake design and 
in Figure 3. 3. During blank configuration are represented 
determinations, the sample tube was immersed to a depth equal 
to that of t he midpoint of the propeller blades [Zacek et al. 
1982] for sample withdrawal (Figure 3. 3a). During unsteady 
state conditi ons, when the product from the crystalliser was 
withdrawn to waste and not to the cell, it was positioned at 
the top of t he fluid in the crystalliser (Figure 3.3b). When 
steady state was finally attained, the offtake tube was 
immersed to the level shown in Figure 3.3a. 
-r- - ' 
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Figure 3.3: Sampling positions inside the crystalliser. 
A problem arose with this first design. While the tube was 
being used as a levelling device (Figure 3. 3b) , air bubbles 
became entrapped inside it. These bubbles remained in the 
offtake tube until they grew large enough to be swept away. 
Often, these same bubbles were pulled down into the cell 
during sampl i ng (Figure 3.3a) and were erroneously counted as 
very large p articles ~ 180~m. 
It was theref ore decided to keep the sampling tube immersed in 
the crystall i sing medium (Figure 3. 3a) during unsteady state 
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in an attempt to stop air being entrained into the offtake 
flow. 
This led to a further problem of deposition of caox crystals 
on the outside of the immersed section of the tube prior to 
steady state being attained. This effect occurred as a result 
of the (unheated) glass tube being immersed in the 
crystallising medium while steady state was being approached. 
These shortcomings led to the following modifications of the 
offtake . tube. 
Elimination o f the bubbles was tackled first. The propeller 
speed was i ncreased to 1100 rpm and the flow rate of hot 
filtered wate r was increased to 60 ml/min. This was done to 
exaggerate t he number and size of the bubbles that might be 
expected under normal experimental conditions (950rpm, 
40mljmin), thereby allowing for easy observation. 
Due to the suction action of the pump, it was impossible to 
prevent minut e bubbles (originating from the crystalliser), 
from entering the glass offtake. Therefore, it was decided to 
attempt to e ntrap the bubbles somewhere in the tube before 
they reached the cell. The idea was to create a small 
reservoir at the top of the u-bend (Figure 3.4) . 







Figure 3.4: Reservoir 
concept for entrapment 
of air bubbles 
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To maintain the constant temperature, the whole of the 
reservoir was_ surrounded py a waterjacket: -
To allow entry of a small quantity of air into the reservoir 
after it had been filled with untreated urine, a tap was 
fitted. In t his way it was hoped that bubbles entering the 
system would r ise to the top of the reservoir and hence would 
not be sucked down the outlet to the Malvern cell. 
It was apprec i ated that the reservoir at the top of the u-bend 
should be as s mall as possible to ensure minimal effect on the 
steady state CSD. However, in the early stages of design 
development, t he reservoir had a relatively large volume of 
3ml to observe the bubbles more easily. 
Unfortunately, due to the action of the pump, a few tiny 
bubbles moving along the lower section of the u-bend in the 
glass tube s till managed to reach the cell. A minor 
modification to the above design was therefore required. This 
comprised a s mall lip at the position where some of the 








incorporation .of lip 
for impeding the flow 
of bubbles. 
The lip had t he desired effect of impeding the flow of tiny 
bubbles until t hey concentrated and grew into a larger bubble. 
Once the bubble was big enough it managed to escape from the 
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glass lip and rose up to the air trap. In this way the lip 
managed to prevent bubbles that were -travelling along the 
bottom of the u-bend from being pulled into the Malvern cell. 
However, despite these design modifications, close inspection 
of the cell windows and the section of tubing between the 
reservoir and cell still showed the presence of bubbles. 
Further improvements in the design were therefore necessary 
and the next modification is shown in Figure 3. 6. In the 
design shown in Figure 3 . 5, the close proximity of the inlet 
(from the crystalliser) and outlet (to the Malvern cell) had 
permitted the easy passage of bubbles to the Mal vern cell. 
This had been obviated by the introduction of the lip. 
t 
Malvern cell 
separation has been 
increased rela tive 
to Figure 3.5 
_..out 
t herm ostatted 
water jacket 
...,. in 
Fiqure 3.6: Raised 
inlet (from the 
crystalliser) in 
relation to the outlet 
(to the Malvern cell). 
In the design shown in Figure 3. 6, the distance between the 
inlet and out let was increased in .an attempt to reduce the 
force with which the bubbles were pulled down into the cell. 
It can be see n that relative to the designs shown in Figures 
3.4 and 3.5, t he inlet to the reservoir is raised in relation 
to its outlet . It was therefore anticipated that the lip 
would no longe r be necessary and hence it was removed. 
Unfortunately , this modification was not successful. Due to 
the high flow rate of 60mljmin, the force exerted on the 
bubbles was t oo strong for them to become trapped in the 
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reservoir. I nstead, they were immediately pulled down into 
the outlet tube (to the Malvern cell) and never entered the 
air trap. To overcome this, the inlet and outlet were 
positioned still further apart as shown in Figure 3.7. This 









Fiqure 3.7: Inlet and 
outlet positioning at 
opposite sides of the 
reservoir to maximise 
the distance between 
them. 
It was realised that an obstruction of some kind was needed to 
counteract the strong pumping action. Four glass indents were 
incorporated into the design (Figure 3.8). These proved to be 











Having solved the problems of air bubbles, a new problem was 
identified. Initial . experiments demonstrated that the 
reservoir produced a concentrating effect on the solution 
causing cryst al deposition on the glass close to the outlet 
tube, well be fore steady state was achieved. Thus the sample 
being measured (in the Malvern cell) was not representative of 
the steady sta te distribution in the crystalliser. 
This deposition was caused by the presence of a large volume 
of urine in Figures 3. 7 and 3. 8 relative to the preceding 
designs~ 
In the next design (Figure 3. 9), the reservoir was retained 
but, to allev iate the problem of deposition, it was made as 
small as poss ible. In doing so, the inlet and outlet were 
placed closer to each other as in Figure 3.4. The connecting 
volume of the reservoir and u-tube was once again made as 
small as poss ible, but spirals were introduced to impede the 
downward flow of bubbles into the cell. The spiral was 
constructed in a stretched configuration to maintain a 
downward flow and therefore reduce the likelihood of crystal 









Incorporation of two 
spirals. 
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This design was successful in preventing the bubbles from 
entering the ~alvern cell. The bubbles either rose to the top 
of the reservoir or were trapped inside the spirals. 
To minimise the distance through which the 
travel between the crystalliser and the cell 
one loop was finally. used (Figure 3 .10) • 
reservoir was also kept to a minimum of 1cm3 . 
sample had to 
a spiral of only 
The volume of the 




Fiqure 3.10: Final 
offtake design with 
a single spiral • 
Another problem with all of the designs (Figures 3. 6-3. 9) 
arose as a result of the distance between the sampling point 
(inside the crystalliser) and the joint of the unheated and 
heated sections of the glass offtake ("a" to "b" in Figure 
3.9). In t he initial designs (Figures 3.6-3.9), a tiny 
deposit was s ometimes seen at the connection point because as 
mentioned prev iously, thermostatting of the entire offtake was 
not possible. 
In an attempt to overcome this problem the glass section "a-b" 
was replaced by tygon tubing to determine whether deposition 
would occur on the tubing (implying that deposition occurred 
on the glass only) • The glass was tapered at point "b" 
(Figure 3.9) and tygon tubing was fitted over the glass. 
However, this proved to be unsuccessful as deposition occurred 
at the tip of the glass taper possibly due to the narrowing of 
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the glass hole . Noting this, a short section of glass near 
point "b" was _ widened and tygon tubing was inserted inside the 
glass up to point "b" (Figure 3 .10) . To ensure a complete 
seal, the tubi ng was covered lightly with high vacuum grease 
before being inserted into the glass section. Thereafter, 
deposition was not noted at point "b" nor in the entire 
offtake. 
The design shown in Figure 3.10 successfully eliminated the 
bubbles and t h e deposition on the immersed section of tubing 
inside the crystalliser. (Indeed, deposition was noted on the 
immersed tygon tubing in only a few experiments; these were 
then discarded and a lower concentration of the feed NaOx 
solution was u s ed). 
III.5 THE CONNECTION BETWEEN THE OFFTAKE 
TUBE AND THE SAMPLING (MALVERN) CELL 
In initial experiments using urine, the total flow from the 
MSMPR crystalliser was directed into the Malvern cell during 
both the unste ady and steady state periods. This protocol 
involved measur ement of a background count using an untreated 
sample, followe d by a period during which there occurred the 
flow of unstea dy and steady state product through the cell. 
Finally the ste ady state sample was measured. 
As described in Chapter III.4, these initial experiments were 
plagued with t h e problem of bubbles in the cell. As a result, 
bubbles appear i ng in the cell during unsteady state operation 
could not be r emoved before a measurement. 
Emptying the cell to remove the bubbles would involve 
reversing the flow of the sample through the cell. As the 
crystalliser i s directly connected to the cell, the reversal 
of sample flow would imply the re-introduction of the unsteady 
state product into the crystalliser. This would therefore 
cause contamina tion of the sample within the crystalliser. 
It was therefor e necessary to divert the flow of the unsteady 
state product f rom the Malvern cell to avoid this problem. 
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In order to change the direction of flow from the crystalliser 
to waste (dqr ing unsteady state) and to the cell (during 
steady state), a 4-port flow switching device was used. 
Figure 3. lla indicates the operation of the switching device 
allowing sample flow from the crystalliser to the Malvern cell 
(Figure 3.11a(i)) or to waste (Figure 3.11a(ii)). 
from crystalliser delrin nut 
I 
~@- @1 to waste to flow cell 
I I 
ferrule 
from stock urine tygon tubing 
a ( i) or cleaning solution b(i) 
from crystalliser r I 
-@- Ollill) to stock urine or to flow cell to waste '-.....-
I connection as used 
from stock urine with switches 
a(ii) or cleaning solution b( ii) 
Fiqure 3.11: 4 port flow switching device and connector. 
In Figure 3 .lla ( i) the switch allowed flow from the 
crystalliser to the flow cell. The switch was used in this 
position for both blank and sample determinations. At the 
same time, the other port of the switch served a dual purpose 
for allowing the recycling of stock untreated urine or the 
flow of a cleaning solution to waste after sample 
determination. 
the switch is reversed to that shown in In Figure 3 .l l a ( ii) 
Figure 3 .lla ( i ) . In this position, the switch allowed the 
crystalliser to be diverted to waste. flow from t h e 
Simultaneously , the urine from the stock solution flowed to 
the cell through the other port and was cycled back to the 
stock volume. If multiple determinations were necessary, this 
port was used to pass a cleaning solution through the flow 
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cell and then to waste. The switch was used in this position 
during the un~teady state . operation of the MSMPR crystalliser. 
A plastic connector that screwed into the switching device is 
shown in Figur e 3.11b. Tygon tubing was inserted into a tight 
fitting, threa ded delrin nut which was later screwed into the 
switch. To e nsure that the tubing was flanged against the 
inner section of the switch (so that there were no leaks from 
a gap between the hole in the switch and the hole in the 
tubing) , a f e rrule was inserted into the end of the tubing 
(Figure "3.11b ( i)). The delrin nut was then pushed to the end 
of the tubing so that it formed a tight fit onto the ferrule 
(Figure 3 ~ 11b ( ii)). Four of these connectors were attached to 
the four ports of the switch. 
Unfortunately, proper sealing of the tygon tubing to the 
switch was not possible. This caused small leakages of the 
sample as we l l as incorporation of air bubbles into the 
flowing stream. Another problem arose as a result of the 
holes in the s witch being of much smaller diameter than that 
of the tygon tubing. This caused blockage of the holes in 
the switch by deposited caox. When blockage occurred, the 
experiment wa s stopped due to overflow of the MSMPR 
crystalliser. The problems of sample leakages and air 
bubbles were overcome, using high pressure vacuum sealant 
around the connections. 
The problem of blockage of the holes in the switch could not 
be solved and it was therefore decided to remove the switch 
from the system. 
With the removal of the switch, the problem arose again as to 
how to divert the unsteady state product from flowing through 
the Malvern c e ll. An alternative approach was to use a 2-way 





waste Malvern cell waste Malvern cell 
b 
dead volume 
waste Malvern cell waste Malvern cell 
Fiqure 3.12: Two types of 2 way valves used. (a): single 
channel; (b): double channel. 
In both of the 2 way valve designs, the glass offtake tube and 
the glass valves were tapered and were connected by tygon 
tubing. This involved warming the glass taper and simply 
pushing on the tygon tubing as a tight fitting sleeve. · Once 
the glass cooled, the seal was complete. 
There were several drawbacks associated with these designs. 
Firstly, the valves and the immediate area around them could 
not be thermostatted at the temperature of the experiment 
because of physical constraints with respect to manipulating 
the taps. As a result, caox deposition occurred near the 
valves before steady state was achieved. Secondly, in both of 
the two way va lves shown in Figure 3.12 there exists a small 
dead volume that is not heated during unsteady state operation 
because it is isolated from the sample flow. In addition, in 
Figure 3.12b there is an additional unheated sample plug 
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trapped in t he unused channel of the valve during unsteady 
state operat~on. Since . mixing of the heated steady state 
sample with t hese unheated sections of sample would have had 
an effect on the CSD, it was necessary to either avoid or at 
least minimi ze such regions. Thirdly, even though the 
fittings were tight, both valves l~aked despite the 
application of high vacuum grease. 
grease led to blocking of the valve. 
Administration of more 
Use of these valves meant that it was not possible to have 
flow through t he cell during the unsteady state period as had 
been done in using the switch. This meant that the flow cell 
would either have to be empty or be filled with untreated 
stock urine during this stage. The presence of static urine 
in the cell wa s preferred as this would allow the cell windows 
to be thermostatted at the correct temperature since the 
untreated urine in the cell was maintained at the same 
temperature a s the sample in the crystalliser. There would 
therefore be no temperature gradient when the steady state 
product was d i verted into the cell. 
The problem of leakage from the valves was not solved so it 
was decided to remove them from the system and replace them 











to waste to cell 
a b 
Fiqure 3.13 : Two types of 2 way valves used with screws. 
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In Figure 3. 13a the glass junction was angled into a Y shape. 
During unstea dy state operation, screw "x" was open and "Y" 
was closed. (This was reversed for steady state operation) . 
However, a c onsequence of this configuration was that a small 
volume of sample was left static in branch "Y" leading to a 
small quantit y of crystal deposition before steady state was 
attained. Therefore, the design was modified (Figure 3 .13b) 
to a T junction but, due to the presence of the horizontal 
connecting s ection, even more deposition occurred along the 
entire length near the adjustable screws. 
This design concept was therefore abandoned. Instead, the 
glass tube wa s split into two angled branches (as in Figure 
3 .13a) and is shown in Figure 3.14. Clamps were used to 
control the flow of sample. 
from crystalliser 




Final connection used 
with the introduction 
of clamps to restrict 
flow. 
During unsteady state operation, clamp "x" was open and clamp 
"y" was closed. Although there still existed a tiny volume of 
liquid in branch "y" that would not become mixed with the rest 
of the samp le, no observable deposition occurred here, 
possibly due to the unheated volume of branch "y" in Figure 
3. 14 being much smaller than that in Figure 3 .13a. When 
steady state was attained, clamp "x" was closed and clamp "y" 
was opened. In this mode, no apparent temperature effect on 
the Malvern r e adings was noted as a stable Malvern obscuration 
value was obta ined. 
With this design, the entire glass offtake (with the exception 
of the two s mall sections of the tapered glass) could be 
thermostatted . The dead volume that was not heated (between 
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the glass tubing and the cell) was kept to a minimum of less 
than 0.25cm3 .. 
The final offtake configuration and its connection to the 
















Figure 3 .15 : The complete offtake design and connections 
from the crystalliser to the flow cell. 
111.6 MALVERN FLOW CELL 
A flow cell was designed for use in the present study (Figure 
3.16) since the cell supplied by the Malvern manufacturers was 
unsuitable for the specific requirements of the project. For 
example, the volume of the original flow cell was too small, 
the connections would have required larger inner diameter 
tygon tubing than that needed for the pre-determined flow 










Malvern flow cell. 
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The newly designed flow cell was constructed from a teflon 
block through the centre of which a cylinder was cut to 
ultimately form the sample chamber. Teflon was selected as no 
deposition of CaOx occurs on this material (Mueller private 
communication). The diameter of the cylinder was equal to the 
diameter of t he receiver lens. This ensured that the laser 
beam would not be obstructed by any part of the cell. 
The cylinder was bored in such a way that the windows on 
either side were flanged against an inner ridge which 
ultimately defined the sample cylinder diameter as lOmm. The 
inner rim of the cylinder facing the laser beam was milled 
with increasing diameter to ensure maximum capture of the 
laser beam. The side facing the transmitter unit was slightly 
tapered. The path length of the laser beam (lOmm) was small 
enough to ensure that the scattered light would be measured 
and that it would not be lost due to scattering at too wide an 
angle within the cell. The total sample volume within the 
cell was 7.07ml. 
111.6.1 FLOW CONNECTORS 
Threaded holes were drilled in the top and the bottom of the 
cell. These threaded holes were not drilled to facilitate 
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flow per se, but were drilled to accomodate two screws. Tygon 
sample tubing_ was pushed into the center of these two custom-
made plastic s crews to form a tight seal. The tubing-to-screw 
connections were sealed with epoxy sealant. High vacuum 
grease was als o applied to the connection. 
Initially, these flow connectors were screwed in as far as 
possible so that they were aligned with the circumference of 
the inner samp le cylinder. However this proved unsuitable for 
two reasons. Firstly, the flow of the sample into the cell 
formed a · fast stream in the path of the laser beam causing 
fluctuations i n the sample measurement. This effect occurred 
irrespective of whether the flow direction through the cell 
was from top t o bottom or visa versa. Secondly, when the flow 
direction wa s downwards, obscuration values increased 
significantly . This was attributed to poor withdrawal of 
sample particles leading to their accumulation in the lower 
curved regions of the cell. As this section is in the laser 
path, these particles were continually measured thereby 
causing a large error in the CSD. 
Improvements i n the cell involved boring the input and output 
holes into a f unnel shape which was tapered to the size of the 
connectors at the outer sections. In addition, the flow 
connectors wer e screwed in half way only. This resulted in a 
gentle flow of sample along the sides of the cell thereby 
diminishing t he effect of the flow patterns. When the 
particles exit ed the cell through the funnelled offtake they 
were no longe r in the path of the laser beam and hence no 
concentration effect occurred. 
111.6.2 CELL WINDOWS 
The cell windows were positioned on either side of the 
cylindrical s ample chamber (Figure 3.16). On the inner side, 
the cell windows were held in place by the ridge of the inner 
cylinder of t he teflon cell. On the outer side they were held 
in position by an o-ring and a perspex retaining wall. The 
retaining wall was itself held in position by screws that 
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passed through the cell and were bolted in at the opposite 
end. This configuration is shown in Figure 3.17. 
'[~ 
~ 
0 @ @ 0 ~ ' / ' 
• 't t i i t rubber glass t glass rubber retaining 
wall 
r ing window Malvern cell window ring retaining wall 
Fiqure 3.17: Placement of cell windows. 
Initial testing of this cell was accomplished using warm, 
filtered, glass-distilled water which was cycled through it. 
While attempting to align the cell, poor laser intensity 
values were obtained due to spurious light energy readings in 
the middle rings as shown in Figure 3.18. 
Source B'ground Record no.O 256 
Rin Data Focus 63 
0 524.97 16 17.85 
1 50.47 17 17.76 
2 28.16 18 18.77 
3 17.29 19 20.06 
4 15.99 20 20.20 
5 14.03 21 20.40 
6 14.84 22 21.30 
7 13.78 23 22.15 
8 14.22 24 23.18 
9 13.76 25 24.10 
10 14.27 26 25.84 
11 14.92 27 27.45 
12 15.16 28 28.71 
13 151.20 29 26~74 
14 16.76 30 24.38 5 10 15 20 25 30 
15 16.83 Ring no 
Fiqure 3.18: Background reading showing error in ring 13. 
When the laser beam impinges on the windows of the cell, part 
of the light is reflected back towards the transmitter. 
Usually this reflection appears as a well defined circle 
however, due to the error in alignment, this circle was poorly 
defined. 
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The table and corresponding bar graph in Figure 3.18 indicate 
the light ener gy in each of 31 concentric rings. Ring 1 is 
associated with the smallest particles and ring 30 is 
associated with the largest measureable particles for a 
particluar lens. Ring 0 indicates the light energy impinging 
on the central detector; it should be made as high as possible 
when aligning the laser beam. Rings 1-30 should indicate 
values below 30 otherwise either the alignment is incorrect, 
or the cell windows are not clean. In the case shown in 
Figure 3.18, r ing 13 indicates an irregular and unacceptably 
high reading during alignment. 
The cell was repositioned by adjusting 2 screws on the cell 
holder to ensure that the laser beam was not obscured by any 
part of the cell. Since repositioning of the cell did not · 
totally eliminate the spurious peak, it was concluded that it 
was due to the windows not being perfectly parallel. 
Accordingly, t he inner cylinder of the cell was remilled. 
Care was also taken to ensure that the screws were tightened 
equally when securing the windows. These modifications 
successfully eliminated the spurious peak. 
A second method to ensure that no obscuration of the laser 
beam occurs due to the cell, involves the correct positioning 
of the reflect ion of the beam from the cell windows. The 
reflection from the parallel windows was therefore maintained 
above the beam expander for each experiment by adjusting the 
screws in the cell holder and this is shown in Figure 3 .19. 
(The beam expa nder is also known as the transmitter lens and 
its function is to expand the diameter of the laser beam, 
which was creat ed in the transmitter unit, to 10mm). 
ideal position 
for reflection 
from cell window 
beam expander 
Fiqure 3.19: Alignment of cell. 
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It was also necessary to ensure that the glass windows were of 
the same thickness. Differences in the thickness can cause 
large errors i n the first and second rings giving rise to the 
observation o f two laser spots from the cell window reflection 
rather than one. 
111.6.3 THERMOSTATIING 
The cell was thermostatted by circulating heated water as 






Design of cell 
thermostatting. 
After the wat er had reached the required temperature, 30 
minutes were allowed for temperature equilibration to be 
achieved. 
111.7 SYSTEM DEVELOPMENT 
DESIGNno.l 
A flow diagram of the first design is shown in Figure 3. 21. 
It is noted that a simple glass tube offtake was used to pump 
sample from t he crystalliser into the cell. Thus, unsteady 
state products flowed through the cell prior to the attainment 
of steady sta te, causing deposition of caox on the glass 
windows. This preferential attachment of the crystals to the 
glass cell wi ndows is attributed to surface charges which 
attract the crystals to attach themselves to the charge sites 
on the window . The crystals were therefore continuously in 
the path of the 






laser beam thereby causing inflated 
w 
0 
W = waste 
P = pump 
Fiqure 3.21: Design no.1 
In an attempt to counteract this effect, a surfactant, Triton 
X100 was added to the bulk untreated urine in varying 
concentrations . Volumes ranging from 1 drop per liter to 1cm3 
per liter wer e used. Care was taken to avoid adding too much 
surfactant whi ch might cause frothing. The increasing volumes 
of Triton used , led to increasing concentrations of NaOx being 
required_ to produce measurable crystallisation. Shor and 
Larson (1971) have described the effects of various ionic and 
surface-active agents . on nucleation and growth rates in their 
experiments i nvolving crystallisation of KN03 from aqueous 
solution. They concluded that the inorganic ionic additives 
used decrease d the nucleation rate and resulted in larger 
crystal sizes, and that the surfactants increased the 
nucleation r a te to produce a smaller sized product. This 
latter finding confirms the findings of the present study that 
higher concentrations of Naox are required to produce 
measurable precipitation in the presence of increasing 
surfactant concentrations. 
After several trial experiments in the present study, it was 
decided to a bandon the use of Triton and rather to restrict 
modifications of the urine to a minimum. Instead, a simple 
procedure was implemented: after thorough cleaning, the 
windows were carefully wiped to remove dust particles and a 
thin film of untreated filtered urine was applied on one side 
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of each window using a chamois leather. 
preferential crystal deposition. 
This prevented 
DESIGNno.2 
The next modification was to allow the sample through the cell 
only after steady state was reached. 
To achieve this, it was 
unsteady state product 
untreated sample had been 
necessary to divert the flow of 
(once a blank determination of 
made) to waste until steady state 
had been reached after 10 residence times. 
A 4 port flow switching valve (described in Chapter III.5) was 









recycle stock untreated 
urine or cleaning 
solution - - - - -
11 
Waste 
Figure 3.22: Design no.2 
-- -w--- -1 iB recycle stock untreated urine Stock 
(or steady state 









With the valve in position "A", untreated urine from the stock 
sample was cyc led by pump Pl through the crystalliser and the 
cell so that a representative blank measurement could be 
taken. Pump P2 was used to cycle the stock untreated urine to 
warm the tubing ~nd to achieve thorough mixing. 
Once a blank r eading had been taken, the switch was turned to 
position "B" (Figure 3. 22), and the unsteady state product 
from the crys talliser was pumped out (Pl) to waste until 
steady state was reached. Meanwhile, heated, untreated urine 
was cycled through the cell by pump P2 to allow the windows of 
the cell to be maintained at a constant temperature. 
Once steady state was reached, the switch was reversed back to 
position "A". Upon entering the cell, the steady state 
product theref ore mixed with the untreated urine already 
present and the mixture was then pumped out to waste. In the 
meantime, the tubing connected to P2 was not needed for the 
experiment and was therefore cleaned. 
DESIGNno.3 
In the early s t ages of the work, it was necessary to determine 
during the unsteady state operation of the crystalliser 
whether the crystal concentration was within the optimal range 
of the Malvern and Coulter instruments. At the same time, 
attempts were being made to obtain a range of NaOx 
concentrations that would create measureable particle 
concentrations for these two instruments. Using Design no.2, 
it was possible to measure a sample from the crystalliser 
during the unst eady state as well as during steady state. 
The procedure that was followed involved reversing the switch 
(from "A" to " B" in Figure 3. 22) after sample measurement so 
that a cleaning solution of warm dilute HCl followed by warm 
filtered water could be pumped (P2) through the cell. 
Thereafter, i t was rinsed with untreated urine which was 
eventually recycled back into the stock supply. In order to 
facilitate this process of multiple sample determinations at 
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various times before steady state, Design no.2 was altered as 








recycle into P2 cleaning solution 
crystalliser for ~
blank determination - - - stock 
or to waste 
0 
Recy le clean ing 
solution or 
untreated urine 
W""- -~ st~ck I aste 
Figure 3.23: Design no.3 
In this design , pump (Pl) was placed on the opposite side of 
the cell to t hat of the crystalliser and a second switch (S2) 
was incorporat ed into the system on the same side of the cell 
as the pump. Switch S2 was not used to change the direction 
of the flow, but was used rather as a connection for the 
various tubes . Note that in Figure 3.23, both "a" and "b" 
have switch S2 in the same position while switch Sl is 
reversed. 
Changing the position of Sl changed the operation of pumps Pl 
and P2. With the switch Sl in positon "a", urine from the 
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crystalliser was pumped (Pl) through the cell to enable the 
measurement o f a blank sample. Simultaneously, P2 pumped 
untreated urine through the other section of tubing. After 
the blank determination, Sl was reversed as shown in position 
"b". This positioning of Sl represents the unsteady state 
operation where the product from the crystalliser flowed to 
waste (P2) while the cell contained untreated stock urine 
pumped by Pl. 
When a sample determination was necessary during the unsteady 
state operation, Sl was reversed to position "a" so that 
sample from t h e crystalliser flowed through the cell and then 
out to waste (Pl). A cleaning solution was simultaneously 
pumped (P2) t hrough the other section of tubing. After an 
unsteady state determination, Sl was reversed to position "b"· 
and the product from the crystalliser was diverted to waste 
(P2) . While this mode was operating, Pl was used to pump a 
cleaning solution followed by untreated stock urine · through 
the flow cell to prime it for another determination. 
The re-positioning of pump Pl resolved another problem that 
had been enc ountered in Design no.2. Using this latter 
configuration resulted in crystals suffering a milling effect 
caused by thei r passage through Pl prior to reaching the cell. 
As a result, crystals flowing through the cell after steady 
state was attained, were not representative of the sample in 
the crystallis er. The re-positioning of Pl on the opposite 
side of the c ell to that of the crystalliser (Figure 3.23) 
caused the sample to exit the cell instead of entering it. 
DESIGNno.4 
Although placing the pump on the opposite side of the cell 
(Design no.3) negated all milling effects, the required flow 
rate of 40mlfmin could not be attained because the path length 
of the sample (2 switches and the cell) had increased. Also, 
the diameter of the holes in the switches was smaller than 
that of the t ygon tubing thereby making it more difficult for 
the pump to pull the sample through 2 switches rather than 
just one. 
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Attempts to achieve this flow rate sometimes resulted in air 
being pulled into the cell through the sides of the glass 
windows and therefore overflow of the crystalliser volume 
above the requ ired 200cm3 resulted. 
At this stage of system development, the concentrations of 
NaOx required to produce measureable crystallisation had been 
identified. Determinations during the unsteady state 
operation were therefore no longer necessary. 
Design no.3 was therefore modified by removing the second 
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0 Recycle stock untreated urine 
This design was similar to design no.2 except for the 
positioning of the pump (Pl) after the cell in the flow 
system. The switch was positioned as in "a" for blank and 
steady state determinations, and was in position "b" during 
unsteady stat e operation when the product from the 
crystalliser was pumped (P2) to waste while untreated urine 
was cycled through the cell. 
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DESIGN no.S 
Tygon tubing. had to be replaced frequently because of wear. 
As a result, it became necessary to incorporate small glass 
connectors between certain lengths of tubing. These are shown 
in Figure 3. 25. The tygon tubing was fitted onto these 
connectors by heating the glass and pushing the former onto 
the tapered sec tions of the connections. 




a = tygon tubing a-
Fiqure 3.25: Glass connections between tubing. 
The use of these connectors allowed sections of tubing that 
were worn by t he pumps to be replaced without disturbing the 
other sections that were fixed into position (eg. connectors 
on the flow cel l). 
It was during this experimental stage that it was decided to 
remove the swi tching device. Reasons for the removal have 
been discussed in Chapter III.5. Various two way valves were 
used in place of the switch but these were later replaced by 
the use of clamps (as discussed in . Chapter III. 5). Figure 
3.26 shows t he fifth system design indicating the clamps 
between the crystalliser and waste (C1) and the crystalliser 
and cell (C2). Figure 3.26a shows downward flow into the cell 
while Figure 3 . 26b shows upward flow into the cell. 
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Figure 3.26: Design no.5 showing both downward (a) and 
upward (b) flow in the cell. 
As explained in Chapter III. 5, the single offtake from the 
crystalliser . was branched with one branch to waste and the 
other to the Mal vern cell. Use of the clamps on these two 
branches meant that only one branch (ie one clamp) was open at 
a time. 
Figure 3.26a indicates downward flow of sample from the 
crystalliser t o the cell. In this mode, it was necessary to 
invert the cell as sample entering from the top would 
immediately be pulled out at the bottom by P2 and the cell 
would not become filled. 
Therefore, with C2 open (Cl closed), the cell was inverted and 
initially was filled (P2) with untreated urine from the stock 
via the cryst alliser. Once filled, the cell was turned 
upright and untreated urine was cycled through it (P2) to 
enable a blank determination to be recorded. 
After measuring the blank, two different protocols were 
possible. The first of these would involve emptying the cell 
and keeping i t as such until steady state in the crystalliser 
had been achieved. Thereafter, the steady state product from 
the crystalliser would flow downwards into the empty cell but, 
as explained, would exit immediately and inversion of the cell 
would be requi red. However, since a blank determination had 
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already been recorded, physical movement of the cell would 
cause gross e r rors in the measured CSD. 
The second p ossible protocol was to close C2 after the blank 
. determination and to open C1, leaving the untreated urine in 
the cell. After attainment of steady state, C1 would be 
closed and C2 would be opened, thereby allowing flow into the 
untreated uri ne in the cell. Mixing of the steady state 
product and untreated urine in this way would therefore not be 
representative of the cso in the crystalliser. Thus, both 
possible protocols for downward flow into the cell were non-
ideal. ·It be came obvious that upward flow would have to be 
considered. 
It was appreciated that there were two potential disadvantages 
of upward flow. Firstly, since upward flow necessitated the 
crystalliser offtake tubing to be connected to the bottom of 
the cell, a further bend in the tubing would be required. It 
was realised that this might cause laminar flow in this bend 
resulting in c rystal precipitation. Secondly, the possibility 
existed that under the effect of gravity, large crystals would 
not be pumped out of the top of the cell (ie, the flow rate 
might not be large enough to counteract the effect of 
gravity). This would mean that large particles would 
circulate in t he cell and would eventually precipitate thereby 
giving distort ed CSD's. 
In order to facilitate the decision of whether to utilize 
downward or upward flow, trial runs using both configurations 
were conducted . No significant differences in the CSD's were 
observed. However, since upward flow had fewer inherent 
difficulties this configuration was deemed to be the more 
suitable. 
Design no.6 
After measurement of the blank in the system depicted by 
Design no.5 (Figure 3.26), untreated urine was retained in the 
cell during unsteady state operation. When steady state was 
attained, the flow of the steady state product was diverted to 
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the cell. Wi th untreated urine already present it was "bubble 
free". However, errors in the CSD arose as a result of the 
mixing which occurred. 
Experiments were accordingly conducted in which the cell was 
emptied after a blank determination, and left as such for 10 
residence times. However, due to a combination of the high 
flow rate (4 0 ·mljmin) of the urine from the crystalliser into 
the empty cel l and the cooling of the glass windows (due to 
the cell be ing empty for 10 residence times), bubbles 
inevitably f ormed in the cell when the steady state product 
was introduced. These bubbles were erronously measured by the. 
Malvern as very large particles. 
Since both approaches for introduction of the steady state 
product into the Malvern cell were problematic, a further 
modification involving the incorporation of three additional 
pumps P3, P4 and P5 was necessary (Figure 3.27). 
The inclusion of P4 allowed a third approach to be 
implemented: untreated urine was cycled through the cell 
during unsteady state operation "a". In order to achieve this 
the inlet to the cell at the bottom was branched (see Figure 
3.27) with pump P4 positioned on the opposite side of the cell 











Fiqure 3.27: The final system design. 
P1,P4: Watson Marlow single channel 502 model pumps 
P3 Minipuls 2 Gilson double channel pump 
P2 Perimax 12 spectec six channel pump 
P5 Cole Palmer high flow rate pump with solid state 
masterflex speed controller 
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P2 and P3 both used PVC calibrated flow tubing 1.42mm ID 
Unsteady state operation is shown in Figure 3.27a. The 
product from the crystalliser flowed to waste via pump P5; 
simultaneously, untreated urine from the stock sample was 
continually cycled through the flow cell via pump P4 as 
described in t he previous paragraph. A few minutes prior to 
steady state being attained, air bubbles in the cell were 
115 
removed by emptying the latter and refilling it with untreated 
urine from the stock supply. 
Emptying the cell involved reversing the direction of flow 
through it (ie reversing P4 to allow downward flow through the 
cell). The sampling tube was removed from the stock untreated 
urine and the cell was emptied as a result of P4 pumping air 
instead of ur ine. Once the cell was empty, the flow through 
the cell was changed (ie P4 was reversed) to upward flow once 
again. The cell was refilled with the stock untreated urine 
without bubbl es appearing on the glass windows. A blank 
measurement was then made by cycling the untreated urine from 
the stock through the cell by P4. 
After the bla nk measurement, .the cell was emptied once again, 
by reversing P4 which was subsequently switched off. Since 
urine had flowed through the cell minutes before, the cell 
windows were still warm. After steady state had been 
achieved, the product from the crystalliser was diverted into 
the flow cel l as shown in Figure 3.27b. This involved using 
C1 to clamp the tube that had been used for the removal to 
waste of - unsteady state product. In addition, clamp C2 to the 
cell from the crystalliser was moved to the other inlet of the 
cell which ha d previously been used to cycle untreated stock 
urine. 
Thus the main features of the final design shown in Figure 
3.27 are as f o llows: 
(i) the offtake from the crystalliser is maintained at a depth 
equal to the midpoint of the propeller blades (Chapter III.4 
and Designs 1- 5); 
(ii) clamps a r e used to divert the sample flow to waste or the 
crystalliser (Chapter III.5 and Design 5); 
(iii) the flow through the cell is upwards (Design 5); 
(iv) pump P4 is placed on the opposite side of the cell 
relative to t hat of the crystalliser to avoid milling effects; 
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(v) untreated sample is cycled through the cell during 
unsteady state operation to maintain the cell windows at the 
correct tempe rature and to ensure mixing of the stock 
untreated sample. 
III.8 OPERATING CONDITIONS 
Residence time 
The particle s ize distribution (PSD) obtained by manipulating 
kinetic data is only applicable to the MSMPR crystalliser 
provided that the holding time r is the mean residence time of 
the crystals in suspension [Randolph and Larson 1971], ie: 
provided that 
T = V/Q . . . . . . . . . . . . . . . . . . . . . . . . . 1 
where V = volume of crystalliser 
Q = total flow rate (in or out) of the crystalliser 
To operate the various pumps within their optimum ranges using 
the available tubing, a residence time of 3. 6 minutes was 
initially test ed. However, the high flow rate of 55ml/min 
necessary to maintain · this residence time caused excessive 
wear and tear on the tubing; as a consequence the residence 
time was changed to 5 minutes. This reduced the required flow 
rate to 40mljmin. 
Flow rate 
The flow system consisted of two running feeds: one of 
filtered, untr eated urine and a second of aqueous NaOx. To 
ensure minimal dilution of the urine in the crystalliser, the 
flow rate of the urine was arbitrarily set at 90% of the total 
flow rate ( ie 36mljmin), while that of the aqueous Naox was 
set at 4mljmin. 
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Propeller speed 
Circulation rat e is defined as the volume of fluid moved by an 
impeller in a unit time (ie pumping capacity of the impeller) 
[McCabe and s mith 1976]. The volumetric flow rate must be 
sufficient to sweep out the entire volume of the vessel in a 
reasonable time. The impeller must also be rotating fast 
enough to ensure that the flow currents it produces reach the 
remotest regions in the crystalliser. The stream leaving the 
propeller carries a fixed amount of kinetic energy (Ek) which 
is released by the shear friction as the current flows through 
the fluid. If the stream does not have sufficient Ek to reach 
the furthest regions of the tank, dead zones are created. 
Therefore, the fluid velocity must be sufficient to provide at 
least a minimum amount of Ek· The flow rate for a propeller 
is proportiona l to agitator speed in revolutions per second 
(rps) multipl i ed by the square diameter of the impeller 
[McCabe and Smi th 1976] (Equation 2). 
Flow rate ~ noa2 . . . • • . . . . . • . . . . • 2 
where n =· the agitator speed in rps 
Da = the d iameter of the propeller 
The propeller speed must also be such that a turbulent regime 
exists inside the crystalliser providing the means of 
entraining material from the bulk of the liquid in the tank 
and incorporat i ng it in the flowing system. 
Bourne and Zabelka (1980) conducted experiments with glass 
beads and pota sh alum in a gradual classification continuous 
crystalliser. Classification occurs when the mean residence 
time T (L) , of a crystal of size L, is different to the mean 
residence time T of the slurry inside the crystalliser. 
Small, medium a nd large sized crystals can each have different 
mean residence times relative to T. Gradual classification 
occurs when T( L) is a smooth continuous function of L. Using 
a contoured ba se tank, Bourne and Zabelka concluded that the 
limiting step in homogenising the suspensions was the pick-up 
of the particles from the base of the tank. The potash alum 
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system is an example of a size-dependent growth process 
[Garside and Jancic 1978]. 
Measurement of suspension speeds is achieved by direct and 
indirect methods. Direct methods include visual, contact, 
radiation and observation of transparent liquid and sediment 
interface. Indirect methods are based upon the height of the 
interface between suspension and clear liquid, measurement of 
solid phase concentration, or measurement of mass transfer 
rates [Rieger and Di tl 1994]. Recently, Godfrey and Zhu 
(1994) used a matched refractive index technique to measure 
axial concentr ation profiles. Using tracer particles, they 
were able to visualise flow patterns by streak photography. 
Zweitering (1958) was the first to use visual methods to 
determine the conditions for complete suspension of all solid 
particles. Using a baffled vessel, he determined the required 
impeller speed as a function of varying vessel dimensions, 
type of stirrer, dimensions and position of stirrer and 
amounts of solids and densities of solids and liquids. 
Using dimensional analysis, Zweitering was able to determine 
suitable dimensionless groups for his experimental data. 
Expansion of the groupings led to Equation 3 to calculate the 
stirrer speed Njs required to just suspend the crystals [Zacek 
et al. 1982] : 
Njs = svO.l(gAp/p)0.45d0.2x0.13 
00.85 
.................. 3 
where S = constant, dimensionless 
v = kinematic viscosity, cm2 /s 
g = gravitational acceleration, cmjs2 
Ap = diff erence between solid and solution density, gfcm3 
p = solution density, gfcm3 
d = crystal size, em 
X = weight percent of solids in suspension 
D = vessel diameter, em 
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Suspension is defined as having zero particles at rest at the 
bottom of the tank for periods in excess of 1 or 2 seconds. 
This equation applies to a flat bottomed tank with impeller 
agitation and has been used by several investigators (Weisman 
and Efferding 1960; Zacek et al. 1982]. It has been supported 
by Nienow (1968) who also established the importance of 
impeller clear ance . . 
Oldshue and Sharma (1992) visually calculated Njs in tanks of 
differing diameter in which impeller heights above the bottom 
of the tank (measured from centerline of impelle~) were 
varied. They also considered shape of the tank bottom, 
varying D/T r atios (defined in Chapter III. 2) and effect of 
percentage solids (ie the percentage of total solids compared 
to the total weight of liquid and corresponding solid) on Njs· 
They found t hat there are three regions in the crystalliser 
where C/T (defined in Chapter III.2) has an effect on Njs for 
both the axial flow pitched blade turbine and the radial flow 
flat blade tur bine tested. 
Calculations o f minimum stirrer speed for complete suspension 
have been proposed by numerous authors all of whom accepted 
Zweitering's definition of suspension. Dietl and Rieger 
(1980) and Musil and Vlk (1980), have critically reviewed 
these proposal s. 
The rate of nucleation depends strongly upon the stirring rate 
(Youngquist a nd Randolph 1972]. Micro-attrition and secondary 
nucleation are a direct consequence of an increased rate of 
stirring a nd particle concentration (Conti 1980]. 
Qualitatively , induction of nucleation by crystal-solid 
impacts has been demonstrated by Lal et al. (1969) and Clontz 
and McCabe (1971). Bennett et al. (1973) studied the effect 
of crystal sus pension circulation on nucleation and reported a 
correlation be tween agitator tip speed and nucleation rate. 
To ensure that the possibility of these effects was minimized 
in the present study, 
possible whi l e still 
the stirring rate was set as low as 
allowing complete mixing. scanning 
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electron microscopy (SEM) micrographs were used to check that 
there was no visible attrition of the crystals. 
Using plots of S vs T/D (where T and D are the vessel and 
impeller diameters respectively) ( Zweitering 1958] the value 
of the dimens ionless constant S for the present system was 
calculated to be 7. (The tank diameter is 6. 35cm and the 
maximum crysta l sized, was assumed to be 45~m). 
Using Zweitering's formula, the minimum stirrer speed to 
suspend a part icle of size 5~m was found to be 387 rpm, while 
that for a particle of size 45~m was 601 rpm. To ensure 
complete homogeneity the stirrer speed was maintained above 
601rpm. 
Reynolds number inside the crystalliser 
There are at least ten dimensionless numbers associated with 
agitation involving heat and mass transfer [Brodkey and 
Hershey 1988] . Dimensional analysis is based on dimensional 
homogeneity e xisting between variables describing the given 
system. - Using a minimum number of dimensions, all other 









flow. He found from his experiments on laminar - turbulent 
transition t hat a dimensionless group of numbers, NRe 
(Equation 4) , could be used to predict empirically the 
transition point. In defining NRe' the characteristic 
velocity is t he tip speed, defined as Ut = ~ND with rotational 
speed N in uni ts of s-1 
. • • . . . . . . . • . • . . . . . • • . 4 
where D = impeller diameter, em 
N = impeller rotational speed, s -1 
p = density of liquid, gjcm3 
~ = viscosity of liquid, gjcm.s 
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When N is s l owly increased from zero, a laminar flow regime 
exists initia lly. A large transitional region extends from 
NRe = 10 to NRe = 103 • In this range, vortex systems near the 
impeller begi n to form. When NRe > 103 turbulent flow exists 
[Perry and Chilton 1973; Brodkey and Hershey 1988]. 
To ensure tha t the solution flow inside the crystalliser would 
be fully turbulent, the impeller tip speed N was calculated 
using a Reynolds number of 104 and was found to be 914.5 rpm. 
The impeller was therefore set to 950 rpm with a corresponding 
Reynolds number of 10388. (These figures were calculated 
using values of density and viscosity for pure water). 
Reynolds number inside tubing 
To ensure f u lly turbulent flow inside the offtake tubing 
between cryst alliser and flow cell, the required Reynolds 
number was c a lculated. The critical value for turbulent flow 
inside a tube is NRe > 2100 [Brodkey and Hershey 1988]. 
Viscous sheer stress is defined as Tv= ~Vfd. 
Inertial · sheer stress Ti = pv2 
NRe = inertial I viscous 
= pVdo/J.L .......•...•.•...•.•.•..... 5 
where p = density, gfcm3 
~ = vis cosity, gfcm.s 
d 0 = pipe diameter, em 
V = average velocity accross the pipe (ie fl~w 
ratejarea of a circle: V = Q/~r2 ) 
A small Reynolds number (<2100) means large viscous forces 
damping out turbulence thereby causing laminar flow. In 
laminar flow, the fluid moves in straight lines along the tube 
axis (z) with no fluid groups moving in the r or ~ directions 
(Figure 3.28). A large Reynolds number (>10000) means large 
inertial forces leading to turbulent flow. (The region 2100 < 
NRe < 10000 i s the transitional region from laminar to fully 
turbulent flow) . 
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z 
Figure 3.28: Flow directions in a tube. 
Using the total flow rate (Q) = 40ml/min and the diameter of 
the offtake t ube as 1. 6mm, the value of NR~ for the system 
designed for t he present study was calculated to be 780,5. 
Since this v a lue is less than the critical value of 2100, 
laminar flow would exist in the tubing. To increase the value 
of NRe' a larger flow rate Q would be needed. However, since 
residence time (= V /Q) must be held constant, a larger flow 
rate Q would need to be offset by a larger crystalliser 
volume. This in turn would cause the required volume of bulk 
urine to incre ase also. Thus it was decided to accept the NRe 
value, recogn ising that a consequence thereof was that the 
solution would not be fully turbulent in the tubing. In the 
earlier offtak e designs of the present study (designs no.2-4), 
this effect c a used crystallisation in the tubing and switches. 
To minimize the effect of laminar flow in the tubing (in the 
final design no. 6) , the offtake tube was made as short as 
possible and was positioned such tbat the flow of sample from 
the crystalli ser was directed downwards, ie in the same 
direction as gravity. 
Settling velocity of crystals inside Malvern cell 
For upward f l ow of the sample through the flow cell, it was 
necessary to determine the maximum size of crystal that would 
be kept in sus pension. Newton's second law of motion states: 
where 
~F = P = d(mU)/dt 
P = rate of change of momentum 
~F = sum of the forces exerted 
. . . . . . . • . . . . . . . . . . • . 6 
d(mU)/dt =change of momentum at an instant. 
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A force balanc e using this law enables the formulation of the 
equation for the terminal velocity (Ut) (Equation 7) of a 
small particle at steady state [Clift et al. 1978; Brodkey and 
Hershey 1988]. 
• ••....•..... • ...••• •• • 7 
where g = gravitational acceleration, cmjs2 
Pp = particle density, gjcm
3 
p = fluid density, gjcm3 
p. = viscosity of fluid, gjcm.s 
rp = rad ius of particle, em 
d = diameter of particle, em 
flow rate through cell = 40mljmin; volume of cell = 7. 07ml; 
d = 45p.m: 
Time for 1ml to flow through= 40/7.07 = 5.658min-1 
Speed of particles = 942.95p.mjsec 
[private communication Dr Hounslow] 
Ut = 1963,86p.mjs (from Equation 7) 
Therefore dmax/45 = (942,95/1963,80) 0 · 5 
[private communication Dr Hounslow] 
and dmax = 31,18p.m 
For a crystal of this size, the force of gravity is more 
influential than Brownian motion collisions. As a result, the 
larger crystal s would be prevented from escaping the cell at 
the top, thus causing them to remain in the path of the laser 
beam. In the present system however, crystals of this size 
were uncommon and no error was reflected in the obscuration 
value during measurement (ie no rapid increase in 
obscuration) • 
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Reynolds number inside Malvern cell 
Stokes (1851) [cited by Brodkey and Hershey 1988], solved the 
problem of a sphere moving very slowly through a stationary 
fluid. Stokes' Law relates the force exerted by the fluid on 
the sphere to viscosity, particle radius rp, and free stream 
velocity u~. The equation for terminal velocity is restricted 
to the region where Stokes' Law applies. The Law is found to 
be accurate up to NRe = 0.5 [Brodkey and Hershey 1988]. 
Assuming that the maximum crystal diameter is 45~m, the 
particle Reynolds number NRe,P is calculated by Equation 8: 
NRe,p = dpU~P/~ 
= 0.129 
.............. · ........ 8 
where U~ = the free stream velocity if the particle is at rest 
(ie the difference in velocity between the fluid 
a nd the particle) 
U~ = Ut (calculated in Equation 7) 
The flow - in t e cell is therefore in the Stokes' Law region. 
III.9 REPRODUCIBILITY AND SAMPLE TESTING 
Obscuration values 
Initial tests were performed by removing samples directly from 
the crystalliser to ensure that the crystalliser was perfectly 
mixed. Initial testing was accomplished using a suspension of 
14,4~m average diameter PDVB latex beads (Coulter Electronics 
Ltd. Luton, England) in 0,2~m filtered isoton [AIChE testing 
committee 1980]. A blank measurement of this stationary 
isoton was taken using the 63mm lens of the Malvern Multisizer 
instrument. Thereafter, the bead suspension was introduced 
into the crys talliser and the stirrer speed of the impeller 
was set to 950rpm. Three samples of this suspension were then 
pipetted from the crystalliser into the empty cell and were 
measured. The suspension was then pumped through the flow 
system to obt ain 10 readings for comparison with the static 
125 
measurements. Average volume mean diameters and obscuration 
values are shown in Table 3.1. 
0[4,3] (J.'m) Obscuration 
Static system 15.18 ± 0.01 0.2476 ± 0.0050 
Flow system 15.19 ± 0.05 0.2274 ± 0.0134 
Table 3.1: Comparative readings of flow and static system 
using Coulter calibration beads in isoton. 
The D [ 4, 3] values are in good agreement. The stationary 
system showed more stable obscuration values than those for 
the flow sys tem. Ideally, the standard deviation of the 
obscuration values should be < 0.01. 
Metastable limits 
Using a residence time of 3, 6 minutes, urine was introduced 
into the flow system. Single urine samples were used 
initially f or each experiment. The test involved the 
determination of the metastable limit (MSL) of the urine with 
respect to NaOx. The MSL is the minimum amount of oxalate 
required to induce detectable precipitation [Ryall et al. 
1985]. 
Ten aliquots (10ml) of 0.45J.'m filtered urine were pipetted 
into particle free Coulter sampling cups. The aliquots were 
incubated at 38°C and each fraction was then titrated with 
0.1ml of successively increasing concentrations of NaOx in the 
· concentration range o. 01 to 0. 2 molfdm3 . The presence of 
crystals afte r 30 minutes was investigated using a Coulter 
counter. 
Thereafter, precipitation was induced in the crystalliser of 
the flow syst em by dosing each urine with NaOx corresponding 
to the MSL concentration. The NaOx concentrations were 
usually betwee n 0.08 to 0.12 molfdm3 . However, in most cases, 
the dosing concentration proved to be too high for the Malvern 
measurements as the crystalliser suspension became very 
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cloudy, sometimes within the first few minutes of the 
experiment. For optimum results, the concentration bar on the 
Malvern screen should be within the ideal range (Figure 3.29) 
as indicated in the loading bar on the right of the figure. 
The center graph (Figure 3. 29) indicates the light energy in 
each of the 31 rings, while the graph on the left gives an 
approximate i ndication of the sizes of the measured particles. 
The obscuration value is indicated at the bottom left of the 
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Fiqure 3. 29: Diagram of screen during sample concentration 
inspect. 
Pooled urines were used to obtain a set of comparative 
experiments on the same sample. At this stage, specimens were 
arbitrarily pooled to provide sufficient volume. The MSL for 
each of five pools was determined each day over the 
experimental period of a week, and were all found to remain 
stable with respect to the MSL determined on the first day. 
Using pooled urines, various dosing concentrations of NaOx 
based upon the measured MSL, were tested. In this way, it was 
possible to i dentify a range of NaOx concentrations that would 
produce measur able crystallisation (in the ideal range of the 
Malvern) in a l most every pool. Concentrations of 0.02 to 0.03 
molfdm3 usual l y achieved this. 
Particle size distributions 
Initially, there was a poor fit between experimental data 
(from urine s amples innoculated with aqueous NaOx) and the 
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proposed model (Chapter II .1. 3 under "Analysis model") . The 
goodness of f i t depends upon the log difference values between 
experimental data and the proposed model: the bigger the 
difference, the poorer the fit. Attempts to improve the fit 
included using a program written for the 63mm lens, but which 
had been modif ied for the 100mm lens and which implemented the 
more correct MIE theory. 
Figure 3. 30 shows the results obtained from pooled samples 
used in this study with both the Malvern program (a) and the 
MIE theory program (b). 
(3.30a) High Und High Und Higt Und High Und Higt Und Higt Und 
Siz_~ ' size ' size ' Size % Size % Size % 188 10C 84.5 100 38.( 95.3 17.1 64.E 7. 6S 41.1 3.4E 16.3 
175 10C 78.€ 99.9 35.4 94.C 15.9 62.E 7 .1~ 37.9 3.2] 14.9 
163 10C 73.] 99.S 32.S 92.4 14.8 61.4 6.6~ 35.5 2.99 13.2 
151 10C 68.e 99.8 30. E 90.S 13.7 60.3 6.18 33.€ 2.78 11.7 
141 1 0C 63.2 99. E 28.4 88.S 12.8 59.4 5.n 31.€ 2.59 10.3 
131 1 0C 58.e 99.4 26.4 86.9 11.S 58. E 5. 3~ 29.€ 2.4( 9.0 
122 1 0C 54./ 99., 24.E 84.€ 11.1 57.8 4.97 27.5 2.24 7.9 
113 1 0C 5o.e 98. E 22.S 81.!: 10.3 56.E 4.62 25.3 2. oc 6.7 
105 1 0C 47.3 98. 21.3 77.!: 9.5E 55. ( 4. 3( 23.] 1. 33 5.7 
97.S 1 0C 44.C 97.3 19.E 72.4 8. 3S 50. E 4. 0( 21. c 
90.9 1 0C 40.9 96.4 18.4 67.4 8.27 45. ~ 3.72 18.8 
Source - Sample Beam length - lOmm Model 1ndp 
Focal length = 100mm Log diff = 4.187 Shape off 
Presen tation = pil Obscuration = 0.2~21 
Volume cone = 0.0201~ Sp.S.A. = 1.1163m fcc. 
Span I D [ 4 , 3 ] 0[3,2] I D[v,0.9] I D[v,0.11 D[v,0.5] 
3.88 13.73um 5.37um 29.66um 2.54um 8.81um 
(3.30b) 
Log Diff = 4.483 Max = 32.1 at band centered at 1.78J.Lm 
obscuration = 0.2921 lens = 100 
High Size V% HSize V% HSize V% HSize V% 
183.99 0.06 27.33 5.41 9.95 4.74 3.36 2.99 
81.93 0.93 21.34 17.15 7.76 1.98 2.98 6.11 
51.26 2.59 16.38 3.11 6.87 1.28 2.38 13.31 
36.38 4.31 12.76 1.98 4.76 1. 76 1.92 32.10 
Figure 3.30: Comparison of the fit between experimental data 
and a proposed model using two dfferent programs: (a) 
original Malvern program using the anomalous theory and (b) 
the MIE theory . 
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Figure 3.30a shows the tabulated equivalent Malvern data which 
is divided into 64 size classes giving a more detailed PSD. 
In comparison , Figure 3. 30b indicates a PSD having 16 size 
divisions. 
For the data analysed by the the original Malvern program (a), 
the log difference value is 4. 187 while that from the MIE 
theory (b), is 4.483. It is thus apparent that a better fit 
is achieved wi th the Malvern program. 
Calibration using latex beads 
Final reproduc ibility testing was accomplished using a mixture 
of calibration beads suspended in 0.45~m filtered isoton. 
Three bead sizes were used namely, 3.2, 8.5 and 14.0~m. Five · 
samples were taken from the waste line after flowing through 
the offtake s ystem, and five samples were pipetted directly 
from the crys talliser during flow experiments. 
particle sizes are shown in Table 3.2. 
The median 
Median diameters (~m) 
Bead size 
no.1 no.2 no.3 
Flow through 
1 3.44 8.31 13.98 
2 3.40 8.35 13.83 
3 3.56 8.32 14.15 
4 3.62 8.42 14.00 
5 3.66 8.44 13.80 
P1.pette 
1 3.32 8.32 13.90 
2 3.48 8.32 13.83 
3 3.48 8.48 13.95 
4 3.57 8.29 13.90 
5 3.71 8.45 14.05 
Table 3.2: Median particle diameters for a mixture of 3 
different sized calibration beads. 
Comparison of the means of the median diameters for each bead 
size using the Students t-test showed no significant 
difference at a 99% confidence level [Miller and Miller 1993]. 
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CaOx precipitation 
In addition to beads, reproducibility tests were also 
performed on the kinetics of caox crystallisation from 
solutions of 10-2M cac12 and NaOx. The residence time used 
was 5 minutes . Measurements were taken using the 100mm lens 
of the Malve rn instrument. To mimic the anticipated 
experimental c onditions in the present study, the NaOx flowed 
at 90% and t he cac12 at 10% of the total flow rate of 
40mlfmin. Flow rates were monitored by collecting outflow 
from the crystalliser in a measuring cylinder as a function of 
time. Two set s of five experiments were performed using the 
flow system. Readings were taken between 8 and 11 residence 
times. The best fit straight lines of plots of log(population 
density) vs size (Randolph and Larson 1971; Jancic and Garside 
1975; Rodgers and Garside 1981] were calculated for the size 
range ·7 .15 - 24. 6J.'m (Brecevic and Garside 1981]. The values 
of growth rate (G) , nucleation rate (B0 ) and mean particle 
diameters (0[ 4 ,3]) are shown in Table 3.3, and are each 
calculated from an average of 8 measurements. Table 3.4 shows 
the average gr owth and nucleation rates of the two sets of 
exper1men t T bl 3 3 s 1n a e . . 
Set One 
Exp G Bo 0[4,3] Obscuration 
(J.'m/min ) (J.'m/min. ml) (J.'m) 
1 0.68 6 2373 16.43 0.3306 
2 0.691 2358 16.15 0.3232 
3 0.698 2268 15.94 0.3296 
4 0.706 2188 15.49 0.3320 
5 0.691 2344 16.45 0.3352 
Set Two 
Exp G Bo 0[4,3] Obscuration 
(J.'m/min ) (J.'m/min.ml) (J.'m) 
1 0.735 1954 16.80 0.3395 
2 0.72 4 2051 16.80 0.3392 
3 0.718 2129 16.66 0.3386 
4 0.713 2168 16.61 0.3321 
5 0.712 2146 16.95 0.3416 
Table 3.3: Kinetic data from reproducibility experiments 
using 10-2M Ca Cl2 and NaOx. G = growth rate; Bo = 
nucleation rat e; 0[4,3] = mean particle diameter. Note that 
the range of t he obscuration values is < 0.01 for each set. 
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G (JLm/min) Bo (JLm/min.ml) 
Set 1 0.694 ± 0.050 2306 ± 482 
set 2 0.720 ± 0.056 2090 ± 545 
Table 3.4: 9 5 % Average growth and nucleation rates of the 
data from the two sets of experiments shown in Table 3.3. 
Reproducibilit y of the experiments was good (p < 0.05) . with 
Table 3.4 indicating the 95% confidence levels for the growth 
and nucleation rates. 
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CHAPTER IV 
IN VITRO EXPERIMENTS 
IV.l INSTRUMENT SETTINGS 
IV.l.l MALVERN 
Malvern measurements are susceptible to stray light as 
discussed in Chapter II .1. 2 under "Background measurement". 
Thus, care was taken to locate the instrument in a windowless, 
dark and dust- free room. 
Range lens 
Initially the 63mm lens with a particle detection capability 
in the size -r ange 1. 2 - 118J'm was used. However, this was 
subsequently changed to the 100mm lens (range 1.9 - 188J'm) to 
be more compa tible with the Coulter settings in which the 
lower limit of measurements was 2.8J'm. 
Despite ·a l ower limit determined by the particular lens 
selected, it is nevertheless possible to measure particles 
below this limit as the instrument has a sub-size measurement 
compensation. However, reduced accuracy of measurement will 
occur if more than 20% of the material is in this sub-size 
class (McCave et al. 1986] . The lower detection limit of 
measurement wi th the 63, 100 and 300mm lenses is approximately 
o. 5J'm. Fraunhofer theory breaks down in this range because 
the particles do not diffract light in the manner required for 
valid applicat ion of the theory (de Boer et al. 1987; Bayvel 
and Jones 1981 ]. 
Vignetting 
Each range l ens has a limited aperture and a maximum 
scattering ang le through which it is able to collect scattered 
light. If the sample is too distant from the range lens, it 
is possible t hat the maximum scattering angle for all the 
particles wi l l not be captured. This error is called 
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"vignetting". It is therefore necessary to ensure that all 
the particles in the sample pass through the beam within the 
working distance of the range lens. This working distance is 
known as the lens cut-off distance x, and is calculated as 
follows [Felton 1990): 
X= f(Rl- Rb)/Rd ........•.........•.• 1 
Where f = focal length 
Rl = lens radius 
Rb = laser beam radius 
Rd = detector radius 
For the 100mm lens, x was calculated to be 133mm. 
Refractive index instability 
Instability in the optical alignment was noticed in the early 
stages of the present study when the blank sample was passing 
through the flow cell. Investigation showed that this 
refractive i ndex instability was due to both temperature 
gradients and to the fast flowing stream of sample into and 
out of the c e ll. The problems of temperature differences was 
eliminated easily as it was noted that the instability 
occurred duri ng initial flow of the sample through the cell 
but that it l ater disappeared after the glassware, tubing and 
flow cell had warmed up. 
The contribut ion from sample flow was noticed only when very 
high flow r a tes (60 mlfmin) were used. When instability 
occurred at the high flow rate (60 mlfmin during early testing 
for the presence of bubbles in the cell), the Malvern was 
programmed t o selectively ignore the scattering in the lowest 
angle (ie rings 1 and 2). However, this procedure should be 
avoided as i t leads to a limitation of the dynamic range of 
the lens. 
The instabilit y was totally absent in the presence of very low 
flow rates; there was no instability at the pre-selected flow 
rate for exper imentation (40mlfmin). 
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Analysis time 
In this work , a maximum analysis time of 2 minutes was used, 
during which 32760 measurement sweeps were collected. During 
this time, a few cell volumes passed through the cell ensuring 
that the largest possible volume of sample was analysed. The 
two minute time averaged measurement was therefore the most 
representative reading possible. 
Scattering matrix 
As discussed in Chapter II.1.2 under "Refractive index", more 
acceptable log difference values can be obtained if necessary 
from an appr oximate scattering matrix (ie the scattering 
matrix calculated by the Malvern but manipulated using the Mie 
theory). Log difference values from the Malvern were 
acceptable, however the more correct Mie theory was used to 
determine whether lower log difference values could be 
obtained. 
In the case when the difference between the refractive index 
of the -parti cle and of the suspending medium is small, 
analysis of s ize distributions should be done using the Mie 
theory (Chapter II .1.1 under "Fraunhofer and Anomalous 
theories" and "Mie theory") . In an attempt to determine 
whether smaller log difference values could be obtained from 
the system, a program using Mie theory written in the 
Chemistry Department at UCT (Seymore PhD Thesis, UCT 1996] was 
used to analyse Malvern data. The results from this program 
are shown in Chapter III. 9 under "Reproducibility and sample 
testing". 
Log differenc e values from this program were not better than 
those from t h e Malvern program. Since the values obtained 
from the latt er were well within the acceptable limit, the 





Since the expe rimental protocol involved comparison of Malvern 
and Coulter da ta, the dynamic ranges of the two machines had 
to be matched as closely as possible. Initially the 63mm lens 
of the Malvern was selected, the particle size range of which 
is 1. 2 - 118J,£m. Accordingly, the 70J,£m orifice tube for the 
Coulter was c hosen with a nominal particle size range of 1.4-
42J,£m. Other coulter orifice tubes that were available (with 
their nominal particle size ranges indicated in brackets) were 
the 140J,£m (2. 8 - 84J,£m), 200J,£m (4.0- 120J,£m) and the 560J,£m (11.2 
- 336J,£m) • 
However, air bubbles on the 70J,£m orifice wafer were 
encountered. These expanded under the vacuum during counting 
and caused e lectrical signal noise, leading to reduced 
accuracy of the counts. Cleaning of the orifice tube 
overnight did not improve the situation. Although it was 
possible to r emove the air by releasing the vacuum, draining 
and careful refilling of the orifice tube, it was very time 
consuming and impractical when readings had to be taken 
immediately. 
It was there fore decided to use the 140J,£m orifice tube 
(nominal part i cle size range 2.8 - 84J,£m) which was found to be 
free of air on the wafer, possibly because a gentler flow of 
sample occurs through it. The aperture current setting was 
1600J,£A. 
The Malvern l e ns was accordingly changed; the lOOmm lens was 
selected as i t provided the closest match to the lower limit 
size range of the 140J,£m Coulter orifice tube. 
Since the crys talliser was removed from the immediate location 
of the Coulter Counter, no noise transmission was encountered. 
Calibration 
Latex calibrat ion beads (Coulter Electronics Ltd. England) of 
diameter 14.4J,£m were used to calibrate the 140J,£m aperture. For 
optimum result s the calibration particles should be 20% of the 
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aperture diameter (Operating Manual Coulter Multisizer Issue 
C). The beads were suspended in 0.22~m filtered Isoton II (a 
bacteriostatte d phosphate-buffered saline solution supplied by 
Coulter Elect ronics) in a measurable concentration such that 
the coincidence was less than 2%. The resulting calibration 
constant Kd wa s calculated at 1331,1. 
Electrolyte and signal noise 
It is standard practice when using the Coulter Counter to have 
the same electrolyte on each side of the aperture. If this is 
not the case , inconsistencies can occur when the electrolyte 
inside the or ifice tube (usually Isoton II) mixes with the 
different ele ctrolyte in which the sample is suspended. In 
the present study, caox crystals in urine were to be measured. 
Therefore, a sample was withdrawn from the stock untreated 
0.45~m filtere d urine and was used to fill the Coulter sample 
jar and orific e tube. (The total volume of raw urine required 
from each part icipant was therefore of necessity, large). 
Signal noise can also arise as a result of a change in 
temperature; t herefore, it was necessary to maintain the urine 
in the Coulte r reservoir and the orifice tube at the same 
temperature a s that of the sample from the crystalliser. This 
was achieved by introducing the untreated urine into the 
Coulter reser voir and orifice tube a few minutes before 
sampling the steady state product from the crystalliser. To 
ensure that the orifice tube had equilibrated to 37°C, it was 
immersed in thermostatted 0.45~m filtered untreated urine 
which was flushed through the aperture for a minute, after 
which three b l ank readings were recorded. 
Stirring 
When recording measurements of the suspension solution, 
adequate m1x1ng is necessary to minimize agglomeration or 
flocculated pa rticle passage, either of which would lead to an 
incorrect size distribution. Stirring of the sample also 
ensures that there is no sedimentation which could lead to 
size classifi cation. This latter situation is especially 
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important since the sample was originally withdrawn from the 
crystalliser where great care was taken in mixing to avoid 
such effects. Careful placement of the overhead glass stirrer 
was necessary to negate possible electrical disturbances from 
itself and the Coulter cup. 
Sampling 
To prevent e r rors from too small sampling volumes, a minimum 
volume of 500#1 for the 140#m aperture was used. For optimum 
results a vol ume of 2000#1 is recommended but this volume was 
not suitable in the present study as each reading requires 25 
seconds. Si nce crystallisation occurs inside the Coulter 
sampling cup , initial and final readings would differ 
substantially. On the other hand, sampling of the 500#1 
volume required an average of 7 seconds and therefore allowed 
an initial a nd final reading to be recorded. The advantages 
of taking a n initial reading were that it introduced 
suspension sample into the orifice tube and that it provided a 
value for comparison with the final reading. 
Careful - cleaning of the orifice tube and aperture was 
necessary bec ause of deposits of caox after many readings. 
This was due to the high concentration of caox in the samples 
taken from the crystalliser. Details of 
procedures a re described in this Chapter 
"Cleaning". 
the cleaning 
IV. 4 . 3 under 
Fortunately, blocking of the aperture did not occur. This is 
attributed t o careful filtering of the blank sample prior to 
commencement of the experiments and to the fact that none of 
the crystals grew or aggregated to sufficient size. 
A problem tha t was encountered with the Coulter Counter was 
breakage of t he mercury column. This seriously affected the 
reading time during sampling since the breaks in the mercury 
caused start / stop probes to react at the wrong times. If 
breakage occurred while sampling, the reading was abandoned. 
In general, breakage is due to either dirt in the mercury, or 
operating fau lts. Apart from changing the mercury, the 
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breakage was usually corrected by applying the vacuum a few 
times. When the mercury breakage was corrected quickly, the 
experimental r un was continued with minimum interruption. 
Data analysis 
The size range capability in this work (as determined by the 
use of the 14 0~m orifice tube) was 2.8 - 84~m and was divided 
into 256 channels. Each channel can be designated as being of 
size (X) which represents either diameter, area, or volume. X 
is defined a s the right edge of that particluar channel. For 
convenience, the left edge of the channel is designated (X-1), 
and the cent re (X-0.5) (Chapter II.2 under "Channel size 
calculation"). 
In all the de terminations, the full range option was used and 
was sometime s supplemented with narrow or window range 
readings. All readings were taken in the linear diameter 
mode. Explanation of these options is discussed in Chapter 
II.2 under " Channel size calculation". The theory of area and 
volume scales with both linear and log laws is discussed in 
the Coulter Multisizer manual Issue C. 
Further mani pulations concerning specific areas of the 
distribution in narrow and window selections were applied 
only when time allowed, as the facility of an on-line computer 
for storage of the data was not available. 
IV.1.3 SCANNING ELECTRON MICROSCOPY 
To validate t he trends in growth and nucleation rates of caox 
in the MSMPR crystallisation experiments, precipitated 
crystals were examined in a scanning electron microscope 
(SEM). This instrument provides information on morphology and 
allows qualit ative and semi-quantitative comparisons to be 
made of crystal number, size and extent of aggregation. 
Using a pasteur pipette, a sample of crystals was aspirated 
from the MSMPR crystalliser after kinetic measurements had 
been completed. This sample was filtered through a 0.2~m 
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Nucleopore fi l ter (13nun diameter) supported in a Sartorious 
membrane filte r clamp (G.m.b.H. Gottingen). The filter paper, 
with the depos ited crystals, was pasted onto an aluminum stub 
for SEM analysis. The sample was coated with approximately 
20nm of Au/Pd in a Polaron 5100 Sputter Coater. 
Specimens tilt ed at 35° to the collector were examined using a 
Cambridge S20 0 scanning electron microscope operating at a 
nominal beam potential of 10kV and beam current of 100~A. The 
secondary elec tron images were recorded on Ilford FP4 roll 
film at 60s f r ame period and 800 lines per frame. 
IV.2 CRYSTALLISATION KINETICS 
By making a number 
Chapter II.2 under 
the steady s tate 
of simplifying assumptions as outlined in 
"Crystalliser" [Randolph and Larson 1971], 
crystal size distribution in an MSMPR 
crystalliser i s represented by Equation 2. 
where 
n = n°exp(-L/G1) ...•..••.•..••... 2 
n° = B0 /G 
1 = V/Q 
L = crys tal size, ~m 
• . . . . • . . . . • . . . . . • . . . • . 3 
. . . . . . . . . . . . . . . . . . . . . . 4 
1 = crystalliser residence time, mins 
G = crys tal growth measured in ~m/min 
n° = the nuclei number density which is related to 
the nucleation rate B0 (nojmin.ml) as shown in 
Equa tion 3. 
By taking logarithms of Equation 2, the following linear 
expression ari ses. 
log n = log n°- L/(2.303G1) . . . . . . . . . . . . . . 5 
A plot of log (n) vs L will therefore yield a straight line of 
slope 1/(2.30 3G1) and intercept log(n°) . 
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By using Equa tions 3 and 5, the values of G and B0 may be 
deduced from the steady state crystal size distribution. The 
values of G a nd B0 given in this chapter are all deduced from 
such plots. 
Hounslow [Hounslow et al. 1988; Hounslow 1990a,b) has 
described another technique to determine the CSD (hence 
nucleation a nd growth) from an MSMPR crystalliser. The 
technique involves transforming the population balance into a 
series of algebraic equations in terms of moments [Randolph 
and Larson 1971]. 
The first four moments (m0 - m3) have a physical meaning and 
are proportional to total number, length, area and volume of 
solid per uni t volume of suspension. Once the moments of the 
distribution have been determined, nucleation and growth rates 
can be calcula ted from Equations 6 and 7 respectively: 
••••••••••••••••• 6 
. . . . . . . . . . . . . . . . • . • . • . • . • . . 7 
Hounslow has further taken into account the process of 
aggregation a nd has described an index of aggregation which 
allows the determination of nucleation, growth and aggregation 
when these processes occur simultaneously in the MSMPR 
crystalliser. This technique was however not used in the 
present study as the method of Randolph and Larson (1971) 
(Equations 3 a nd 5) was preferred. 
The Coulter Counter automatically measures the total number of 
particles in the distribution and therefore results can be 
used directly with Equation 5. On the other hand, the Malvern 
Particle Sizer is not based on a number measurement but gives 
a percentage volume distribution. However, using the 
following Equation (8), values proportional to the population 
density can be evaluated [Brecevic and Garside 1981] . 
• • • • • • • • • • • • • • • • • • • • • • 8 
where 
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To compare results from the Coulter and Malvern, the procedure 
of Brecevic and Garside (1981) was followed. They calculated 
the best-fit straight lines of plots of log(population 
density) versus crystal size in the size range 7. 3 - 23. 2J.'m. 
In the present study, the size range for the best-fit straight 
line was take n to be 7 - 24J.'m. The values for n obtained 
with the Mal vern Particle Sizer were then multiplied by a 
constant factor in order that the lines obtained from the 
Malvern and the Coulter gave the same value of population 
density at L = 10J.'m [Brecevic and Garside 1981]. All 
experiments performed in the present study were repeated on 
three different urine pools. 
Figure 1 shows an example of a population density plot 
obtained from experiments using both the Coulter and Malvern · 
particle sizer. The two size distributions demonstrate good 
aggreement. It appears that the population density plots from 
the Malvern a nd the Coulter form a curve that can be fitted by 
two straight lines: one below about 71-'m and the other between 
7J.'m and 25J.'m . The plot therefore indicates an increase in 
population density below 7J.'m. This increase is greater than 
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Fiqure 1: Steady state crystal size distribution (1 = 5 
minutes) showing measurements by the Coulter Counter and 
Malvern Parti cle Sizer. 
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Possible expl anations for this deviation include that on 
average smaller crystals grow at a slower rate than larger 
crystals, and that secondary nuclei are born directly into the 
micrometer size range [Brecevic and Garside 1981]. These two 
effects would lead to a greater increase in the number of 
large particl es relative to the increase in the number of 
small particl es. A plot of log (population density) versus 
crystal size will therefore lead to curvature of the graph. 
Each distribution was well represented (R2 > 0.95) by a 
straight line in the size range 7~m - 24~m. 
Multiple regression analyses ( Statgraphics version 6. 1, 
Statistical Graphics Corp. 1992) were performed to determine 
significant differences (p < 0.05) in the intercept and slope 
(from which nucleation and growth rates of caox are 
calculated) between the various experiments within each pool. 
Results from the multiple regression analyses are shown in 
Appendix 1. 
The suspension density MT (mmolfdm3) represents the total 
crystal mass produced and was calculated in the present study 
using the following equation published by Randolph and Larson 
(1971): 
. . . . . . . . . . . . . . . . . . . . . . 9 
where fv is t he volume shape 
al. 1988]) a nd p is the 
(2.22g/cm3). 
factor (taken to be W/6 [Kohri et 
density of the caox crystals 
The total cal cium and oxalate concentrations in solution in 
the crystallis er were calculated using the following equations 
[Kohri et al. 1988]: 
[Ca]sol = Ca - MT 
[OX]sol = Ox - MT 
................... 10 
•••••• • •••••••••••• 11 
where Ca and Ox represent the calcium and oxalate 
concentrations (mmolfdm3) respectively in the feed solutions. 
Dilution fact ors were taken into account when calculating 
these values. The endogeneous oxalate (diluted to 90% of its 
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original c oncentration) and the exogenous oxalate 
concentration were summed. This exogenous oxalate was diluted 
to 10% of its original concentration in experiments 
investigating the effect of oxalate concentration (Chapter 
IV.4.1 under "Effect of NaOx") and temperature (Chapter IV.4.2 
under "Effect of temperature") while it was diluted to 5% in 
experiments using inhibitors (Chapter IV. 4. 3 under "Effect of 
various inhibi tors"). 
The supersatur ation ratio S was calculated using the computer 
program Equil developed by Werness et al. (1985). The total 
concentrations of citrate and magnesium in solution inside the 
crystalliser were calculated by summing their respective 
endogeneous and exogenous concentrations after dilution 
factors had been taken into account. Dilution of all other 
urinary const ituents to 90% of their original concentration 
were also taken into . account when calculating the 
supersaturation. Values of suspension density, calcium and 
oxalate concentrations and supersaturation are tabulated in 
Appendix 2. 
- IV.3 EXPERIMENTAL PROCEDURE 
Urine collection a d pre-treatment 
Participants were all healthy males without any prior history 
of stone dise ase. All were in the age group 20-30 years. 
Each participant was required to collect a 24-hour urine 
sample in a 2. 5 dm3 glass bottle while remaining on their 
normal diets. 
The collection bottles were thoroughly cleaned overnight by 
soaking in a 5% Centrad solution (Merck KGa, Darmstadt, 
Germany) and rinsing with deionised . water. To eliminate 
effects which the detergent might have on the urine, the 
bottles were then soaked in a 5% HN03 solution overnight and 
rinsed with deionised water. To preserve the urine samples, 
1mlfdm3 of a 20% wfv sodium azide solution was added per 2 dm3 
urine. 
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Individual ur ine samples were tested for infection using 
Boehringer Mannheim dipsticks (Combur-10-test). 1. 5 dm3 of 
urine from each of 8 individuals was then pooled and 
thoroughly mi xed in a 25 dm3 vat. The minimum number of 
samples required for statistical pooling was determined in a 
separate exper iment using ANOVA (Appendix 3). This experiment 
showed that a minimum of 5 samples were necessary to ensure 
that each pool was statistically different [Jappie PhD Thesis, 
UCT 1996]. 
The pooled ur ine sample was then filtered through Sartorious 
cellulose acet ate filters (prefilter and 0.45#m) to remove all 
crystalline and non-crystalline matter. The filtration 
apparatus was cleaned using the method described previously 
for the collection bottles. The bulk urine was used at its 
native pH . 
Representative samples were then withdrawn from the pool and 
analysed for the following constituents, and these values are 
tabulated in Appendix 4. 
1. Chloride, phosphate, urate and creatinine were determined 
by private p a thologists using the methods described by Tietz 
(1976). 
(1a). The determination of chloride in urine involves the 
use of a t wo phase Ag/AgCl type ion-selective electrode 
(Beckman CX3 instrument). 
surface of the electrode 
The equilibrium developed at the 
is dependent on the solubility 
product Ksp of silver and chloride ions in solution. 
Introduction of chloride ions into the system disrupts the 
Ksp with t he resultant movement of Ag+ ions from the AgCl 
phase of the electrode to the sample solution which is mixed 
with a buf fered solution. The Ag+ metal phase of the 
chloride electrode responds indirectly to the chloride ion 
activity i n the sample. The potential at the chloride 
electrode i s then referenced to a sodium reference chamber. 
(1b). The de termination of phosphate in urine is achieved by 
a 10 to 20 fold dilution and acidification of the sample to 
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pH 3. The phosphate reacts with ammonium molybdate in 
sulphuric acid solution to form the coloured complex 
ammonium phosphomolybdate. Absorbance is measured at 340nm 
using a Boehringer Mannheim Hitachi 717 spectrophotometer. 
(1c). An enzymatic colorimetric test using uricase is 
applied for the determination of uric acid. 
uricase 
uric acid + o2 + 2H20 -------> allantoin + C02 + H202 
2H2o2 + 3,5- dichloro-2-hydroxybenzenesulphonic acid + 4-
peroxidase 
aminophenazone ---------> N-(4-antipyryl)-3-chloro-5-
sulphonate-p -benzoquinonemonoimine + HCl + 4H2o 
The hydroge n peroxide (H202) which is formed reacts (under 
catalysis of peroxidase) with the compounds shown to give a 
red-violet quinoneimine. Absorbances are measured at 750 
and 546nm using a Boehringer Mannheim Hitachi 717 
spectrophotometer. 
(1d). Creat i nine concentration in urine is determined by the 
colour change occurring in the following reaction: 
(OH)-
creatinine + picric acid ------> 1:1 creatinine-alkaline 
picrate complex (red) 
The rate o f formation of the creatinine picrate complex is 
proportional to the creatinine concentration in the sample. 
Measurements are made at 520 and 560nm using a Beckman CX3 
instrument. 
2. Calcium (Ca ), potassium (K), magnesium 
were determined using a Varian Techtron 
absorption spectrophotometer, (Techtron 
Melbourne, Aus tralia, 1970). 
(Mg) and sodium (Na) 
AA-5 flame atomic 
Appliances, South 
An air-acet ylene flame was used with a 10cm burner head 
(serial no. 5639). Settings of the AAS for each element are 
shown on pag e 145. 
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Element ). slit width lamp current 
(nm) (nm) (mA) 
Ca 422.7 50 5 
K 766.5 300 5 
Mg 285.2 50 5 
Na 589.0 200 5 
Lanthanum chloride was added to samples for the 
determination of Ca, K and Mg. The lanthanum acts as a 
complex inhibitor to bind with phosphate thereby eliminating 
any interfe rences due to this ion. The lanthanum chloride 
was added t o the sample in a concentration to give 10, 000 
ppm in the final solution [Willis 1961]. A drop of 
concentrated HCl was added to clear cloudiness that 
developed on addition of the lanthanum solution. 
For the determination of Na, potassium chloride was added to 
the sample to suppress its ionization [Bassett et al. 1978]. 
It achieves this because it has a lower ionization potential 
than Na and therefore creates an excess of electrons when 
the solution is nebulized into the flame; this results in 
the suppression of Na ionization. 
3. Oxalate was determined by enzymatic assay (Sigma kit, 
procedure no. 591). 
The method is based upon the oxidation of oxalate by oxalate 
oxidase fo l lowed by the measurement of 
produced during the reaction 
hydrogen peroxide 
by a peroxidase-
catalyzed reaction as shown below: 
oxalate oxidase 
oxalate + 02 -------------> 2C02 + H202 
Peroxidase 
H202 + MBTH + DMAB -----------> Indamine dye + H2o 
The hydrogen 
benzothiazolinone 





(dimethylami no)benzoic acid (DMAB) in the presence of 
peroxidase. Indamine dye, having an absorbance maximum at 
590nm, is produced in this reaction. The intensity of the 
colour produced is measured by a spectrophotometer (LKB 
Biochrom Novaspec 4049 spectrophotometer) and is directly 
proportional to the concentration of the oxalate in the 
sample. 
4. Citrate wa s determined by enzymatic assay (Boehringer 
Mannheim UV me thod, cat.no. 139076). 
Citrate is converted to oxaloacetate and acetate in a 
reaction catalyzed by the enzyme citrate lyase (CL). 
Oxaloacetate and its decarboxylation product pyruvate are 
then reduce d to L-malate and L-lactate respectively by· 
reduced nic otinamide-adenine dinucleotide (NADH) in the 
presence of the respective enzymes 
(MDH) and lactate dehydrogenase (LDH). 
malate dehydrogenase 
The amounts of NADH 
oxidised in the last two reactions are stoichiometric with 
the amount of citrate present in the sample, and is 
determined by measuring the NADH using a spectrophotometer 
set at -a wavelength of 340nm. 
CL 
citr ate -----> oxaloacetate + acetate 
MDH 
oxal oacetate + NADH + H+ -----> L-malate + NAD+ 
LDH 
pyruvate + NADH + H+ --------> L-lactate + NAD+ 
Storage 
After aliquot s of urine had been withdrawn from the bulk, 
filtered urine for the above analyses, the latter was 
refrigerated overnight at 6°C. Before each experiment, it was 
warmed to room temperature. A representative sample of 3dm3 
was then withdrawn from the bulk sample and refiltered through 
the 0.45~m Sar torious cellulose acetate filters to remove any 
crystalline matter that had deposited overnight. This second 
filtration s t ep was found to be necessary as background 
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measurements on the unfiltered overnight sample were sometimes 
unacceptably h igh. 
Sometimes massive overnight precipitation in the bulk sample 
occurred. After filtration, further heavy deposition of 
crystals occurred when the sample was warmed to 37°C. These 
samples were discarded. Analysis of the deposits using xray 
powder diffrac tion (XRD, Philips PW1130/90/96, CuK2 wavelength 
= 1.542A) s howed uric acid crystals. By testing each 
individual uri ne prior to pooling, it was possible to identify 
two particula r participants whose samples were those which 
consistently induced crystal deposition. These individuals 
were consequently excluded from the experimental population 
group. 
Cleaning 
Prior to t he experimental runs, all the glassware (ie 
crystalliser and adjoining glassware, conical and volumetric 
flasks) was c leaned thoroughly for 12 hours in a 5% contrad 
solution and for a further 12 hours in a 5% HN03 solution 
followed - finally by rinsing with 0.45pm filtered glass 
distilled water. The baffles and stirrer were also cleaned in 
this way. 
In addition, the supply tubing and the Malvern cell were 
flushed firstly with deionised water and then with a 10% HN03 
solution. They were then rinsed with 0.45pm filtered glass 
distilled wate r. 
The flow-cel l windows were soaked in a 5% HN03 solution 
overnight and thoroughly rinsed with deionised water. They 
were wiped wi th lens tissue to remove dust particles and a 
thin layer of urine was applied to the inside face of each 
window to ensure that surface charges which might potentially 
attract and a t tach air bubbles or crystals were minimized. 
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Thermostatting 
Heated water from a water bath was used to thermostat the 
crystalliser, offtake tube and flow cell at 37°C. All 
solutions wer e incubated at 37°C for 90 minutes prior to 
commencement of the crystallisation experiments. The 
crystalliser, offtake tube, flow cell and adjoining tubing 
were all rins ed with the bulk thermostatted urine. The supply 
tubing for t he NaOx and inhibitor solutions were also rinsed 
with their r e spective solutions to avoid minute dilution from 
the deionised water used for cleaning. The thermostatted 
urine was the n cycled through the crystalliser, offtake tube 
and cell and finally back to the stock solution for a further 
15 minutes. This was done to ensure mixing of the stock urine 
and also to warm the connecting tygon tubing. 
Experimental method 
At this stage , the propeller was set in motion to agitate the 
urine in the crystalliser. In order to achieve the pre-
selected residence time of 5 minutes, the total flow rate into 
and out· of the crystalliser was required to be 40mljmin 
(Chapter III . 8 under "Residence time"). Therefore the flow 
rate of the urine into the crystalliser was set at 36mljmin 
and that of the NaOx solution at 4mljmin. 
The connecting tygon tubing between the offtake from the 
crystalliser and the Malvern cell was clamped tightly so that 
no product from the former could enter the cell during 
unsteady stat e operation. After crystallisation had been 
initiated, a l l the product from the crystalliser was diverted 
to waste prior to the attainment of steady state. Meanwhile, 
untreated uri ne from the stock supply was cycled through the 
Malvern cell ensuring that it became thoroughly mixed and that 
the cell itse lf and connecting tygon tubing was maintained at 
the temperature of the experiment. 
After 8 residence times, the flow cell was emptied and 
refilled with the untreated urine by reversing the direction 
of flow into the cell (Chapter III.7 under "Design no.6"). 
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This was done to remove any air bubbles that might have 
developed on the cell windows. The laser was then aligned 
with the flow cell and blank measurements were recorded until 
a stable reading was registered. Usually, three such readings 
were necessary. 
The flow cell was then emptied and the clamp from the 
crystalliser offtake to the flow cell was released (Chapter 
III.7 under "Design no.6"). At the same time, the clamp from 
the crystalliser to waste was tightened. The offtake from the 
crystalliser was. therefore diverted into the flow cell after 
10 residence times. After allowing the flow of several 
volumes of the cell, several measurements were recorded. 
Steady state was indicated by a stable obscuration value. 
IV.4 IN VITRO EXPERIMENTS 
IV.4.1 EFFECT OF NaOx 
The first set of experiments were performed to investigate the 
effect of varying the concentration of NaOx on the 
crystallisation of calcium oxalate within the same urine pool. 
As described previously, the first task was to identify a 
range of e xogenous NaOx concentrations that produced 
measureable precipitation. This range was found to be 20-30 
mmolfdm3 and was independent of the endogenous oxalate in the 
urine. Using analytical grade reagents, an aqueous solution 
of NaOx withi n this range was prepared and was used as the 
first concent ration in the sequence of experiments on a 
particular ur ine pool. As explained earlier, urine flowed 
into the crystalliser at 36mlfmin and a separate feed was used 
for Naox at 4ml/min. 
The extent o f 
concentration 
Mal vern) , wa s 
crystallisation produced from this first NaOx 
(as indicated by the obscuration value on the 
used to identify two further suitable 
concentrations for the in-flowing Naox solution. These three 
~aox concentrations were then used to initiate crystallisation 
in three urine pools. Nucleation and growth rates in the 
three pools a r e shown in Table 1. 
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GROWTH NUCLEATION 
J,Lm/min nojmin.ml (*10 3 ) 







5 2.5 0.7191 0.6532 3.662 3.514 
3 0.8186 0.7532 3.322 3.264 
2 0.6596 
!~ 
0.7345 4.018 2.920 
!· 6 2.5 0.8183 0.7915 4.053 4.059 3 0.8102 0.8106 5.449 5.106 
2 0.7856 
!· 
0.6623 2.827 3.217 
!· 7 2.5 0.8204 0.7085 1.890 3.419 3 0.9743 0.7736 2.710 3.723 
Table 1: Growth and nucleation rates for varying 
concentrations of exogneous NaOx after being admitted to the 
crystalliser. (* denotes significant difference p < 0.05) 
The concentra tion of NaOx shown in the table corresponds to 
the concentration of exogenous oxalate after being admitted to 
the crystalliser. 
Figure 2 is a graphical representation of the data given in 
Table 1 and shows growth and nucleation rates of caox crystals 
as a function of increasing Naox concentrations. 
were calcula ted as described in Chapter 
These rates 
IV.2. under 
"Crystallisation kinetics". Although in general, values for 
the Coulter are higher than those for the Malvern, the trends 
in the nucleation and growth rates for the two instruments are 
in good aggreement. The higher Coulter values can be 
explained in terms of the time delay in getting the sample to 
the Coulter for analysis. The graphs indicate an increase in 
growth rates with increasing NaOx for all the samples. 
However, trends in the nucleation rate are not consistent. 
Growth and nucleation rates are plotted as a function of the 
supersaturation ratio s in Figure 3. The growth rate 
increases wit h increasing supersaturation for all samples 
while trends for the nucleation rate are not apparent. In 
general, the trends for the Coulter and Malvern agree with the 
exception of the nucleation variation in sample 7. 
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Figure 4 ind icates the relationship between nucleation and 
growth rates for each sample. No trend is observed for the 
Malvern data ; however samples 6 and 7 indicate an increase in 
nucleation rates with increasing growth rates for the Coulter. 
The increase in the growth rates as more concentrated Naox was 
added to the crystalliser (shown in Figure 2) is supported by 
SEM (Figure 5 ). The most common morphology observed was that 
of COD cryst als; their size increased from 15-28J,Lm as the 
concentration of NaOx increased. COM crystals were observed 
at sizes below 10J.Lm. Aggregation of COD crystals was present 
in some samples with the largest aggregate size being 10J.Lm. 
Semi-quantitatively, the number of crystals increased with 
increasing c oncentrations; samples 6 and 7 showed increases in 
the number o f small crystals below 5J.Lm (this is shown in the 
micrographs of sample 6 in Figures 5A,B). 
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Figure 4: Nucleation rate plotted · against growth rate for 
varying concentrations of NaOx. 
5A: [NaOx] = 2mmolfdm3 
mag: 1.46KX 
maximum crystal size = 15~m 
5B: [NaOx] = 3mmolfdm3 
mag: 543x 
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maximum crystal size = 25~m 
Figure 5: SEM micrographs of samples innoculated with 2 and 
3mmolfdm-3 NaOx. 
IV.4.2 EFFECT OF TEMPERATURE 
The effect of three temperatures ( 18, 38 and 58 °C) on the 
crystall_isation of caox was investigated using an arbitrary 
concentration of NaOx = 3mmolfdm3 throughout. Nucleation and 
growth rates for these experiments are given in Table 2. 
GROWTH NUCLEATION 
~m/Min nojmin.ml (*10 3 ) 
Sample Temp ( °C) Coulter Malvern Coulter Malvern 
18 0.5108 0.4640 
}* 
5.267 10.30 
8 38 0.8811 }* 0.4624 2.524 }* 5.395 
58 0.9461 0.7452 1.160 3.587 
18 0.6989 0.5942 
}* 
4.125 5.781 
9 38 1.111 }* 0.8012 1.405 }* 2.268 }· 
58 1.504 1.227 0.8814 0.6255 
18 0.6346 0.1946 7.014 10.15 
10 38 0.6237 0.6069 }* 3.669 }* 8.644 }· 
58 1. 037 0.9182 2.142 2.351 
Table 2: Growth and nucleation rates for various 
temperatures at a constant exogenous NaOx concentration of 
· 3mmoljdm3 inside the crystalliser. (* denotes significant 
difference p < 0.05). 
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Graphical repr esentations of these data are given in Figure 6. 
Within each sample, general trends for the Coulter and Malvern 
showed good agreement in that growth rates increased with 
increasing temperature for each sample while nucleation rates 
decreased. With regard to the individual rates at each 
temperature, growth rates are lower and nucleation rates are 
higher for the Malvern data relative to the Coulter data. 
Figure 7 illustrates growth and nucleation rates at different 
temperatures plotted against the supersaturation ratio. 
Inspection of Figure 7 in conjunction with Table 2 shows that 
the growth rates increase sharply with increasing temperature, 
while supersaturation values show little variation. On the 
other hand, nucleation rates show the opposite trend. The 
small variation in supersaturation is not surprising since a 
constant NaOx concentration was used to initiate 
crystallisation. 
Figure 8 shows the rate of nucleation as a function of the 
growth rate. All three samples indicate an increase in 
nucleation rate as the growth rate increased. This 
observation was substantiated by both the Coulter and Malvern 
data. 
SEM showed l i ttle deposition at 18°C. However, COT (in the 
size range 25-30J.Lm) (Figure 9A) was the predominant phase in 
all samples; in addition some COD crystals of size 20J.Lm were 
also present. COM were observed occasionally. An increase in 
temperature pr oduced a decrease in the size of COT crystals to 
20J.Lm, an increase in the number of COD crystals and the 
formation of COM (Figure 9B). At 58°C a mixture of COM and 
COD of sizes 10-15J.Lm were observed (Figure 9C). Although an 
aggregate is shown in Figure 9B, it was not a commonly 
observed feature. 
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9A: COT and COD and 
some isolated COM 
18°C, mag: 982x 
9B: Aggregate of COT 
with COD and COM's 
38°C, mag: 1.04Kx 




Figure 9: SEM micrographs showing varying caox morphologies 
at varying temperatures. 
Comparison of results obtained in the temperature and oxalate experiments 
A comparison of the temperature and oxalate experiments can be 
made. Temperature experiments were performed using a constant 
exogenous oxa late concentration of 3mmolfdm3 ; therefore the 
experiment at 38°C can be compared to the oxalate experiment 
at 37°C in which the NaOx feed concentration was 3mmolfdm3 . 
From Tables 1 and 2, it is seen that growth and nucleation 
rates for the two experiments are similar. 
A comparison of the change in the growth and nucleation rates 
as a function of temperature and oxalate concentration can 
also be made . From Tables 1 and 2, it is apparent that an 
increase in temperature from 18°C to 58°C (Table 2) has a much 
greater effec t on both the nucleation and growth rates than 
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occurs when the exogenous oxalate concentration 
c rystalliser is increased from 2 to 3mmoljdm3 




increasing t emperature is more than double that of the change 
with increasing oxalate concentration. 
This difference in rates is also reflected in the large change 
in both the nuc"leation and growth rates at the different 
temperatures which were accompanied by little change in the 
supersaturation (Table 2 and Appendix 2). In comparison, 
results for the varying oxalate concentrations show smaller 
changes in nucleation and growth rates with an accompanying 
larger change in supersaturation (Table 1 and Appendix 2). 
The large difference in rates is also indicated by 
connsideration of the graphs of nucleation rate vs growth rate 
(Figures 4 a nd 8 respectively). 
IV.4.3 EFFECT OF VARIOUS INHIBITORS 
To further test the efficacy of the entire crystalliser 
system, a ser ies of experiments involving three common urinary 
substances r egarded as inhibitors, was undertaken. For this 
purpose, the concentration of NaOx that was used to initiate 
crystallisation was that which produced the highest 
measureable precipitation in the untreated sample. The 
crystallisation response of the urine to this NaOx challenge 
alone was use d as the control for comparison with experiments 
incorporating the inhibitor. Inhibitors that were tested were 
citrate, magnesium and chondroitin sulphate A. Separate 
experiments were also conducted using combinations of citrate 
and magnesium to investigate their synergistic relationship. 
In addition, the effect of introducing these inhibitors into 
the crystall i ser via different routes was investigated. In 
the first set of such experiments, the pooled urine was dosed 
with the i nhibitor prior to being introduced into the 
crystalliser. 140ml of various concentrations of an aqueous 
solution of the inhibitor was added to the stock urine of 
volume 2800ml. In this method, the flow of the treated urine 
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was kept at 36ml/min while an aqueous solution of NaOx was 
introduced at 4mljmin through a different inlet. 
In the second set of these experiments, a solution of the 
inhibitor wa s introduced into the crystalliser via an 
independent feed flowing at 2mljmin; the flow rate of the NaOx 
was adjusted to 2mljmin while that of the urine (via a third 
inlet) was ma intained at 36mljmin. In order that the final 
concentration of oxalate inside the crystalliser be equivalent 
to that used in the first set of experiments, the 
concentration of the NaOx feed solution was doubled. 
Effect of citrate 
Inhibitor dosing of pooled urine prior to introduction into the crystalliser 
Urines were dosed with citrate concentrations usually 
occurring in normal urine. These were in the range 1-2 
mmoljdm3 [Ber g and Tiselius 1989]. The ensuing growth and 
nucleation rates are given in Table 3. 
GROWTH NUCLEATION 
JLm/Min nojmin.ml (*10 3 ) 
Sample [Citrate] Coulter Malvern Coulter Malvern 
mmoljdm3 
0 0.9517 0.7682 4.291 3.248 
11 1.020 0.9010 0.6887 1.216 2.226 
1. 275 0.8664 0.6613 2.264 
}-ll 
3.564 
1.530 0.5529 0.7250 8.332 5.863 
0 0.7306 0.6836 3.602 5.797 
12 1.020 0.5882 0.6350 3.685 3.255 
1.275 0.5973 
'll 
0.6051 f'll 2.081 2.083 
1. 530 0.5473 0.5841 3.158 2.997 
0 0.8446 0.7207 5.403 8.736 
13 1.020 0.7921 0.6886 3.596 4.991 
1.275 0.7116 I'll 0.6793 2.517 f'ii 3.241 
1.530 0.6949 0.6650 5.130 5.656 
Table 3: caox growth and nucleation rates in the presence of 
various exogenous concentrations of citrate. The 
concentration of the feed NaOx was kept constant at 
3mmoljdm3 i nside the crystalliser. (* denotes significant 
difference p < 0.05). 
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Concentrations shown in Table 3 indicate the final 
concentration of exogenous citrate in the crystalliser. 
Growth and nucleation rates are plotted as a function of 
citrate concentration in Figure 10. Results obtained from 
both the Ma l vern and Coulter instruments show that with 
increasing c oncentrations of citrate, growth decreases. On 
the other hand, nucleation rates show a general decrease up to 
a citrate c oncentration of 1 to 1.2mmolfdm3 after which 
nucleation inc reases. 
Growth rates were found to increase with increasing 
supersaturation ratio as indicated in Figure 11. However, the 
trend in nucle ation rates is not clear. 
The relationship between nucleation and growth rates is shown 
in Figure 12 . No trend for the Coulter or the Malvern is 
observable for the three samples. 
SEM confirmed the trends in growth rates as a function of 
citrate concentration. This manifested itself by a decrease 
in the - average size of the COD crystals (most common 
morphology) from 20-10J.Lm in all samples (Figure 13). A few 
large COT were noted in some samples, but they were not 
typical. I ncreasing the citrate concentration led to an 
increase in t he number and size (up to 10J,Lm) of COM crystals 
(Figure 13B) . In addition, the total number of crystals 
appeared to decrease with increasing citrate concentration 
(Figure 13) . Aggregation was not typical in any of the 
samples analys ed. 
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Piqure 12: Nucle ation rate as a function of growth rate for 
varying concentrations of citrate added to the urine pool. 
25A: [Mg] = 1.927mmoljdm3 
mag: 542x 
max cryst al size = 35~m 
25C: [Mg ] = 5.781mmoljdm3 
mag: 544x 
max cryst al size = 28~m 
25B: [Mg] = 3.850mmoljdm3 
mag: 544x 
large COD at 43~m 
250: [Mg] = 7.708mmoljdm3 
mag: 549x 
max crystal size = 15~m 
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Figure 25: s urvey photographs at similar magnifications of 
sample 26 showing the effect · of varying magnesium 
concentrations. 
13A: no citrate 
mag:1.58Kx 




ave COD crystal size = 10~m 
Figure 13: SEM micrographs of caox deposition in the absence 
and presence of citrate. 
Inhibitor dosing via a separate feed into the crystalliser 
Table 4 indic ates the growth and nucleation rates which were 
determined as a function of the concentration of citrate, the 
latter being admitted to the crystalliser via a separate feed. 
GROWTH NUCLEATION 
~m/Min nojmin.ml (*103 ) 
Sample [Citrate) Coulter Malvern Coulter Malvern 
mmoljdm3 
1. 071 0.8586 0.7479 2.328 2.065 } 
23 1. 785 0.7850 0.7429 1.884 2.031 
3.570 0.7890 0.4439 1.884 1. 928 * 
7.140 0.7512 0.6364 0.1370 0.1037 
t 0.8925 0.7626 0.7431 2.259 
}· 
4.942 
24 1. 071 0.6653 0.5901 3.892 4.696 
1.785 0.6659 0.6122 1. 355 2.080 
3. 5 70 0.6500 0.5901 1.514 1.416 
1. 071 0.7114 0.6910 4.053 ~ 5.304 } 
25 1. 785 0.6978 0.6855 2.000 1.861 
3. 570 0.5472 0.5760 3.029 ~ 3.627 * 
7. 140 0.9229 0.5127 0.05146 0.3371 
Table 4: CaOx growth and nucleation rates in the presence of 
various citrate concentrations introduced into the 
crystalliser via a separate feed. Exogenous NaOx 
concentration inside the crystalliser was kept constant at 
2.5mmoljdm3 • (*denotes significant difference p < 0.05). 
t citrate concentrations in this sample were different from those in 23 and 25 as the 
composition of specimen 24 was significantly different 
Concentrations shown in Table 4 indicate the 
concentration of exogenous citrate in the crystalliser. 
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final 
Figure 14 shows a graphical representation of caox growth and 
nucleation r ates as a function of citrate concentration. 
Growth rates demonstrate an initial decrease at low citrate 
concentrations, but then tend to level off (exceptions: sample 
23, Malvern data; sample 25, Coulter data). 
In two cases (samples 23 and 25) the two instruments gave 
contradictory results at higher citrate concentrations. With 
respect to nucleation rates, both instruments showed a 
general decr ease with increasing citrate concentrations 
(Figure 14). 
Figure 15 ind icates that both the growth and nucleation rates 
increase wit h increasing supersaturation ratio for both 
instruments. The change in growth rates is however much 
smaller than the change in nucleation rates with increasing 
supersaturati on. Individual values for the Coulter and 
Malvern are i n good agreement. 
The variation in nucleation rates with growth rates is 
indicated in Figure 16; no trend is obvious. 
SEM of sample s 23 and 24 revealed decreases in the number of 
both COM a nd COD crystals as the citrate concentration 
increased (Figure 17). A decrease in the size of these 
crystals was noted in the physiological range of citrate 
concentrations (Figure 17A,B); however, little change in the 
size of COM was seen above this range (Figure 17C,D) (note the 
magnification of Figure 17C is 776x) . Aggregation was not 
noted in thes e samples and intergrowth was not typical at any 
citrate concentration. The morphology of the COD in the 
presence of c itrate was not in its common octahedral form and 
is shown in Figure 17E. 
Although COD (25~m) and aggregates thereof and also COM (20~m) 
were observed in sample 25 at the lowest citrate 
concentration , they were absent at the highest citrate 
concentration . At this latter concentration, only tiny 
crystals of COM and COD 1-2~m were identified; aggregates (up 
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ucleation rate as a function of growth rate for 
varying concentrations of citrate admitted to the crystalliser 
via a separate feed. 
17A: [cit] = 1.071mmoljdm3 
mag: 1.41Kx 
max COD size = 28~m 
17C: [cit] = 3.570mmoljdm3 
mag: 776x 
max size COM,COD = lO~m 
17B: [cit]= 1.785mmoljdm3 
mag: 1.55Kx 
max size COD,COM = lO~m 
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17D: [cit] = 7.140mmoljdm3 
mag: 1. 36Kx 
max size COM = 7~m 
17E: Typical COD 
morphology in the 
presence of citrate. 
Figure 17: SEM micrographs of caox deposition in the 
presence of varying citrate concentrations. 
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Comparison of the two citrate experiments 
A comparison of the general trends in growth and nucleation 
rates for the experiments in which citrate was introduced into 
the test urine via different routes can be made. In making 
this comparison, it is noted that citrate concentrations in 
experiment 2 (where citrate was introduced into the 
crystalliser via a separate feed) overlapped those of 
experiment 1 (where citrate was added to the urine pool) and 
also included levels above the normal physiological range. 
Growth and nucleation rates decreased with increasing citrate 
concentration in both experiments to a similar extent. 
Increasingly high concentrations of citrate in experiment 2 
continued to show the decreasing trend in nucleation rates 
observed in experiment 1. 
The trend of increasing growth rate with increasing 
supersaturation is observed in both experiments with 
experiment 2 having a larger range of supersaturation due to 
the larger range of citrate concentrations used. The range of 
growth rates for each experiment is comparable. Other 
comparisons a re not possible because no obvious trends were 
observed. 
Effect of magnesium 
Inhibitor dosing of pooled urine prior to introduction into the crystalliser 
Physiological concentrations of magnesium (1-10mmoljdm3) 
[Takasaki 1972] were used in experiments to investigate its 
effect on caox crystalli~ation (Hesse et al. (1986) quote 1-
5mmolfdm3 as the physiological range for magnesium). Table 5 
presents the values of growth and nucleation rates of caox in 
the presence of various magnesium concentrations. The 
concentrations shown indicate the final concentration of 
exogenous magnesium in the crystalliser. 
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GROWTH NUCLEATION 
(*10 3 ) J'm/Min nofmin.ml 
Sample [Magnesiur coulter Malvern Coulter Malvern 
mmo lfdm 
0 0.9114 0.7682 1. 526 
2.087 l 14 2 . 478 0.8944 0.7675 1.280 2.097 
3 . 304 0.8776 0.6120 2.226 1. 829 * 
4.955 0.7757 0.6541 4.326 5.823 




15 2 . 478 0.6961 0.7201 1. 339 1. 014 
3 . 304 0.6413 0.6988 1.209 1.974 * 






16 2 . 478 0.8241 0.8338 2.037 1.989 
3.304 0.8185 0.8053 " 2.883 5.314 * 
6.607 0.5203 0.6802 8.085 4.750 
Table 5: caox growth and nucleation rates in the presence of 
various exogenous concentrations of magnesium. The 
concentration of the feed NaOx was kept constant at 
2.5mmolfdm3 inside the crystalliser. (* denotes significant 
difference p < 0.05). 
Growth and nucleation rates are plotted against magnesium 
concentrations in Figure 18. The trend of decreasing growth 
rate with increasing magnesium concentration is indicated by 
both the Coul ter and Malvern in all three samples. Nucleation 
rates in s amples 14 and 16 decrease initially but then 
increase at h igher magnesium concentrations. Sample 15 shows 
inconsistent results for the Malvern. Overall, the variation 
in nucleation rate is larger than the variation in the growth 
rate as a function of increasing magnesium concentration. 
Growth and nucleation rates are plotted against 
supersaturati on ratios for each sample in Figure 19. All 
samples indicate an increase in growth rates with an increase 
in the supers aturation ratio, with samples 14 and 16 showing 
little variat ion above a supersaturation of 60. With respect 
to the trends in nucleation with supersaturation, sample 15 
175 
shows conflipt ing trends for the Coulter and Malvern. On the 
other hand, samples 14 and 16 indicate a decrease in 
nucleation above a supersaturation ratio of 47. 
Plots of nucl eation rate vs growth rate are given in Figure 




of sample 16 at various magnesium 
- 6.607mmoljdm3) are shown in Figure 21(A-
for sample 16 are typical of all the 
samples. Figure 21A,B at the lower magnesium concentrations 
show mostly large COD and COM crystals of sizes in excess of 
20~m. Figure 21C,D at higher magnesium concentrations reveal 
an increase i n the number of tiny crystals, thereby confirming 
the increase in the nucleation rate with increasing magnesium 
concentration (depicted by the graphs in Figure 18). These 
crystals were commonly COM of size less than 5~m (Figure 
21C, D, E). Sample 16 showed a reduction in the number of 
crystals in the 'size range of 20-30~m as the concentration of 
magnesium inc reased (Figures 21A-D) confirming the kinetic 
observation of lower growth rates with increasing magnesium 
concentration . In general, the morphology of the COD was the 
same as that observed in the presence of citrate (Figure 17E). 
Qualitatively , COM was as common as COD with the former in the 
size range 5-10~m. In general, the number of crystals 
appeared to decrease as the concentration of magnesium 
increased. Aggregates ( 2 O~m) were only noted in all samples 
in which magnesium was absent (Figure 21A) suggesting that 
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Figure 18: Pl ots of growth and nucleation 





1.0 Sample 14 7.0 Sample 14 
& & & ~6.0 • 0.8 t.. 
& • • c E: 5.o .E 




iii ~ 3.0 ~ 0 .4 ~ 
~ c: 
& • 0 :2 2.0 • (!; 
"' • Q) & 0.2 u & 
~ 1.0 
0.0 0.0 
0 10 20 30 40 50 60 70 80 90 0 10 20 30 40 50 60 70 80 90 
Supersaturation ratio S Supersaturation ratio S 
1 01 Sample 15 3 .0 Sample 15 
~ 2.5 • 
~ 0.8 1 t.. 
c: • E . E • •• & c 2.0 E • & .E 
.3. 0.6 & 
0 
Cl c: 
Q) ;1 .5 
a; 
Q) & 
~ 0.4 '§ &.A. 
~ c: 1.0 • 0 .Q (!; a; 
0.2 Q) • g 0.5 
z 
0.0 0.0 
0 10 20 30 40 50 60 70 80 90 0 10 20 30 40 50 60 70 80 90 
Supersaturation ratio S Supersaturation ratio S 
101 Sample 16 10.0 1 Sample 16 
.a.• M' I _.a. .I Q) 
0.8 t.. 8.0 1 
c ~ I .E • I c: 
E .E 
6 .0 .3. 0.6 0 
Cl & .s • 
Q) IIl • a; 
Q) 
~ 0.4 '§ 4 .0 
~ c: 
0 .Q & (!; a; 
0 .2 
Q) 
2.0 & u 
::J z 
0.0 0.0 
0 10 20 30 40 50 60 70 80 90 0 10 20 30 40 50 60 70 80 90 
Supersaturation ratio S Supersaturation ratio S 
Fiqure 19: Nucleation and growth rates as a function of 
supersaturation ratio s for 




















0.5 0.55 0.6 0.65 0.7 0.75 0 .8 . 
3.0 
M" t 2.5 










g 0 .5 
z 
Growth rate G (J.Im/min) 
Sample 15 
0.0 L-----------------------------------













Growth rate G (J.Im/min) 
Sample 16 
0 
0 85 0 .9 0.95 0 .5 0.55 0.6 0.65 0 .7 0.75 0 .8 . 




Figure 2 0: Nucleation rate as a function of growth rate for 
varying concentrations of magnesium added to the urine pool. 
21A: no exogenous magnesium 
mag: 1.11Kx 
max COD = 30JLm 
21C: [Mg] =3.304mmoljdm3 
mag: 1.76Kx 
max COD = 25JLm 
larger number of COM < 5JLm 
21B: [Mg] = 2.478mmoljdm3 
mag: 1. 03Kx 
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max COD = 25JLm, COM = 20JLm 
21D: [Mg] = 6.607mmoljdm3 
mag: 1. 83Kx 
max COD = 22JLm, COM = 13JLm 
21E: Sample 14 
[Mg] = 4.955mmoljdm3 
mag 570x 
max COD = 27JLm 
heavy deposits of COM <5JLm 
Figure 21: SEM micrographs of caox deposition in the 
presence of varying concentrations of magnesium added to the 
urine pool; micrographs A-D are from sample 16 and 
micrograph E is from sample 14. 
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Inhibitor dosing via a separate feed into the crystalliser 
Table 6 indicates the growth and nucleation rates for varying 
concentrations of magnesium introduced into the crystalliser 
via a separate feed. The magnesium concentrations shown 
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Table 6: caox growth and nucleation rates in the presence of 
various magnesium concentrations introduced into the 
crystalliser via a separate feed. Exogenous NaOx 
concentration inside the crystalliser was kept constant at 
2.5 mmolfdm3 • (*denotes significant difference p < 0.05). 
The growth a nd nucleation rates are plotted against the 
concentration of magnesium in Figure 22. Growth and 
nucleation r a tes decrease with increasing concentrations of 
magnesium; t he decrease in nucleation rate is greater than 
that of the decrease in growth rate. Nucleation and growth 
rate trends demonstrated by Coulter and Mal vern measurements 
show good agr eement. The exception is sample 28 where the 
trends disagre e at the highest magnesium concentration. 
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Growth and nucleation rates are plotted as a function of 
supersaturation in Figure 23. Values for the Coulter and 
Mal vern are in agreement. Both the growth and nucleation 
rates increase with increasing supersaturation. 
Figure 24 shows plots of nucleation rate versus growth rate 
with samples 26 and 27 indicating a general increase in 
nucleation wit h increasing growth. 
SEM confirmed growth inhibition in all samples as shown in the 
survey photographs in Figure 25. COD crystals decreased in 
size from 30Jlm in Figure 25A at a magnesium concentration of 
1. 927mmolfdm3 to 15JLm in Figure 25D at a magnesium 
concentration of 7.708mmolfdm3 . Extremely large COD crystals 
of size 50Jlm were rare and are noted in Figure 25B. Also the 
uncommon morphology of COD crystals (previously observed in 
both citrate and magnesium experiments) is evident in all the 
micrographs in Figure 25. Tiny COM crystals of sizes below 
10Jlm were common at the two lower magnesium concentrations; 
however, they were rarely noted at the two higher magnesium 
concentrations . 
All samples a t the lowest magnesium concentration (Figure 25A) 
showed heavy deposits of single COD and COM crystals; only 
sample 28 s howed marked intergrowth of COD crystals. In 
samples 26 and 28 the COM phase was dominant at the two lower 
magnesium concentrations. Aggregates of COD crystals were of 
the order of 15Jlm (Figure 25A, B); the average size of these 
decreased t o below 10Jlm with increase in magnesium 
concentration (Figure 25C,D) suggesting that magnesium might 
be an inhibitor of aggregation. 
of large c r ystals decreased 
In general, the total number 
with increasing magnesium 
concentration as is evident in the series of micrographs in 
Figure 25, all of which were recorded at similar 
magnifications . This tends to support the kinetic 
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Fiqure 22: Growth and nucleation rates of caox in the presence 
of magnesium when admitted to the crystalliser via a separate 
feed. _.. Coulter 
• Malvern 
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Figure 23: Growth and nucleation rates as a function of 
supersaturation ratio s at different magnesium concentrations 
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Nucleation rate as a function of growth rate at 
different magnesium concentrations added to the crystalliser 
via a separate feed . . 
186 
Comparison of the two magnesium experiments 
A comparison of the general trends in growth and nucleation 
rates for the experiments in which magnesium was added to the 
urine pool pr ior to being admitted into the crystalliser (in 
experiment 1) and was added as a separate feed into the 
crystalliser (in experiment 2) can be made. 
magnesium concentrations in the two 
comparable. 
The ranges of the 
experiments are 
Growth rates decreased with increasing magnesium concentration 
to a similar extent in both experiments. Nucleation rates 
also decrease d as the concentration of magnesium increased; 
however, in e xperiment 1, nucleation rates showed an increase 
at the higher magnesium concentrations. 
Trends of . increasing growth rate with increasing 
supersaturation are in agreement for the two experiments. 
Comparison of nucleation rate with increasing supersaturation 
showed oppos ite trends in the two experiments. Other 
comparisons a re not possible because no obvious trends were 
observed. 
Effect of a combination of citrate and magnesium 
Inhibitor dosing of pooled urine prior to introduction into the crystalliser 
Results are shown in Table 7. Final exogenous inhibitor 









nojmin.ml (*103 ) 
[Inhibit~r] 
mmolfdm 







magnesium 3.304 0.8028 11 0.7055 
citrate & 1.020 





magnesium 3.304 0.6892 
ci trat~ & 1. 02 c 
magnes1um 3.304 0.5519-






citrate 1.02C 0.7126 0.7288 
magnesium 3.304 0.7950 111 0.7682 
citrate & 1.02~ 























Table 7: cao x growth and nucleation rates in the presence of 
various exog enous concentrations of citrate, magnesium and 
combinations thereof. The concentration of the feed Naox 
was kept constant at 2.5mmolfdm3 inside the crystalliser. (* 
denotes significant difference p < 0.05). 
Figure 26 shows that the introduction of citrate or magnesium 
or combinations thereof caused a decrease in growth and 
nucleation r a tes in all samples. This inhibitory effect was 
more pronounc ed in the presence of citrate than in the 
presence of magnesium. The mixture of citrate and magnesium 
inhibited caox growth rates in all three samples t9 a greater 
extent than was achieved by either citrate or magnesium alone. 
Nucleation r a tes in the presence of a citrate and magnesium 
mixture were lower than those for magnesium alone, but higher 
than those calculated for citrate alone. 
Figure 27 ind icates the relationship of growth and nucleation 
rates with r e spect to supersaturation. An increase in growth 
188 
rate with increasing supersaturation ratio is indicated for 
all samples. The trend and individual values of the growth 
rate are in good agreement for the Coulter and Malvern. 
However, large differences in individual values of the 
nucleation r a te for the two instruments are seen in Table 7 
and also when they are plotted as a function of 
supersaturation in Figure 27. No trend in the nucleation rate 
as a function of supersaturation is apparent. 
Figure 28 i s a plot of nucleation rate vs growth rate. 
Although values for the two instruments tend to indicate 
differences, the trends show an overall increase in nucleation 
with increasing growth rate. 
SEM showed t hat all 3 caox crystal phases were present in the 
control sampl es and that intergrowtn of COD-COD and COM-COD 
was common (Figure 29). COT crystals were extremely large 30-
so~m but were rare in all samples. 
The series of micrographs 
features. The inclusion 
decreased bot h the size 





Figure 30 shows some interesting 
only citrate in the test urine 
number of COM and COD crystals 
urine sample which was treated 
with magnesium only also showed a decrease in the size of COM 
and COD but there was no change in the number of crystals 
(Figure 30C) . Aggregation of COD crystals only was also 
present in t ese samples; COD aggregates having sizes up to 
2 O~m were obs erved. COT crystals were not detected in the 
presence of citrate or magnesium alone. The mixture of 
citrate and -magnesium decreased the size of COD crystals (from 
20~m to 15~m ) (Figure 30D) relative to the control and 
individual magnesium and citrate samples. The size of the COM 
crystals in all samples was unchanged at 10~m. No COT 
crystals were noted in sample 17 while no intergrowth was 
noted in any sample. Samples 18 and 19 showed two large COD 
crystals at 50~m. The number of small crystals (<5~m) 
increased whe n compared to samples treated with magnesium or 
citrate alone for pools 17 and 19. 
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Growth and nucleation of caox in the presence of 
varying concentr ations of citrate and magnesium in the pooled 
urine . 
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Piqure 27: Nucleation and growth rate as a function of 
supersaturation ratio s for varying concentrations of citrate 
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to the urine 
29A:Intergrowth of COD 
into a star shape 








.Figure 29: SEM micrographs showing intergrowth that was 
common in the control samples ( ie exogenous magnesium or 
citrate absent). 
30A:control sample 
no citra te or magnesium 
mag: 1. 32Kx 
max COD = 30JLm 
30C: [Mg ] = 3.304mmolfdm3 
mag = 1 32Kx 
max COD,COM = l7JLm 
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JOB: [cit] = 1.020mmolfdm3 
mag: 120Kx 
max COD = 6JLm, COM = 13JLm 
30D: [cit] = 1.020mmolfdm3 
[Mg] = 3.304mmolfdm3 
mag: 135x 
max COD = l5JLm 
Figure 30: SEM micrographs showing crystallisation in the 
absence and presence of citrate, magnesium and a mixture 
thereof. 
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Inhibitor dosing via a separate feed into the crystalliser 
Introducing the citrate-magnesium combination into the 
crystalliser via a separate feed gave the growth and 
nucleation rates shown in Table 8. Final exogenous inhibitor 








nojmin.ml (*10 3 ) 
[Inhibito5] 
mmoljdm 
Coulter Malvern Coulter Malvern 
citrate 2.678 0.8416 
magnesium 5.781 1.228 
0.6394 
0.7060 
citrate.& 1.339 ~* 
magnes1um 2.891 0.5266 0.5696 
citrate . & 2.6~~ 
magnes1um 5.78~ 0.6754 
~ 
..., 
citrat e 2.678 0.5382 




citrat e.& 1.339 ~~ 
magnes1um 2.891 0.4767 0.5144 
citrat e & 2.678 
magnesium 5.781 0.3595 
citrat e 2.678 1.387 
magnes ium 5.781 1.355 
citrat e & 1. 3~~ 
magne sium 2.89~ 1.483 
citrat e & 2.678 

































Table 8: c aox growth and nucleation rates in the presence 
of various citrate and magnesium concentrations and 
combinations thereof introduced into the crystalliser via a 
separate feed. Exogneous · Naox concentration inside the 
crystalliser was kept constant at 2. 5mmoljdm3 . (* denotes 
significant d ifference p < 0.05). 
Figure 31 s hows that the growth rate in the presence of 
citrate alone was always lower than when only magnesium was 
introduced i nto the crystalliser. This also occurred with 
195 
nucleation r a tes in samples 30 and 31; however sample 29 
showed that magnesium had a greater effect on nucleation. 
The trends i n growth in samples 29 and 30 were individually 
confirmed by both techniques. In both samples, the mixtures 
(both high and low concentrations) · produced lower growth rates 
than either citrate and magnesium respectively. In sample 31, 
coulter and Malvern data were not in agreement and hence 
general trends were not obvious. 
Trends in the nucleation rates for samples 29 and 31 were 
individually confirmed by both techniques. In general, 
nucleation rat es in the presence of citrate were always lower 
than those in the presence of magnesium. The nucleation rate 
in the presence of the higher concentration mixture was lower · 
than that of magnesium in all cases except the Coulter 
determination of sample 3 0. No other clear trends were 
obvious. 
Figure 32 shows the variation of growth and nucleation rates 
with supersaturation. Trends for the Coulter and Malvern are 
in agreement. Individual values for sample 31 however show an 
increase for t he Coulter when compared to the Malvern. Trends 
for the growth rate show a maximum between supersaturation 
ratios of 55 and 60 for samples 29 and 30 while sample 31 
indicates an increase in the growth rate. No trend in 
nucleation r ate with increasing supersaturation can be 
deduced. 
Plots of nucleation rates vs growth rates are shown in Figure 
33. No trends are apparent for the three samples. 
Survey micrographs (all recorded at approximately the same 
magnification) in Figure 34 show the effect on the size and 
number of crystals of the addition of citrate alone (Figure 
34A), magnesium alone (Figure 34B) and in combination (Figure 
34C,D). 
The samples t reated with citrate only, showed a large amount 
of COD crysta ls and varying amounts of COM's (Figure 34A) • 
196 
samples treat ed with magnesium alone (Figure 34B) showed no 
change in the size of the COD crystals in samples 30 and 31; 
however, samp le 29 showed larger COD crystals relative to 
those of the citrate sample. A · few aggregates were seen in 
these samples. The number and size of COM crystals was lower 
in the samples containing magnesium only when compared to the 
samples contai ning citrate only. 
Generally the samples treated with the citrate and magnesium 
mixture showed an increase in the number of small crystals 
(COM and COD). A few aggregates (20pm) of tiny crystals were 
seen only in s ample 29 (Figure 34C). 
When the citr ate and magnesium concentrations were doubled, 
tiny crystals only (invariably COD Figure 34D) were 
observed. The exception was sample 31 which showed COD 
crystals of similar size to the samples with citrate and 
magnesium alone (Figure 34D). A small amount of aggregation 
was noted in sample 30 only. In general, the number of large 
crystals was reduced in samples 29 and 30 while sample 31 
showed small d ifferences when compared to samples treated with 



























































citrate and magnesium concentrations when 
crystalliser via a separate feed. 
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Fiqure 32: Nucleation and growth rate as a function of 
supersaturation ratio s at different citrate and magnesium 
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l'iqlire 33: Nucleation rate as a function of growth rate for 
different concentrations of citrate and magnesium added to the 
crystalliser via a separate feed. 
34A: [cit]=2.678mmolfdm3 
mag: 571x 
max COD,COM = 15~m 
34C: [cit] = 1. 339mmolfdm3 
[Mg] = 2.891mmolfdm3 
mag: 56 0x 
max COD = 20~m 
34B: [Mg] = 5.781mmolfdm3 
mag: 567x aggregate = lO~m 
max COD = 15~m 
34D: [cit] = 2.678mmolfdm3 
[Mg] = 5.781mmol/dm3 
mag: 553x 
max COD = 15~m 
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Figure 34: Survey photographs at 






inside the .magnesium concentrations in 
crystalliser. 
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Comparison of the citrate-magnesium combination experiments 
A comparison of the general trends in nucleation and growth 
rates for the addition of citrate and magnesium in the pooled 
urine (exper i ment 1) and the addition into the crystalliser 
via a separate feed (experiment 2) can be made. 
Experiment 2 did not include a control sample (ie a sample in 
which exogenous citrate or magnesium was absent). As such a 
comparison of the mixture can only be made with the individual 
additions of citrate and magnesium and not to a control 
sample. 
The concentrations of citrate and magnesium used in experiment 
2 were higher than those used in experiment 1. Trends due to 
the citrate a nd magnesium mixture in which their respective 
concentrations were the same as when their individual effects 
were examined separately can be compared. A combination of 
the inhibitor s at the concentrations used in the experiments 
examining their individual effects show that growth rates were 
generally lower than those for the individual citrate or 
magnesium in both experiments. Nucleation rates for the 
combination were generally higher than those for citrate only 
and lower tha n those for magnesium only for experiment 1 and 








rates are in 
agreement for both experiments. No trends for nucleation rate 
with respect to growth rates is apparent for the two 
experiments. 
Effect of chondroitin sulphate A 
Inhibitor dosing of pooled urine prior to introduction into the crystalliser 
An aqueous s o lution of chondroitin sulphate sodium salt, type 
A (Sigma Chemical co. serial no:C8529) was added to the urine 
pool which wa s subsequently thoroughly mixed. Concentrations 
were in the range 7. 6 - 21.6 mgfdm3 , corresponding to that 
202 
occurring for GAGs in normal urine [Ryall et al. 1981]. 
Growth and nucleation rates of caox in urines containing 
various concentrations of chondroitin sulphate (CSA) are given 
in Table 9. Final concentrations of CSA inside the 
crystalliser are expressed in mgjdm3 (and not in mmolfdm3 as 
an accurate mo lecular mass was not available). 
GROWTH NUCLEATION 
(*10 3 ) J.'m/Min nojmin.ml 
Sample [CSA) Coulter Malvern Coulter Malvern 
(mg j dm3 ) 
0 0 0 6210 ] 0.6980 2.140 2.967 
]· 
20 10. 69 0.7550 0.6565 1.992 1. 882 
16. 04 0.6070 .. 0.6265 1. 684 } 1.779 
21. 38 0.6575 0.6563 0.9812 1.205 




21 10. 69 0.7069 0.6625 5.296 4.393 
16. 04 0.6769 0.6398 4.173 4.029 
21. 38 0.6786 0.6849 3.412 3.795 
0 0.6366 0.6563 5.584 6.027 
]· 
22 10. 69 0.6431 0.6755 4.730 4.436 
16. 04 0.6905 0.6712 4.461 3.575 
21. 38 0.6868 0.6750 2.261 2.822 
Table 9: caox growth and nucleation rates in the presence of 
various exogenous concentrations of chondroitin sulphate A. 
The concentration of the feed NaOx was kept constant at 
2.5mmolfdm3 inside the crystalliser. (* denotes significant 
difference p < 0.05). 
caox growth and nucleation rates are plotted against the 
concentration of CSA in Figure 35. Values calculated from the 
Malvern and Coulter data show good ~greement in the trends for 
both nucleat i on and growth. Growth rates did not vary. 
However, nucleation rates decreased with increasing 
concentrations of CSA for all three samples. 
Figure 36 indicates that there is little variation in either 
the growth rate or the supersaturation ratio within each 
sample. However, nucleation rates decreased with small 
203 
increases in the supersaturation. Individual values for the 
Coulter and Ma lvern are in agreement. 
Figure 37 shows the relationship between the nucleation rate 
and growth r a te. Sample 22 shows a decrease in nucleation 
rate above a growth rate of 0.64 while smaller variations are 
shown in sampl es 20 and 21. 
A small incre ase in the size of COM crystals but not of COD 
crystals with increasing CSA concentration was seen using the 
SEM. A few COT crystals were present at extremely large sizes 
(Figure 38A, B) in the control sample but these were either 
absent or significantly smaller at the highest concentration 
of CSA. Intergrowth and aggregation were noted in the control 
sample (Figur e 38A, B, C) but the extent of both was reduced · 
after treatment with CSA. Figures 38D,E,F, are micrographs of 
a sequence of samples in which 380 does not contain CSA while 
38E, F contain increasing concentrations of CSA. A reduction 
in the total number of crystals is seen with increasing CSA 
concentration . The absence of tiny crystals at the highest 
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Figure 35: Growth and nucleation rates as a function of CSA 
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Figure 36: Nucleation and growth rate as a function of 
supersaturation ratio S at different ~oncentrations of CSA in 
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Piqure 37: ucleation rate as a function of growth rate for 
different concentrations of CSA in the urine pool. 
38A: Contro l 
Large COT s howing 
growth into COD 
mag: 1.02KX 
38C: Contro l 
Intergrowth of COD 
mag:2.61KX 
38E: 16.04mgjdm3 CSA 
mag:1.32KX 




38D: Control, Omgjdm3 CSA 
mag: 1. 08KX 
max COD,COM = 15~m 
38F: 21.38mgjdm3 CSA 
mag: l.llKX 
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max COD = 15~m, COM = 20~m 
Fiqure 38: SEM micrographs of caox crystallisation in the 
presence of varying concentrations of CSA. 
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Inhibitor dosing via a separate feed into the crystalliser 
These experiments were not performed for the following 
reasons: first ly, in order that this series of experiments 
would be performed under precisely the same conditions as the 
previous set (especially with respect to the ratio of whole 
urine to inhibitor), a large amount of CSA would have been 
required; secondly, such quantities of CSA were prohibitively 
expensive. 
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CHAPTERV 
GENERAL DISCUSSION AND 
CONCLUSIONS 
V.l IN VITRO EXPERIMENTS 
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There are two major aetiologic theories of calcium oxalate 
(CaOx) urinary stone formation. The first is based upon the 
supersaturation of urine with respect to calcium and oxalate, 
while the second focusses upon the presence or absence of 
inhibitors of caox crystallisation. The present work has 
investigated a spects of both of these. 
Calcium and oxalate 
Early research by Flocks (1939), showed that stone formers 
excreted more calcium than controls over a 24 hour period. As 
a result, he postulated the importance of calcium over oxalate 
in stone for mation. This finding has been supported by 
various worke rs [Hodgkinson and Pyrah 1958; Robertson and 
Morgan 1972; Hodgkinson 1974; Baumann et al. 1977; Robertson 
et al. 1978] . However, just as many investigators have not 
found any d i fference in calcium excretion between the two 
groups [King et al. 1968; Welshman and McGeown 1975; Jorgensen 
1975; Tiselius et al. 1978; Ryall and Marshall 1983; Ryall et 
al. 1984]. 




calcium excretion in controls and stone formers. They 
that normal calcium excretion needs to be properly 
before classifying patients as hypercalciuric. 
According to these workers there is no definite link between 
calcium excretion in the urine and the number of stone 
episodes. 
Investigations into the urinary excretion of oxalate by 
numerous authors have shown higher excretion in stone formers 
when compared to controls [Hodgkinson 1974; Pinto et al. 1974; 
Robertson et al. 1971,1976a,1978]; however, as with . calcium 
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excretion, other studies have been unable to find a difference 
[Tiselius 1977; Galosy et al. 1980]. Contradictions are 
possibly due to numerous and somewhat unsatisfactory methods 
for oxalate de termination [Robertson et al. 1981b]. Ryall and 
Marshall (1990) point out that the significance of the 
spontaneous c onversion of ascorbate to oxalate in urinary 
oxalate deter minations was only recognised in 1983-1984 by 
various workers, and that this factor would have to be taken 
into account when considering earlier studies. 
In 1969, Robertson and Nordin found that the calcium 
concentration required to 
urine was abnormally high 
the normal uri nary range. 
evidence that a small 
induce crystallisation of caox in 
whereas that of oxalate was within 
This has formed part of the growing 
inqrease in the urinary oxalate 
concentration is more of a risk factor than a larger increase 
in urinary c alcium concentration in caox stone formation 
[Robertson and Nordin 1976; Robertson et al. 1981a; Hallson 
and Rose 1989 ] . 
Calcium can react with oxalate to form both an insoluble caox 
salt and a s oluble non-ionised caox complex [Robertson and 
Peacock 1980). The increase in urinary calcium concentration 
causes only a small increase in the urinary saturation of caox 
whereas an i ncrease in urinary ~xalate concentration produces 
a larger inc rease in Caox saturation that could lead to 
crystallisation [Robertson and Peacock 1980]. 
Since oxalate is now 
important determinant 
commonly regarded as 
of stone formation 
being a more 
than calcium, 
crystallisation experiments were performed in the present 
study using t he addition of oxalate rather than calcium. The 
concentrations of oxalate required to produce measureable 
crystallisation were higher than physiological urinary oxalate 
levels. Never theless, addition of high oxalate concentrations 
to produce crystallisation has been used previously [Kavanagh 
et al. 1993). 
Factors which lead to a high urinary supersaturation of caox 
(such as an i ncrease in calcium or oxalate concentrations) are 
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generally cons idered to be risk factors in caox urolithiasis. 
This is a cons equence of supersaturation being a pre-requisite 
for crystallisation. However, although high supersaturation 
of caox increases the risk of crystal formation, it does not 
necessarily i ncrease the risk of stone formation since small 
crystals can be excreted harmlessly from the renal tract. 
This implies t hat the important mechanisms in stone formation 
are growth and aggregation of crystals rather than nucleation. 
The promotion or impaired inhibition of these two processes is 
therefore a r i sk factor in urolithiasis. 
In the present study, experiments have shown that increasing 
concentrations of oxalate increase both the nucleation and 
growth of caox crystals. This confirms findings of Kohri et 
al. (1988) and is also in agreement with those of Randolph and 
Drach (1981) who reported decreasing growth and nucleation of 
caox with decreasing oxalate concentrations at constant 
calcium:oxalat e ratio in an MSMPR crystalliser using synthetic 
urine. 
caox forms 3 hydrates: the thermodynamically stable 
monohydrate (COM), the metastable dihydrate (COD) and the 
unstable trihydrate (COT) [Gardner 1975; Garside et al. 1982; 
Brecevic et al . 1986]. For a given set of conditions, one of 
these phases will represent a minimum in the free energy of 
the system and will therefore be thermodynamically stable 
[Gardner 1975 ; Brecevic et al. 1986]. Other phases appearing 
under the s ame given conditions will be metastable with 
respect to the stable phase. 
The increase in growth and nucleation noted in the present 
study was confirmed by SEM which showed larger sizes and 
increased crys tal numbers of COD as a function of increasing 
oxalate conce ntrations. The presence of COD as the 
predominant phase in this study (performed at 37°C) supports 
the findings of Dent and Sutor (1971) who showed that COD 
crystallisation is the critical factor in the initiation of 
oxalate urinar y stone disease. Using an MSMPR cry.stalliser 
with artificia l urine as the crystallising medium, Miller et 
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al. (1977) also found COD crystals to be the only product 
formed. 
The present system does not allow the measurement of 
aggregation. SEM however, confirmed the occurrence of 
aggregates in some samples. 
The results of the present study are therefore in agreement 
with the general view that an increase in the urinary oxalate 
concentration increases the supersaturation leading to a 
greater risk of stone formation through a promotion of 
nucleation, growth and possibly aggregation [Robertson and 
Nordin 1976; Robertson and Peacock 1983]. 
Temperature 
The effect of temperature on the crystallisation of caox was 
investigated using a constant initiating concentration of NaOx 
of 3mmoljdm3 . The results indicate that growth rates increase 
and nucleation rates decrease with increasing temperature. 
The trends of increasing growth rates and decreasing 
nucleation rates with increasing temperature are in agreement 
with the findings of Garside et al. (1982). They explain 
these trends as being due to the presence of both stable and 
unstable phases of caox. In the present study, the favoured 
caox phases were: COT at 18•c, coo at 38•c and COM at 58·c. 
(COT and COD are thermodynamically unstable phases with 
respect to COM, and as such, have higher solubilities, 
therefore making them the kinetically favoured phases [Skrtic 
et al. 1987] ) . Using an MSMPR crystalliser with cac12 and 
Naox as the c rystallising medium, Garside et al. (1982) found 
that the nucleation of COT crystals at 9•c was higher than the 
nucleation of COM crystals at 37•c and 45•c. In further 
support of t he present study, Brecevic et al. (1989), using a 
batch crystal liser, found that COD crystals had a lower 
nucleation r a te than COT crystals when precipitated from a 
solution of c a c12 and NaOx. 
There is little variation of supersaturation with a change in 
temperature. This is not surprising since (a) temperature is 
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not taken int o account in the calculation of supersaturation 
and (b) crystallisation is initiated in each experiment via 
the same NaOx concentration. Therefore, within a sample, only 
two variables in the supersaturation calculation change at the 
different temperatures: the concentration of calcium and the 
concentration of oxalate. These changes are dependent only 
upon the change in the extent to which crystallisation occurs 
at the differ ent temperatures. Since the latter is ·small, a 
narrow range of supersaturation values occurs in these 
experiments. 
The presence of different caox hydrates has been reported at 
varying leve ls of supersaturation by Gardner (1978) and 
Gardner and Doremus (1978). They found that the main growth 
phase at low and medium supersaturation was COT while COD was 
the important growth phase at high supersaturation. Although 
there was lit tle change in the supersaturation in the present 
study, differ ent hydrates were nevertheless observed by SEM as 
mentioned e a rlier. It is therefore concluded that the 
distribution of hydrates in the present system is governed by 
temperature. 
In support o f these findings are those of Gardner (1975) who 
noted that COT crystals precipitated first at temperatures of 
10-37°C using a precipitating solution of NaOx and cac12 . 
Brecevic and Garside ( 1981) also noted the precipitation of 
only COT crystals from a solution of NaOx and CaCl2 in an 
MSMPR crysta lliser operating at 25°C. Using the same 
crystallising medium, Garside et al. (1982) reported that COT 
was the predominant phase below 25°C with COM dominating above 
30°C. In add ition, they showed that the nucleation of COT was 
greater than that of COM and concluded that the hydrate formed 
is determined by kinetic rather than thermodynamic factors. 
The suggestion by Gardner (1975) that COT undergoes a solid 
state transformation to COM is in contrast to the studies of 
Brecevic et al. (1986) whose batch experiments, using equal 
volumes of NaOx and CaCl2, suggest a solution mediated 
process. More recently, Kavanagh et al. (1993) found a 
mixture of COT and COD crystals at 37°C in minimally diluted 
(92%) urine sing an MSMPR crystalliser. 
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The mixture of hydrates obtained in the present study 
precipitated from weakly acidic solutions (pH 5) with total 
calcium and oxalate concentrations each of 10-3M. The 
presence of hydrate mixtures is in agreement with the results 
of Gardner (1975) who reported that such mixtures were formed 
in solutions of pH 4-8 with total calcium and oxalate 
concentrations in .the range 10-4M 10-2M. (The pH and 
concentrations used in the present study were within these 
ranges). 
The transformation of COT to COM 
high activati on energies of 188 
transformation have been recorded 
is temperature sensitive; 
and 109 KJfmol for this 
by Gardner (1976) and 
Tomazic and Nancollas (1979) respectively. Skrtic et al. 
(1987) have also qualitatively demonstrated the strong 
temperature dependence of the COT to COM transformation 
process in batch experiments when they identified significant 
transformation within one hour. However, the time required 
for this transformation is much longer than the time spent by 
the crystals in an MSMPR crystalliser. This implies that the 
different crystal phases are preferentially nucleating at 
different temperatures which is in agreement with the results 
of Garside et al. (1982). 
The conditions of steady state precipitation in the MSMPR 
crystalliser have been shown to produce all 3 hydrates of caox 
in the present study. It has also been shown that the hydrate 
precipitated is strongly temperature dependent and that 
formation of COT (rarely found in kidney stones) is favoured 
at lower t emperatures and COM at higher temperatures. 
Furthermore, an increase in temperature causes a greater 
increase in nucleation and growth rates than that of an 
increase in t he concentration of Naox at the temperatures and 
concentrations used. 
Citrate 
The presence of citrate in urine was first reported by Amberg 
and McClure i n 1917. An association of low citrate excretion 
and urinary stone formation was later shown by Boothby and 
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Adams ( 1934) • various investigators have therefore attempted 
to find a difference in urinary citrate excretion between 
stone formers and controls. Early research indicated that 
there was no apparent difference [Thomas and Howard 1959; 
canary et al . 1964; Robertson et al. 1968,1978; Pak et al. 
1978]. More recently however, reduced levels of citrate 
excretion have indeed been reported in stone formers [Welshman 
and McGeown 1976; Schwille et al. 1979,1982; Menon and Mahle 
1983; Nikkila et al. 1989; Sakhaee et al. 1989; Laminski et 
al. 1990; Alaverz Arroyo et al. 1992; Trinchieri et al. 1992] 
thus implying the importance of hypocitraturia as a risk 
factor in calc ium stone formation. 
Citrate-to-cal cium ratios have been measured by Parks and Coe 
(1986) and a l so Conte et al. (1989). Both studies showed a· 
reduction in this ratio in stone formers. Hobarth and 
Hofbauer (1991) have also shown lower citrate excretions in 
recurrent stone formers when compared to single stone formers 
and controls. However no significant difference between the 
latter two groups was found. Cupisti et al. (1992) have 
measured 24 hour urinary levels of calcium, oxalate and 
citrate. The y concluded that the most important abnormality 
distinguishing recurrent from single stone formers was the low 
excretion of c itrate in the former group. 
The factors responsible for decreased citrate excretion in 
stone formers have been investigated by Burr and Nuseibeh 
(1990) and a l so by Nicar et al. (1983). Burr and Nuseibeh 
(1990) found that the single most important factor related to 
hypocitraturia was low urinary potassium. They also found 
that variations in urinary volume significantly contributed to 
variations i n urinary citrate and that this was linked to 
stone disease . Nicar et al. (1983) found a positive 
correlation 
calcium and 
between urinary citrate and 





cations, calcium and magnesium, enhance citrate excretion by 
complexing cit rate and therefore inhibiting its reabsorption. 
Citrate is known to form complexes with calcium [Hastings et 
al. 1934; Nicar et al. 1983; Parks and Coe 1986]. This 
complexation is dependent upon 
decrease in t he concentration of 




al. 1993a]. Hypocitraturia would therefore 
(Tiselius et 
enhance the 
saturation of calcium salts as it would produce a greater free 
calcium ion c oncentration; the risk of caox crystallisation 
would therefor e increase (Meyer and Smith 1975]. 
Citrate is also known to be an inhibitor of caox 
crystallisation (Meyer and Smith 1975; Hallson et al. 1983; 
Ryall et al. 1985; Kok et al. 1986; Tiselius et al. 1993a] in 
vitro. Inhib ition is thought to occur as a result of the 
binding of cit rate onto the growth sites on the surface of the 
caox crystals (Kok et al. 1986; Berg and Tiselius 1989; Grases 
and Costa-Bauza 1990]. The heterogeneous growth of Caox on 
calcium phosphate is also counteracted by citrate [Berg and 
Tiselius 1989 ] . Ryall et al. (1981) showed that inhibition of 
caox growth by citrate occurred at physiological citrate 
concentrations . However, much higher citrate concentrations 
were necessary to achieve aggregation inhibition to the same 
extent. They therefore concluded that appreciable inhibition 
of caox aggregation by citrate at physiological concentrations 
was unlikely. 
On the other hand, Kok et al. {1986,1987) have shown reduced 
inhibition of aggregation, but ~ot of growth with a decreased 
citrate concentration. In later work, Kok et al. (1990) 
showed that inhibition of Caox aggregation in urine from 
controls and stone formers seeded with COM crystals, was 
related to t he citrate content in the urine. In support of 
this, Tiselius et al. {1993a) have shown inhibition of caox 
crystal aggregation by citrate. They have suggested that 
citrate might efficiently inhibit the aggregation of COM 
crystals [Tise lius et al. 1993b]. Using a suspension of COM 
crystals, they measured the rate of sedimentation in the 
presence of varying concentrations of citrate and found that 
at physiologic al concentrations, it reduced the rate of COM 
crystal sedime ntation. They concluded that the reduced rate 
of sedimenta tion reflected an inhibition of crystal 
aggregation s ince large crystal aggregates sediment more 
rapidly than s mall ones (Hess et al. 1989]. 
On the other hand, Robertson 








physiological concentrations using an MSMPR crystalliser with 
simulated whole urine conditions. Appreciable inhibitory 
activity was only noted at extremely high citrate 
concentrations . 
The results of the present experiments indicate that, above 
physiological urine oxalate concentrations, citrate (at 
physiological urine concentrations) inhibits both the growth 
and nucleation of caox, irrespective of how the citrate is 
introduced i nto the crystalliser. The inhibition of growth 
was more pronounced however in experiment 1 (when the citrate 
was added to the urine pool prior to it being pumped into the 
crystalliser) . 
Ryall et al. 
The results are in agreement with those of 
(1981) who found growth inhibition at 
physiological citrate concentrations. The results are not in 
agreement with those of Rodgers and Garside (1981) who found 
higher growth rates with increasing citrate concentration in 
an MSMPR crystalliser; however they used synthetic urine 
whereas rea l urine was used in the present study. 
Nevertheless, a decrease in growth rate is expected in the 
presence of c itrate; Rodgers and Garside accounted for their 
discrepancy as being due to the increasing solution 
supersaturation. In contrast to Robertson and Scurr (1986), 
no significant increase in the inhibition of growth above 
physiological citrate concentrations was noted in the present 
study. 
Nucleation i nhibition occurred at all citrate concentrations 
in the present study, with the exception of one sample. The 
decrease in t he nucleation rates was more pronounced at the 
high concentr ations of citrate used in experiment 2 (when 
citrate was i ntroduced into the crystalliser via a separate 
feed). The depressed nucleation rates confirm the results of 
Rodgers and Garside (1981). 
Citrate also had a significantly favorable effect on caox 
supersaturation in the present study. Experiment 1 (citrate 
concentration range: 0 to 1.530 mmolfdm3) indicated a 25% 
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reduction in the caox supersaturation ratio for the three 
samples which were tested. Experiment 2 (citrate 
concentration range: 1.071 to 7.140 mmolfdm3) led to a 35% -
60% reduction in the supersaturation for the various samples. 
Since the pre sent study has also shown that nucleation and 
growth rate s both increase with increasing caox 
supersaturation, it is concluded that citrate has a favorable 
effect on the risk of caox crystallisation in urine. 
The reduction in supersaturation observed in the present study 
is in agreement with the results of Robertson and Scurr (1986) 
and Tiselius et al. (1993a) who showed that increasing 
concentrations of citrate decreased the ion-activity product 
of caox. Ti selius et al. (1993a) found that this effect 
occurred in the acidic range but was more pronounced at 
alkaline pH. (The range of pH in the present study was 5.8 -
6.2). According to these workers, this occurs as a result of 
greater complex formation of citrate with calcium due to an 
increased diss ociation of citrate at higher pH. 
However, this decrease in caox crystallisation at alkaline pH 
occurs at t he risk of increased calcium phosphate {CaP) 
crystallisation [Tiselius 1993a). This is due to the 
preferential precipitation of CaP at alkaline pH. This in 
turn increase s the risk of heterogeneous crystallisation of 
caox on CaP. The effect of citrate on this process has been 
investigated by Berg and Tiselius (1989). They concluded that 
alkaline citrate significantly inhibited caox growth on 
hydroxyapatite and also reduced the growth of CaP. 
SEM in the present study showed both COM and COD as the 
dominant crys tal phases in contrast to Rodgers and Garside 
{1981) who, using XRD, noted predominantly COT crystals with 
only small t r aces of COD crystals. However, these workers 
conducted their experiments in a synthetic urine. In support 
of the decrea sing growth and nucleation rates with increasing 
concentrations of citrate, SEM showed that both the total 
number of c r ystals and their size {COD) decreased. An 
increase in t he number and size of COM crystals {<10~m) when 
the citrate wa s added to the pooled urine was also noted. The 
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increase in t he number of smaller crystals together with the 
decrease in t he size of COD crystals with increasing citrate 
concentration in the present study is in support of the 
findings of Tiselius et al. (1993a). They found that 
increasing concentrations of citrate shifted their size 
distributions towards smaller crystals. 
Aggregation of COD and COM crystals was only observed in the 
control samples to which citrate had not been added, implying 
that citrate inhibited aggregation. This is in support of 
results repor ted by Tiselius et al. {1993a,b), Kok et al. 
(1986,1987,1990), Grases and Costa-Bauza (1990) and also 
Robertson and Scurr (1986). 
The altered morphology of the COD crystals obtained in the 
presence of c itrate (and sometimes magnesium) in this study 
{Chapter IV, Figure 17E) has also been reported by Werness et 
al. (1981b) i n the urines of patients with urolithiasis. They 
suggest that this change in crystal morphology from the 
typical tetragonal bipyramidal ( ie octahedral) habit (to a 
twinned cryst al) may be due to the presence or absence of 
inhibitors. {The altered morphology arises from the twinning 
of four cryst als to form a single crystal with a four-fold 
rotational symmetry). 
The results of the present study have therefore demonstrated 
the inhibitory potential of citrate on both the nucleation and 
growth of caox, and also its ability to significantly reduce 
the supersatur ation with respect to caox. 
Magnesium 
Interest in t he inhibitory role of magnesium in caox stone 
formation can be traced back to Hammarsten {1929) [cited by 
Takasaki et al. 1972]. Shortly thereafter, Cramer (1932) 
[cited by Res nick et al. 1982a] demonstrated experimentally 
that dietary magnesium restriction induced urolithiasis in 
rats. Further work using animals has shown that stones 
induced by magnesium and vitamin a6 deficiency can be 
prevented by dietary magnesium supplementation [Heaton and 
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Anderson 1965 ; Lyon et al. 1966; MacManus and Heaton 1969; 
Rushton and Spector 1982]. 
Unlike citrate however, most studies have been unable to show 
lower magnes ium excretion in stone formers. Various 
investigators have reported no difference in 24 hour magnesium 
excretion bet ween stone formers and controls [Welshman and 
McGeown 1975; Robertson et al. 1978; Johansson et al. 1980a; 
Bach et al. 1981). However more recently, Trinchieri et al. 
(1992) have shown magnesium excretion was significantly 
reduced in the ir stone formers. 
Investigators have attempted to explain the inhibitory role of 
magnesium as a function of the ratio of magnesium to calcium 
concentration [Takasaki 1972; Johansson et al. 1980b]. 
Indeed, Johansson ( 1982) lists numerous papers reporting low 
magnesium: calc ium ratios in stone formers when compared to 
controls. They found that this ratio declined with increasing 
calcium values for both groups, but was lower in stone formers 
than in contro ls for corresponding calcium values. 
The role of magnesium in caox crystallisation processes is 
unknown. Depending upon its concentration, it can either 
promote or i nhibit growth [Angell and Resnick 1987]. At 
physiologic concentrations, it promotes growth but inhibits 
aggregation [Ryall and Marshall 1981]. As far as caox stone 
prevention is concerned, it is thought that magnesium plays a 
dual role [Re snick et al. 1982a]. Firstly, in vitro studies 
have shown that magnesium can increase the solubility of caox 
by forming s o luble complexes with oxalate [Hammersten (1929) 
cited by Kohri et al. 1988; Miller et al. 1958; Elliot et al. 
1965;]. Secondly, the inhibitory effect of magnesium on caox 
crystallisation appears to be related to adsorption onto the 
crystal surface thereby preventing growth through competition 
for a lattice position [Smith et al. 1973]. The first effect 
is important, as a decrease in urinary magnesium would suggest 
an increase in urinary oxalate levels and, as already 
discussed, a small increase in this parameter is more 
effective in increasing caox supersaturation than a similar 
increase in ur inary calcium concentration. 
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The effect of physiological concentrations of magnesium on 
caox crystall isation has been investigated in vitro using 
artificial and real urine. In most cases, magnesium has been 
shown to decr ease the formation of caox [Randolph and Drach 
1981; Hallson et al. 1982; Li et al. 1985; Robertson and Scurr 
1986; Kohri e t al. 1988; Rodgers and Wandt 1991). However, 
neither Rober tson et al. (1973) nor Tiselius and Fornander 
(1981) could find any inhibition of caox growth in the 
presence of magnesium. In addition, Robertson et al. (1973) 
did not observe inhibition of caox aggregation in the presence 
of magnesium. 
Desmars and Tawashi (1973), investigated the effects of 
physiological concentrations of magnesium on caox 
crystallisation in a pH adjqsted saline solution of CaCl2 an~ 
oxalic acid. They found that within the pH range 4.5 - 8.2, 
magnesium was a powerful inhibitor of COM crystal growth. 
They also f ound that alkalinization favours the growth of 
caox. 
Ryall et a l . (1981) used several inhibitors (including 
magnesium) to determine their effect on the growth and 
aggregation of caox seed crystals using a coulter Counter. 
They found t hat magnesium at concentrations between 10-7-10-4 
molfdm3 promoted growth while concentrations of 10-3 molfdm3 
inhibited growth. They also noted an increase in aggregation 
inhibition i n the presence of magnesium at concentrations 
between 10-6-10-3 molfdm3 • 
Various inves tigators have studied the role of magnesium on 
caox crystal lisation in synthetic urine using an MSMPR 
crystalliser [Li et al. 1985; Robertson and Scurr 1986; Kohri 
et al. 1988] . Li et al. ( 1985) found a reduction in the 
nucleation r a te at magnesium concentrations above 2 mmolfdm3 
and a reduction in the growth rate above 3 mmolfdm3 . 
Meanwhile Robertson and Scurr (1986), found that magnesium 
inhibited both the nucleation and growth of caox at magnesium 
concentrations above the physiological level but that no 
inhibition of aggregation occurred at any concentration of 
magnesium. Kohri et al. (1988) confirmed the findings of Li 
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et al. (1985 ) by showing that magnesium inhibited both the 
nucleation a nd growth of caox at physiological concentrations 
of oxalate a nd magnesium. However, they found that caox 
growth increa sed with increasing magnesium concentrations at 
high oxalate c oncentrations. 
The results o f the present study suggest that increasing the 
magnesium concentration retards the growth of caox at oxalate 
concentrations above the physiological range. The effect 
occurred irrespective of the manner in which the magnesium was 
introduced i nto the crystalliser. The decrease in the growth 
rate of caox was however greater in experiment 1 (when the 
magnesium was introduced into the pooled urine) rather than 
experiment 2 (when the magnesium was introduced into the 
crystalliser via a separate feed). This was also observed for 
citrate. 
No comparison can be made of the present results with those of 
Robertson and Scurr (1986) due to the large range of magnesium 
concentrations used (10-4-10-2 molfdm3 ) in their study 
relative to t he smaller range used in the present study (0 -
6.607 mmol/dm3 ). comparisons can however be made with Kohri 
et al. (1988) and Li et al. (1985) both of whom used magnesium 
concentrations in the range 0.5 - 15 mmolfdm3 • 
The inhibition of growth found in the present study is in 
agreement wit h the results of Li et al. (1985) but is contrary 
to the findings of Kohri et al. ( 1988) • The latter showed 
growth promot ion at the same oxalate concentration of 2. 5 
mmolfdm3 as t hat used in this study. This concentration is in 
the middle of the range (0.6 - 3.6 mmol/dm3 ) investigated by 
Kohri et al. (1988) and occurs where the effect of increasing 
magnesium c oncentration changes from an inhibitory to a 
promotory ro l e in their study. It is possible therefore that 
the trends r eported by these workers might also have occurred 
in the present system if oxalate concentrations greater than 
2.5 mmol/dm3 had been employed. 
In agreement with Kohri et al. (1988) and Robertson and Scurr 
(1986), the nucleation rate in the present study decreased at 
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all concentra tions of magnesium in experiment 2. However, 
experiment 1 indicated a promotion of nucleation above a 
magnesium concentration of 2.5mmolfdm3 . The increase in 
supersaturation that occurs during the rapid phase of crystal 
growth is r e lieved by an increase in the nucleation of 
crystals and possibly explains the observed promotion of 
nucleation [Robertson and Scurr 1986]. 
Like citrate , magnesium also had a favorable effect on the 
caox supersat uration. Experiment 1 (magnesium concentration 
range: 0 to 6 .607 mmolfdm3 ) indicated a reduction of 27% in 
the supersatu ration in the three samples. Experiment 2 
(magnesium c oncentration range: 1. 927 to 7. 708 mmolfdm3 ) led 
to a reduction of 26% to 37% in the supersaturation in the 
three sample s. The decrease in supersaturation with 
increasing ma gnesium concentrations is in agreement with the 
findings of Robertson and Scurr (1986) and of Kohri et al. 
( 1988) and is due to complexation of oxalate by magnesium 
ions. 
Both the t r ends in growth and nucleation rates with 
supersaturation appear to be in agreement with Kohri et al. 
(1988). The growth rate increased with increasing 
supersaturation irrespective 









increasing s upersaturation in experiment 1 and increased with 
increasing s upersaturation in experiment 2. The decrease in 
nucleation with increasing supersaturation in experiment 1 is 
unexpected. However, it is noted that Kohri et al. ( 1988) 
also found a decrease in nucleation at supersaturations above 
60. 
No obvious trends between nucleation and growth rates 
occurred. However, it is possible that the nucleation rate 
peaks at growth rates between 0 . 6 5 and o • 7 5 . On the other 
hand, the nucleation rate appears to correlate with the 
inverse of t h e growth rate at growth rates above 0.75. This 
is in agreement with the results of Kohri et al. (1988). 
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SEM in the pr esent study indicated mostly COD crystals, which 
is in agreeme nt with the observations of Kohri et al. (1988) 
who suggested that at high magnesium concentrations, a high 
supersaturation may encourage the formation of the CaOx 
dihydrate rather than the less stable trihydrate. The absence 
of COT crystals in the present study is supported by the 
findings of Li et al. (1985) who reported that magnesium 
decreases the nucleation and growth rates of COT. It is also 
known that ur inary trace elements, in particular magnesium, 
stabilize COD (Rodgers and Wandt 1991]. 
The results o f the present study have shown that magnesium 
inhibits both the nucleation and growth of caox. The ability 
of magnesium to reduce the risk of stone formation by lowering 
the supersaturation with respect to caox has also been 
demonstrated. 
Citrate and magnesium 
A comparison of the individual effects of citrate and 
magnesium add itions on the same sample indicates that citrate 
has . a greate r inhibitory effect on both the growth and 
nucleation of caox. This effect was noted in both cases where 
the inhibitor was either added to the pooled urine prior to 
being admitted to the crystalliser (experiment 1) or where it 
was incorporated via a separate feed (experiment 2). However, 
one sample i ndicated that magnesium lowered the nucleation 
rate more than citrate in experiment 2. 
Both citrate arid magnesium individually reduced the level of 
supersaturation from that of the control sample in experiment 
1. Since the concentrations of citrate and magnesium were not 
the same in t he two experiments, no conclusion can be made as 
to which inhibitor had a greater effect on the 
supersaturation. However, Tiselius ( 1991) has reported that 
citrate was more efficient than magnesium in lowering the ion 
activity product of caox. 
SEM showed t hat in the presence of citrate or magnesium alone 
(in both expe riments) COD was the predominant phase ; varying 
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amounts of COM crystals were also observed. . COT and the 
intergrowth of crystals were only present in the control 
samples which did not contain any added citrate or magnesium. 
The absence of COT crystals in the presence of magnesium is in 
agreement with the observations of Li et al. (1985) and Kohri 
et al. (1988) and suggests that COD crystals are 
preferentially formed in the presence of citrate and also 
magnesium. 
Lower concentration mixture (experiment 2) 
When a mixt ure of citrate and magnesium was used in 
concentrations at 50% of their original values, growth and 
nucleation rat es in two of the three samples were found to be 
lower than those recorded for citrate and magnesium alone. 
SEM supported the results of the kinetic experiments; on those 
occasions when SEM indicated a slight decrease in the number 
of small crys tals compared to that occurring in the presence 
of citrate or magnesium alone, the corresponding nucleation 
rates from the kinetic experiments were lower, and visa versa. 
SEM showed t hat the addition of both citrate and magnesium 
produced COD as the predominant phase with varying amounts of 
COM crystals. 
Higher concentration mixture (experiments 1 and 2) 
When the conce ntration of citrate and magnesium in the mixture 
was doubled (so that they were the same as those when they 
were individually investigated), further decreases were 
observed in t he growth rate in all six samples for the two 
experiments. For experiment 2 however, this decrease was not 
as pronounced as the decrease using the lower concentration 
mixture in the same experiment. 
The nucleation rates for all six samples in the two 
experiments were generally lower than those when magnesium 
alone was pre sent. The nucleation rates were lowered with 
respect to t he nucleation rates in the presence of citrate 
only one of the three samples in experiment 2 (but not in 
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·experiment 1) . This indicates that a combination of citrate 
and magnesium is more beneficial than using either one alone. 
In experiment 2, both instruments showed that the nucleation 
rate decreased in one sample, showed contradictory results in 
another sample , and showed an increase in the third sample 
compared to t he lower concentration mixture. 
SEM revealed that the mixture in experiment 1 caused a 
reduction in t he size of COD crystals relative to those of the 
control and i ndividual citrate and magnesium in experiment 1. 
This evidence supports the kinetically observed decrease in 
the growth rat es for the mixture compared to the growth rates 
of the control and also those of the samples involving citrate 
and magnesium alone. As was the case with the lower 
concentration mixture, SEM supported the results of the 
kinetic exper i ments; on those occasions when SEM indicated a 
decrease in t h e number of small crystals compared to citrate 
or magnesium alone, the corresponding nucleation rates from 
the kinetic e xperiments were lower than those of the latter, 
and visa versa . 
SEM revealed that the mixture in experiment 2 caused a 
reduction in t he number of large crystals with a corresponding 
small reduction in the number of small crystals. This 
supports the experimentally observed decreasing growth and 
nucleation rates for the mixture when compared to those 
obtained in experiments involving citrate and magnesium 
individually. 
Comment 
The lower inhi bitory power of the higher concentration mixture 
implies that the inhibitory effect on both nucleation and 
growth of a c ombination of citrate and magnesium is greater at 
lower concentrations of the two inhibitors. 
The decreases in both the growth and nucleation rates with a 
combination of citrate and magnesium is in agreement with the 
results of We rness et al. (1981a). Using hydroxyapatite 
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seeded crysta l growth experiments they showed that the 
inhibitory a c tivity of citrate and magnesium was additive, 
albeit in calc ium phosphate and not caox crystallisation. 
Chondroitin sulph te A 
High molecular weight molecules (macromolecules) are present 
in urine and urinary stones [Rodgers and Jappie 1996] and 
include glycoproteins (eg Tamm-Horsfall mucoprotein, 
nephrocalcin [Hess 1991)) and glycosaminoglycans (GAGs). 
GAGs are polysaccharide chains composed of repeating 
disaccharides of identical compositions [Cao et al. 1993]. In 
total there a r e 7 types of GAG, which are all sulphated except 
for hyaluronic acid [Gianotti et al. 1989). Several of these · 
are present i n urine occurring in both a free form or in 
association with proteins such as glycoproteins [Cao et al. 
1993]. 
Most studies have ascribed a major portion of the inhibitory 
activity of urine in in vitro experiments to these urinary 
GAGs [Robertson et al. 1976b; Bowyer et al. 1979; Ryall et al. 
1981; Resnick et al. 1982b; Scurr and Robertson 1986; Edyvane 
et al. 1987; Shum et al. 1988; Ryall et al. 1991; Gohel et al. 
1992] while other studies have shown urinary GAGs to be 
promoters of caox crystal nucleation [Hallson and Rose 1979; 
Drach et al. 1982; Rose and Sulaiman 1982,1984; Rodgers et al. 
1993]. 
It has been s uggested that most of the inhibitory activity of 
GAGs is due t o chondroitin sulphate (CS) [Bowyer et al. 1979; 
Ryall et al. 1981]. (CS occurs as a number of isomers with 
"A" and "C" d iffering in the positioning of the sulfate on 
carbon 4 and carbon 6 respectively) . CS (in both A and c 
forms) is t he most predominant GAG found in urine and 
constitutes a bout 55% of the total GAG content [Nishio et al. 
1985]. This has led to investigations of whether urinary GAG 
excretion is lower in stone formers relative to normals. 
Results have been conflicting with some authors confirming 
lower excretions in stone formers [Robertson et al. 1978,1984] 
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while others have failed to find a difference (Sallis et al. 
1981; samuel l 1981; Ryall . and Marshall 1983; Ryall et al. 
1987; Hwang et al. 1988]. Trinchieri et al. (1992) even 
report higher GAG excretion in their stone formers compared to 
their controls. They suggest this could be due to the higher 
urine volumes and protein intakes of their stone formers. 
Meanwhile, Gianotti et al. (1989) investigated whether it is 
more important to consider 24 hour GAG excretion or 24 hour 
GAG concentration and showed significant differences in both 
of these between their stone formers and their controls. 
The inhibitory potential of GAGs has been ascribed to either 
their degree of sulphation (Foye et al. 1976] or to their 
polyvalent anion structure [Sallis and Lumley 1979] . The 
basis for the former lies in . the belief that acidic sulphates 
have a strong affinity for calcium ions. Of particular 
interest is that both hyaluronic acid and heparan sulphate are 
the main GAGs in the matrix component of urinary calculi, 
while cs is absent [Nishio et al. 1985; Roberts and Resnick 
1986] . This implies that the former are promoters and the 
latter is an inhibitor of caox stone formation. 
The second a pproach is supported by Fellstrom et al. (1986) 
who have shown that the differences in the charge densities of 
the polyanions can explain the d.ifferences in their inhibitory 
activities. They found that the polyanions with the highest 
charge densit y (heparin and pentosan polysulphate) produced 
the strongest inhibition of caox crystal growth while weaker 
inhibition was found with CS and Tamm-Horsfall glycoprotein. 
On the other hand, Angell and Resnick (1989) obtained 
different results to those of Fellstrom et al. (1986). These 
workers showed that the binding affinity (of the GAGs tested) 
for CaOx decr eased in the order: heparin > hyaluronic acid > 
CS > pentosan polysulphate. More recently, Suzuki et al. 
(1994) showed that CS is included into caox crystals only in 
the absence of heparan sulphate. They concluded that the 
selective inclusion of GAGs 
function of their relative 
their concent ration. They 
into crystals and stones is a 
binding affinity rather than of 
further concluded that heparan 
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sulphate and cs compete for specific binding sites on the 
crystal surfac e. 
Both seeded [Robertson et al. 1973; Fellstrom et al. 1986; Kok 
et al. 1988 ; Shirane et al. 1990) and MSMPR crystalliser 
systems [Robertson and Scurr 1986; Kohri et al. 1989] have 
been used to show inhibition of caox growth and aggregation by 
GAGs. In 198 6, Springmann et al. investigated the effect of 
urine on the aggregation of caox crystals in a flow system 
using an MSMPR crystalliser with an on-line Couette 
agglomerator. The agglomerator was continuously seeded with 
crystals generated in the MSMPR crystalliser and a particle 
size distribution (PSD) of the product from the agglomerator 
was measured using a zone-sensing particle counting analyser. 
Using a synthetic urine control sample and samples containing 
5% volume in volume of urine from controls and stone formers, 
they found t hat stone formers had a greater number of large 
particles compared to controls. The effect of GAGs was not 
tested in the ir system. Nevertheless, they proposed that the 
lowered aggregation inhibition found in the stone formers was 
due to a defic iency of high molecular weight macromolecules. 
Shum and Gohel (1993) point out that GAGs tested in 
crystallisation studies are commercially prepared from the 
tissues of origin [eg Kohri et al. 1989] and contain cs 
isomers and heparin. The GAGs found in urine consist mainly 
of CS and heparan sulphate. Therefore they argue against 
using commerc ially available GAGs but recognise that until 
preparatory scale separation of these GAG classes is achieved, 
commercially available GAGs will have to be used to represent 
urinary GAG a c tivities. 
Consensus on the role of cs in caox growth and nucleation has 
not been ach ieved. In some studies it has been shown to 
inhibit growth [Crawford et al. 1968; Robertson et al. 1973; 
Ryall et al. 1981; Robertson and Scurr 1986], while others 
[Gjaldbaek 1982; Ryall et al. 1991] have failed to confirm its 
inhibitory r o le. Pak et al. (1979). and Kohri et al. (1989) 
have shown i t inhibits nucleation while Robertson and Scurr 
(1986) found promotion of nucleation. 
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Rodgers et al . ( 1994) investigated the role of chondroitin 
sulphate A (CSA) in ultrafiltered urine. Using turbidimetry 
and Malvern particle size analysis, they compared 
crystallisation in macrofiltered and ultrafiltered samples and 
observed a promotory effect for urinary macromolecules (UMM). 
However, this effect was not ascribed specifically to CSA 
since the lat ter was found to decrease the crystallisation 
rate, crystal numbers and crystal sizes of CaOx. They 
therefore suggested that CSA was an inhibitor of both CaOx 
nucleation a nd growth. Unlike the present study, their 
results were obtained in ultrafiltered samples in which UMM > 
10kD had been removed. 
Despite the l ack of consensus concerning the role of CS in 
caox nucleation and growth, many investigators have agreed 
that cs is an inhibitor of caox aggregation [Bowyer et al. 
1979; Ryall -et al. 1981; Gjaldbaek 1982; Robertson and Scurr 
1986; Scurr and Robertson 1986; Rodgers et al. 1994]. Using 
concentrations of CS in 1% urine, Ryall et al. (1981) 
concluded that a major portion of the inhibitory effect of 
urine on crystal aggregation could be ascribed to CS by 
comparing the inhibition in the presence of CS to that in the 
presence of normal 1% urine. It's effect on growth, however, 
was suggested as being due to the synergistic effects of other 
urinary const i tuents. Later work by Ryall et al. (1986,1991) 








was unlikely to 
reports, they 
contribute a 
significant proportion of the inhibitory activity of caox 
crystallisation in vitro. 
Using an MSMPR crystalliser with artificial urine as the 
crystallising medium, Robertson and Scurr (1986) observed weak 
inhibition of growth and aggregation and a small decrease in 
crystal mass due to CSA. Above physiological concentrations 
however, there was an increase in inhibition of growth and 
aggregation with a promotion of nucleation. This latter 
effect, which had also been noted by Resnick et al. (1982b) in 
their study of UMM' s on caox crystallisation, occurs as a 
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result of the need to relieve the increase in supersaturation 
during the rapid phase of crystal growth. 
Contrary to these findings, Kohri et al. (1989), also using an 
MSMPR crystalliser and artificial urine, found that CSA 
decreased the nucleation rate and increased both the growth 
rate and suspension density. 
The experiment s in the present study showed little change in 
the growth rate with increasing concentrations of CSA; however 
there was a sharp decrease in the nucleation rate. The latter 
finding is therefore in agreement with the results of Kohri et 
al. ( 1989) • A possible explanation for the small change in 
growth rates may lie in the small concentration range of CSA 
used in this s tudy. If a relative molecular mass of 50,000 is 
assumed, then the concentration range used in this study was 
2x1o-7 4x1o-7 molfdm3 which falls into a narrow band 
compared to t h e ranges of 10-6-10-8 molfdm3 used by Kohri et 
al. (1989) and 10-9-10-5 molfdm3 used by Robertson and Scurr 
(1986). The r a nge used corresponded to that occurring for GAGs 
in normal urine (as stated earlier on page 201) 
An increase i n the caox supersaturation can increase the rate 
of nucleation and growth of caox crystals. In the present 
study, the sma ll variation in the growth rate is reflected in 
the small c hange in supersaturation with increasing 
concentrations of CSA. In fact, the results indicate an 
increase in s upersaturation with increasing CSA concentration. 
This latter e f fect possibly explains the small increase in the 
growth rates noted. 
SEM revealed no change in the size of COD but a small decrease 
in the size of COT with increasing concentrations of CSA. 
This suggests that growth might be inhibited by increasing the 
concentration of CSA. Meanwhile, the observation that tiny 
crystals (<5~m ) were absent (ie only large crystals were 
noted) in the sample containing the highest concentration of 
CSA confirms the increasing growth rates. The decrease in the 
total number o f crystals with increasing concentrations of CSA 
confirms the decreasing nucleation rates observed in the 
crystallisation experiments. 
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Aggregation wa s not observed at any of the concentrations of 
CSA thereby s upporting the widely held view that CSA is an 
inhibitor of caox aggregation. 
morphology o f COM and little 
There was no change in the 
change in that of COD with 
increasing CSA concentrations. It is interesting to note that 
Shirane et al. (1994) also observed that, in the presence of 
chondroitin s ulphat_e C (CSC), there was no change in the 
morphology of COM. 
The present study has attempted to investigate the individual 
role of CSA which is the most abundantly occurring .GAG in 
urine. At the concentrations tested, the study was unable to 
conclusively s how the role of CSA with respect to its effect 
on the growth of caox. Similarly CSA had little effect on the 
supersaturation of caox. However, the inhibitory effect of 
CSA on the nucleation of caox was conclusive. Although the 
present system is unable to measure aggregation, the SEM 
observations suggest that CSA is indeed a possible inhibitor 
of this proces s. 
Concluding remarks 
It is general l y thought that citrate and magnesium exert their 
effects primarily through their ability to complex with 
calcium and oxalate respectively and thereby reduce the level 
of supersatur ation of caox. In the present study these 
inhibitors we re shown to be active within their normal 
physiological concentrations. Citrate was found to be a 
stronger inhibitor of both caox growth and nucleation than 
magnesium. Combining the two inhibitors had a favorable 
inhibitory eff ect on both the growth and nucleation within and 
above physiol ogical concentrations of the two inhibitors. 
This indicates that a combination of magnesium and citrate is 
a stronger inh ibitor than either citrate or magnesium alone. 
Both citrate and magnesium are well defined molecules and 
their urinary levels are easily manipulated by prophylactic 
treatment [Fetner et al. 1978; Johansson et al. 1980a; Hesse 
et al. 1992; Pak et al. 1992; Abdulhadi et al. 1993; Hofbauer 
et al. 1994]. The inhibitory roles of both citrate and 
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magnesium on caox crystallisation and their effect in 
increasing caox solubility as shown in the present study are 
therefore important. 
CSA on the other hand inhibited nucleation without a 
significant r eduction in supersaturation. Since it is likely 
that GAGs act by adsorbing onto the surfaces of the forming 
crystals creating an energy barrier to both crystal growth and 
aggregation [Leal and Finlayson 1977; Brockis et al. 1980; 
Fellstrom et al. 1985] rather than by forming soluble 
complexes, the small reduction in supersaturation is expected. 
No trend in t h e growth rate with increasing CSA concentration 
was indicated in the present study. However, results from the 
SEM suggest that with increasing concentrations of CSA, 
inhibition of growth might occur. 
As discussed by Rodgers et al. (1994), the charge density and 
degree of sulphation of CSA can influence the role played in 
the crystallis ation of caox [Fellstrom et al. 1986]. In that 
light, it is more meaningful to use CS fractions isolated from 
fresh human urine than to use commercially prepared samples 
from different sources. Nevertheless, information can be 
gained from the use of commercial preparations of cs (as in 
the present study); indeed, they have been used by many 
workers in pr evious studies [Ryall et al. 1981,1986,1991; 
Fellstrom et al. 1986; Grases et al. 1988,1989; Kohri et al. 
1989; Shum and Gobel 1993; Rodgers et al. 1994]. 
Synergism is l ikely to be an important factor in determining 
the role of urinary macromolecules, and as such, the role of 
CS might diffe r in the presence and absence of other urinary 
macromolecules . This might explain the reasons for the 
differing role s of CS proposed by various workers. Although 
the present s tudy of the role of CSA was conducted in a 
macrofiltered urine sample in which most of the urinary 
macromolecules were present, cognizance must be taken of the 
absence of Tamm-Horsfall mucoprotein which might have 
influenced the ultimate conclusions. 
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V.2 COMPARISON OF THE MALVERN AND 
COULTER TECHNIQUES 
The present study has revealed that the Malvern Multisizer has 
several advantages over the Coulter Counter for particle aize 
distribution analysis. These are the following. 
1. The Coulter counter has apertures that can become 
blocked; the Malvern Multisizer has no apertures. 
2. The Coulter Counter requires sample matching with a 
suitable electrolyte; the Malvern has no such requirement. 
3. The Coul ter Counter requires expensive 
standards whi ch change their size in distilled 
electrolyte [Allen 1992] leading to the 





instrument does not require calibration as it is based on the 
fundamental physical properties of light scattering. It uses 
conventional Fourier optics to transform the scattered light 
incident on the receiver lens into a diffraction pattern 
which ultimately provides a particle size distribution. 
4. The Malvern method is non-destructive and non-intrusive 
because the light intensity and wavelength are too low to 
damage the particles. Samples can thus be recovered. In the 
Malvern, samples can be measured in-situ; therefore they do 
not have to be isolated from their natural environments. On 




in the sample to be measured; this has been shown to 
fragile aggregates [Gibbs 1982; Gibbs and Konwar 
5. Fast and precise measurements (requiring one second) can 
be achieved with the Malvern, while the Coulter Counter 
requires a minimum of 7 seconds for a measurement (if no 
blockage or other complicating factors occur). 
6. In the Malvern, the entire sample is measured (ie all the 
particles pas s through the laser beam); thus the diffraction 
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pattern is r epresentative of all the particles. Continuous 
measurement allows temporal changes in the particle 
characteristic s to be determined. However, the Coulter 
Counter measures only a small volume of the sample and an 
average of a number of measurements yields the closest to a 
continuous measurement. (In practice, a continuous 
measurement i s not a viable option because too much sample 
would be requi red). 
7. The Malve rn is more versatile as it can be used with 
different types of samples that do not need to be conducting 
(or do not nee d to be compatible with a conducting medium). 
8. The Malver n is easier to operate than the Coulter Counter 
due to pre-programmed commands available in the Easy Mode 
operation. 
9. In the Malvern, a volume distribution is generated 
automatically ; furthermore, if the density is constant, the 
volume distribution is equivalent to the weight distribution. 
The Coulter Counter on the other hand calculates a number 
distribution 
distribution. 
which can be transformed to a volume 
10. The lower limit of detection of the Coulter Counter is 
higher than t hat of the Malvern. 
11. Dense or large particles are difficult to force through 
the aperture o f the coulter Counter. Such a problem does not 
arise in the Malvern. 
Both the Coult er Counter and the Malvern Multisizer have a 
wide size range. However extending the available range on 
both machines is time consuming. For the Coulter Counter, 
this would involve changing the orifice tube while for the 
Malvern it involves changing the lens. In both cases either 
re-calibration or re-focussing respectively is necessary; this 
is not always possible in kinetic measurements when time is a 
limiting factor . 
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The major adva ntage of the Coulter Counter is that it counts 
actual praticle numbers, thereby allowing the population 
density to be determined. The actual number density cannot be 
determined by the Malvern. 
Another advantage that the Coulter Counter has over the 




In the Malvern instrument, complex mathematical 
is needed. Both techniques are highly 
Experimental work using both Malvern and Coulter principles 
has recently been performed. Davies and Collins (1988) 
compared the size distribution of boron powders using both 
instruments and concluded that the Malvern yielded larger 
sizes by as much as 30%. The present study supported this 
finding with the Malvern indicating larger sizes than the 
Coulter counte r by 15%. In their studies of clays, Agrawal et 
al. (1991) r eported difficulties in comparison of monomodal 
results from the two techniques. On the other hand, Garside 
and Brecevic (1981), working on caox crystallisation in 
inorganic solutions, demonstrated good agreement in nucleation 
and growth rat es as determined by the two instruments. 
In the in vi t ro experiments of the present study, trends in 
the nucleation and growth rates for the two techniques showed 
good aggreement. In general, individual results showed 
agreement but values calculated from the Coulter Counter data 
were sometimes larger than those calculated from the 
corresponding Malvern measurements . 
nucleation a nd growth rates can be 
crystallisation during the time 
Again, these elevated 
attributed to possible 
delay associated with 
measurements using the coulter counter. 
Chigier (1984 ) has reviewed the difficulties of comparing data 
obtained from more than one instrument. He points out that 
measurements should be made simultaneously in the different 
instruments. If this is not possible then separate 
independent monitoring is needed to ensure that the conditions 
within the me asurement volume are on average identical when 
taking consecutive readings. 
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V.3 CONCLUDING COMMENTS 
In concluding this thesis, there are two questions to be 
addressed: 
(i) to what extent have the objectives been achieved? 
(ii) has this project made a contribution to existing 
knowledge i n urolithiasis research? 
The first two objectives dealt with the design, construction 
and development of an MSMPR crystalliser and a thermostatted 
flow cell. Tests using the Coulter Counter showed that the 
MSMPR crystall iser conformed to the requirements necessary to 
satisfy fundamental MSMPR crystalliser constraints. Several 
flow system de signs were developed to allow for the withdrawal 
of representat ive samples from the crystalliser. The final 
flow system de sign enabled non-invasive continuous measurement 
of the sample dispersion from the crystalliser to be effected. 
Coulter Count er and Malvern particle sizing were used 
successfully in the present study for the measurement of 
crystal size d istributions in Caox crystallisation experiments 
in undiluted urine. The on-line application of the flow cell 
is unique in t his field of study. The use of undiluted urine 
in in vitro, MSMPR crystalliser experiments is also unique. 
Furthermore, t he initiation of crystallisation by the addition 
into the cryst alliser of only NaOx rather than both NaOx and 
cac12 , represe nts yet another new approach. 
Individual and synergistic effects of the various inhibitors 
were confirmed by two different methods, thereby lending 
confidence t o the results and highlighting the potential 
therapeutic v a lue of both citrate and magnesium in preventing 
caox kidney s tone disease. That the Mal vern and Coulter 
Counter result s from the in vitro experiments showed general 
agreement and further that they supported the findings of 
other workers , indicate that the on-line Malvern flow system 
represents a satisfactory model for studying crystallisation 
in urine. 
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The objective s defined for the present study have therefore 
been achieved . 
It is suggest ed that the method outlined in this study for the 
use of an MSMPR crystalliser with an on-line Malvern Particle 
Sizer as a non-invasive, non-destructive sizing technique will 
be of benef i t to other scientists involved in the study of 
caox crystallisation. In particular, caox crystallisation 
with respect to nucleation and growth kinetics; the system 
lends itself very well for the investigation of the effects of 
a wide varie ty of crystallisation inhibitors and promoters. 
This design and its successful application using minimally 
diluted urine , suggests that the work described in this thesis 
will indeed make a meaningful contribution to existing 
knowledge in the field of urolithiasis research. 
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APPENDIX! 
Table of probability values (p) for the results from 
multiple regression analyses showing significant differences 
(p < 0.05) in the intercept and slope (from which nucleation 
and growth rates of caox were calculated) between the 
various e xperiments within each pool. p-Values are 
indicated only where a significant difference was found. 
Coulter Malvern 
Sample Intercept Slope Intercept Slope 
5 0.00001 0.00001 
6 0.0002 0.0317 
7 0.0005 0.0457 
8 0.00001 0.00001 0.0086 
9 0.00001 0.00001 0.00001 0.00001 
10 0.0405 0.0007 0.0005 
11 0.0007 
12 0.00001 0.0338 
13 0.0084 0.00001 
14 0.0433 
15 0.00001 0.0011 
16 0.0033 0.0223 0.0064 
17 0.0170 0.0003 
18 0.0352 0.0001 
19 0.00001 
20 0.0070 0.0082 0.0213 




25 0.0078 0.00001 
26 0.0005 0.0006 0.00001 0.0480 
27 0.0016 0.00001 
28 0.0261 0.0080 
29 0.0005 0.0219 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































statistical requirements for pooled urines (Jappie PhD 
Thesis UCT, 1996]. 
It is assumed that having pooled the urines from N subjects, 
a measurement of. a variable from a sample of the pooled 
urine would produce a value equal to the mean of the 
variable f r om measurements made on the N separate urines. 
The varianc es would also be expected to be the same. 
The statist ic used to determine the number of subjects for a 
particular variable is the standard deviation of the mean, 
also called the standard error {SE). TheSE is defined as 
the root of (the variance of variable)jN. Clearly, the more 
subjects p articipating in the study, the smaller the SE and 
the more r e liable the mean. As a guide to determining the 
required number of subjects, the SE is plotted against N. 
It is usefu l to have the plots for all variables on the same 
set of axes , since the required number for one variable may 
be quite different from that for another. However, since 
the SE's o f the variables may differ markedly, they may be 
expressed relative to the corresponding means, which 
produces a ratio, SEjmean, which is independent of units. 
The plot s hows the relationship between this statistic and N 
for all var iables using experimental data. 
From the p lot it is apparent that Na (sodium) shows the 
greatest va riation, relative to the mean, and CREAT the 
least varia tion. Note that the results for CIT and Cl are 
virtually i dentical, so that their symbols overlap. From 
the plot i t is seen that once more than 5 urines are pooled, 
there is a smaller error in the measured variables when 
compared t o pooling less than 5 samples. Also, there is 
little change in this error (ie graphs level off) after 5 
urines and therefore this must be the minimum number of 
urines that must be pooled to ensure that the variation of 
the measure d variables will be at a minimum and will also be 
the same be tween pools. 
06 
















Appendix 3 (cont) 
TAP WATER DATA 
10 
~or SUJJECTS 
VNllA!l[ ............... CA 8--B-8 IIC ~ ~ ~ K ¥--¥--¥ OX 
e---r-e en ~ IJlAT£ ....._.. CREAl ._..... PI()S ~ a. 
APPENDIX4 
Composition of each of the pooled samples. 
are in mmolfdm3 . 
Sample pH citrate oxalate calcium 
5 6.25 1.51 0.93 2.5 
6 6.35 1.92 0.48 2.0 
7 6.15 2.71 0.50 3.6 
8 6.35 2.01 0.66 2.3 
9 5.95 2.00 0.52 3.3 
10 5.85 2.00 0.75 2.3 
11 6.25 1. 60 0.38 1.7 
12 6.20 1. 34 0.36 1.5 
13 6.20 1. 53 0.41 1.8 
14 6.20 1.12 0.52 3.1 
15 6.35 1.02 0.46 1.5 
16 6.25 1.19 0.53 2.4 
17 6.15 1.45 0.64 2.5 
18 6.15 1. 37 0.57 2.5 
19 6.00 1.43 0.63 2.8 
20 6.35 0.57 0.46 1.9 
21 5.90 1. 04 0.41 1.9 
22 6.00 0.78 0.41 2.1 
23 5.95 1.26 .o. 43 3.2 
24 6.00 1.22 0.63 2.3 
25 6.25 1. 52 0.49 2.5 
26 6.25 1.28 0.48 3.1 
27 6.10 1.16 0.54 2.0 
28 6.10 1.50 0.52 2.9 
29 5.90 1.80 0.64 2.5 
30 5.90 1.21 0.68 2.7 































Sample sodiun potassium urate creatinine phosphate Cl-
5 78.2 24.1 2.1 8.6 21.2 85 
6 21.6 13.1 1.5 5.9 11.6 64 
7 66.7 16.6 2.2 9.2 22.9 115 
8 28.2 9.6 1.9· 6.7 18.7 70 
9 84.9 40.7 2.0 8.2 23.0 85 
10 60.1 23.1 1.8 7.2 17.5 53 
11 54.4 37.1 1.6 6.2 14.6 55 
12 68.5 39.6 1.0 6.2 16.1 87 
13 56.4 29.8 1.7 6.6 14.8 57 
14 66.8 37.7 1.4 6.8 16.8 82 
15 41.5 28.0 1.0 5.4 11.9 53 
16 45.3 27.5 1.7 5.5 14.8 54 
17 52.6 38.7 1.6 7.1 17.5 73 
18 62.0 33.0 1.8 7.7 15.7 64 
19 53.7 24.6 1.7 7.7 13.7 47 
20 59.8 21.6 1.5 7.3 13.8 75 
21 48.8 25.8 1.8 6.6 15.0 74 
22 53.8 27.5 1.7 7.0 16.4 73 
23 59.8 29.5 2.0 8.0 20.9 82 
24 60.4 26.1 1.9 7.8 18.8 78 
25 59.8 25.6 1.9 8.0 19.5 75 
26 56.3 39.7 1.7 8.3 21.2 88 
27 77.3 26.9 1.9 8.3 20.8 82 
28 52.4 41.8 1.6 9.2 16.4 95 
29 49.9 32.4 1.6 9.5 18.3 64 
30 58.2 27.0 1.8 9.1 20.4 63 
31 55.8 38.0 1.8 9.1 18.8 72 
